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Substantial efforts have been made to improve the reproducibility and reliability of scien-
tific findings in health research. These efforts include the development of guidelines for the
design, conduct and reporting of preclinical studies (ARRIVE), clinical trials (ROBINS-I,
CONSORT), observational studies (STROBE), and systematic reviews and meta-analyses
(PRISMA). In recent years, the use of prediction modelling has increased in the health
sciences. Clinical prediction models use information at the individual patient level to
estimate the probability of a health outcome(s). Such models offer the potential to assist in
clinical decision-making and to improve medical care. Guidelines such as PROBAST
(Prediction model Risk Of Bias Assessment Tool) have been recently published to
further inform the conduct of prediction modelling studies. Related guidelines for the
reporting of these studies, such as TRIPOD (Transparent Reporting of a multivariable pre-
diction model for Individual Prognosis or Diagnosis) instrument, have also been developed.
Since the early 2000s, oral health prediction models have been used to predict the
risk of various types of oral conditions, including dental caries, periodontal diseases and
oral cancers. However, there is a lack of information on the methodological quality and
reporting transparency of the published oral health prediction modelling studies. As a
consequence, and due to the unknown quality and reliability of these studies, it remains
unclear to what extent it is possible to generalise their findings and to replicate their
derived models. Moreover, there remains a need to demonstrate the conduct of prediction
modelling studies in oral health field following the contemporary guidelines. This doctoral
project addresses these issues using two systematic reviews and two empirical analyses.
This thesis is the first comprehensive and systematic project reviewing the study quality
and demonstrating the use of registry data and longitudinal cohorts to develop clinical
prediction models in oral health.
Aims
• To identify and examine the quality of existing prediction modelling studies in the
major fields of oral health.
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• To demonstrate the conduct and reporting of a prediction modelling study following
current guidelines, incorporating machine learning algorithms and accounting for
multiple sources of biases.
Methods
As one of the most prevalent oral conditions, chronic periodontitis was chosen as the
exemplar pathology for the first part of this thesis. A systematic review was conducted
to investigate the existing prediction models for the incidence and progression of this
condition. Based upon this initial overview, a more comprehensive critical review
was conducted to assess the methodological quality and completeness of reporting for
prediction modelling studies in the field of oral health. The risk of bias in the existing
literature was assessed using the PROBAST criteria, and the quality of study reporting
was measured in accordance with the TRIPOD guidelines.
Following these two reviews, this research project demonstrated the conduct and
reporting of a clinical prediction modelling study using two empirical examples. Two
types of analyses that are commonly used for two different types of outcome data were
adopted: survival analysis for censored outcomes and logistic regression analysis for binary
outcomes. Models were developed to 1) predict the three- and five-year disease-specific
survival of patients with oral and pharyngeal cancers, based on 21,154 cases collected
by a large cancer registry program in the US, the Surveillance, Epidemiology and End
Results (SEER) program, and 2) to predict the occurrence of acute and persistent pain
following root canal treatment, based on the electronic dental records of 708 adult patients
collected by the National Practice-Based Research Network. In these two case studies,
all prediction models were developed in five steps: (i) framing the research question; (ii)
data acquisition and pre-processing; (iii) model generation; (iv) model validation and
performance evaluation; and (v) model presentation and reporting. In accordance with the
PROBAST recommendations, the risk of bias during the modelling process was reduced
in the following aspects:
• In the first case study, three types of biases were taken into account: (i) bias due to
missing data was reduced by adopting compatible methods to conduct imputation;
(ii) bias due to unmeasured predictors was tested by sensitivity analysis; and (iii)
bias due to the initial choice of modelling approach was addressed by comparing
tree-based machine learning algorithms (survival tree, random survival forest and
conditional inference forest) with the traditional statistical model (Cox regression).
• In the second case study, the following strategies were employed: (i) missing data
were addressed by multiple imputation with missing indicator methods; (ii) a multi-
level logistic regression approach was adopted for model development in order to fit
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the hierarchical structure of the data; (iii) model complexity was reduced using the
Least Absolute Shrinkage and Selection Operator (LASSO) for predictor selection;
and (iv) the models’ predictive performance was evaluated comprehensively by
using the Area Under the Precision Recall Curve (AUPRC) in addition to the Area
Under the Receiver Operating Characteristic curve (AUROC); (v) finally, and most
importantly, given the existing criticism in the research community concerning the
gender-based and racial bias in risk prediction models, we compared the models’
predictive performance built with different sets of predictors (including a clinical set,
a sociodemographic set and a combination of both, the ‘general’ set).
Results
The first and second review studies indicated that, in the field of oral health, the popularity
of multivariable prediction models has increased in recent years. Bias and variance are
two components of the uncertainty (e.g., the mean squared error) in model estimation.
However, the majority of the existing studies did not account for various sources of
bias, such as measurement error and inappropriate handling of missing data. Moreover,
non-transparent reporting and lack of reproducibility of the models were also identified in
the existing oral health prediction modelling studies. These findings provided motivation
to conduct two case studies aimed at demonstrating adherence to the contemporary
guidelines and to best practice.
In the third study, comparable predictive capabilities between Cox regression
and the non-parametric tree-based machine learning algorithms were observed for
predicting the survival of patients with oral and pharyngeal cancers. For example, the
C-index for a Cox model and a random survival forest in predicting three-year survival
were 0.82 and 0.84, respectively. A novelty of this study was the development of an
online calculator designed to provide an open and transparent estimation of patients’
survival probability for up to five years after diagnosis. This calculator has clinical
translational potential and could aid in patient stratification and treatment planning,
at least in the context of ongoing research. In addition, the transparent reporting of
this study was achieved by following the TRIPOD checklist and sharing all data and codes.
In the fourth study, LASSO regression suggested that pre-treatment clinical factors
were important in the development of one-week and six-month postoperative pain following
root canal treatment. Among all the developed multilevel logistic models, models with a
clinical set of predictors yielded similar predictive performance to models with a general
set of predictors, while the models with sociodemographic predictors showed the weakest
predictive ability. For example, for predicting one-week postoperative pain, the AUROC
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for models with clinical, sociodemographic and general predictors were 0.82, 0.68 and
0,84, respectively, and the AUPRC were 0.66, 0.40 and 0.72, respectively.
Conclusion
The significance of this research project is twofold. First, prediction models have been
developed for potential clinical use in the context of various oral conditions. Second, this
research represents the first attempt to standardise the conduct of this type of studies in
oral health research. This thesis presents three conclusions: 1) Adherence to contemporary
best practice guidelines such as PROBAST and TRIPOD is limited in the field of oral
health research. In response, this PhD project disseminates these guidelines and leverages
their advantages to develop effective prediction models for use in dentistry and oral health.
2) Use of appropriate procedures, accounting for and adapting to multiple sources of bias
in model development, produces predictive tools of increased reliability and accuracy
that hold the potential to be implemented in clinical practice. Therefore, for future
prediction modelling research, it is important that data analysts work towards eliminating
bias, regardless of the areas in which the models are employed. 3) Machine learning
algorithms provide alternatives to traditional statistical models for clinical prediction
purposes. Additionally, in the presence of clinical factors, sociodemographic characteristics
contribute less to the improvement of models’ predictive performance or to providing
cogent explanations of the variance in the models, regardless of the modelling approach.
Therefore, it is timely to reconsider the use of sociodemographic characteristics in clinical
prediction modelling research. It is suggested that this is a proportionate and evidence-
based strategy aimed at reducing biases in healthcare risk prediction that may be derived
from gender and racial characteristics inherent in sociodemographic data sets.
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It has long been recognised that prediction models hold the potential to benefit clinical
decision-making, health care policy making and to improve patients’ health outcomes.
Though prediction modelling represents an important element in the armamentarium of
oral health promotion strategies, the clinical use of such models remains sparse due to
their unknown reliability and reproducibility. Providing comprehensive insights into these
aspects of clinical prediction modelling studies in the oral health context forms the basis
of this PhD research.
Section 1.1 of this chapter introduces the background to the body of research under-
pinning this thesis. Section 1.2 summarises the current context and thereby identifies gaps
in the existing body of knowledge. Section 1.3 provides the research questions and aims of
the current research. Section 1.4 presents the original contributions of the project to the





Oral diseases represent a major public health concern worldwide. In 2019, The Lancet
published two articles (Peres et al., 2019; Watt et al., 2019) calling for radical actions
to end the global neglect of oral health. The urgency and importance of this call were
underpinned by the high prevalence and inequalities in oral diseases, and the adverse
impacts they bring to the quality of life for afflicted individuals. Oral diseases include
a variety of acute, aggressive and chronic oral conditions that affect the teeth, tongue,
mouth and surrounding tissues. Globally, the top three most prevalent oral diseases are
dental caries, periodontal diseases, and oral cancers (James et al., 2018). To tackle this
global health challenge, there is a need for a range of oral health care strategies, including
prevention, early detection and specific, appropriate treatment regimes. These activities
benefit from prediction modelling research because prediction can inform the risk of
developing a disease or estimate the outcomes of a course of treatment, thereby assisting
in clinical decision-making. For example, prediction can help oral health professionals
to identify populations who are at high risk of developing oral diseases and inform the
appropriate response in framing early intervention opportunities.
Clinical prediction models (also known as risk prediction models, clinical prediction
rules) have been known for more than 30 years in health and medical research. A typical
example is QRISK (Anderson et al., 1991), a model used for predicting cardiovascular
risk and assisting clinicians in identifying and formulating early interventions suitable
for individual patients. In the field of oral health, clinical prediction models also play an
important role and have garnered considerable interest from both researchers and oral
health care practitioners. Using these data-driven predictive tools, oral health professionals
seek to achieve better diagnoses and prognoses for a number of oral diseases, including
dental caries (Abernathy et al., 1987), periodontal diseases, (Lai et al., 2015), tooth loss
(Krois et al., 2019), fracture of dental ceramics (Ren and Zhang, 2014), and oral cancers
(Kim et al., 2019).
Clinical prediction models can be categorised into diagnostic and prognostic variants
(Steyerberg et al., 2019). A diagnostic model is developed to estimate the risk of having
a disease. A prognostic model is used to predict the probability of the progression and
prognosis of a disease (e.g., cancer survival). A prediction model allows questions such as:
‘What is the risk of achieving a specific health outcome for a population at a specific time,
given the data available at that time?’ to be answered. From this question, it can be seen
that there are four key components of a clinical prediction model: a target population, a
specific health outcome to be predicted, information characterising the population, and an
1.1 Background 3
underpinning algorithmic mathematical or statistical model. These four elements include
the following characteristics:
• Target population: The population of interest.
• Outcome: What are we predicting?
• Available information used: This usually includes an individual’s demographics,
clinical characteristics, laboratory test results, and other variables of individual
members of the target population. Various sources of data can be used in prediction
modelling research. These include longitudinal cohorts, cross-sectional and case-
control studies, clinical trials and electronic medical records.
• Modelling approach: A mathematical/statistical/data dependent algorithm that de-
scribes how the model outcomes have been generated from available data. These
approaches to modelling can be broadly classified into two categories: statistical
models and machine learning algorithms.
Once a model is developed, its predictive outcomes must be communicated to other
researchers and potential users, including clinicians and data custodians. A common way
to present such a clinical prediction model is to report the models’ characteristics (e.g., its
variables’ corresponding coefficients) along with its predictive ability (i.e., how well the
model can predict the outcome). The performance/capability of a prediction model can be
evaluated using a range of metrics, including the models’ ability to distinguish the positive
from the negative observations (referred to as ‘discrimination’), and its ability to achieve a
predicted probability as close as possible to the observed ones (referred to as ‘calibration’).
Therefore, the primary goal of a prediction modelling study is to optimise the performance
metrics used in the evaluation as determined by the reduction in the squared difference
between the predicted and the observed values (referred to as mean square error, MSE).
The MSE can be described as the total of Bias2 +Variance. By reducing the MSE, both
the bias and the variance are minimised. Keeping the MSE low may, in the absence of
any additional contributions from the unmeasured data, enhance the generalisability and
applicability of prediction models and their outputs from one study to another.
Once the model and its predictive ability are presented, assessing the quality, relia-
bility, and clinical impact of the model become important for other researchers and end
users of the model (e.g., clinicians and policy makers). These assessments not only help
to answer questions such as: ‘To what extent can we trust the developed models?’, but
also encourage model developers to consider a range of aspects which may improve the
quality of their prediction modelling studies. These aspects include (but are not limited
to): data quality, appropriate approaches used for capturing the relationship between the
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variables, models’ interpretability, models’ ease of use and result interpretation, and the
study reproducibility.
• Data quality concerns the consistency of collection and coding of the variables
in multiple data sets. This includes defining data dictionaries, using consistent
definitions and measurement systems for variable values. If the collected data has
subtle biases (e.g., measurement error), then the models will incorporate these errors
and generate biased estimates as a consequence. Additionally, data quality also
relates to data completeness and addresses questions concerning the proportion of,
and reasons for, missing information. Missing data occur when data values are not
observed and recorded for any given variable in a sample. Multiple studies have
shown that missing data may compromise the validity of study findings in clinical
trials (Little et al., 2012), observational cohort studies (Howe et al., 2016), and
studies using electronic health records (Petersen et al., 2019; Stiglic et al., 2019).
• Modelling approaches concern the model’s complexity (e.g., how long does it take
to train the model?), the model’s interpretability (e.g., can every step of the model
be understood?), the model’s ability to reflect the data generating mechanism (e.g.,
what, if any, are the pre-defined assumptions relating to the relationships between
variables?).
• The reproducibility of a study concerns the transparent reporting of the conduct
of a study and how easily it may be replicated. These considerations relate to
the various stages of modelling, including the selection procedure for participants,
the definition of predictors and outcomes, the consistent measurement of variables
and their values, consideration and accommodation of missing data, methods and
codes used in statistical analyses, and the methods used for evaluating the models’
performance evaluation.
As has been observed over recent decades, it is not unusual for clinical prediction
models to outperform human clinical judgement alone (Ægisdóttir et al., 2006; Wiggins,
1981; Zellner et al., 2021). The capacity of prediction models to assist with clinical
activities has led to a continual increase in the number of publications discussing prediction
models (Steyerberg et al., 2019). As shown in Figure 1.1, in the 1960s, there were fewer
than 10 publications listed on PubMed with the terms ‘prediction model’ or ‘prognostic
model’, as compared to over 3500 identified in 2020.
1.2 Gaps in the existing research
Though the number of prediction models is increasing, the implementation of these models
in clinical practice has remained stagnant. Potential reasons, reported in the literature
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Figure 1.1: Number of publications per year listed in PubMed searched by title and abstract
‘prediction model’ OR ‘prognostic model’ OR ‘diagnostic model’ up to 2021 (searching was
conducted on 18th March 2021).
such as The Lancet - Digital Health (Futoma et al., 2020) and Nature - Digital Medicine
(Sutton et al., 2020), include inter alia: (i) poor generalisability and predictive performance
with respects to discrimination and calibration when used with new populations, (ii) the
paucity of evidence to indicate models can improve patients’ health outcomes and aid
in clinical decision-making, and (iii) doubt surrounding the quality of the studies used
to develop the models. This thesis aims to address the third concern. The first research
gap identified for this PhD project is the dearth of evidence addressing the quality of the
published prediction modelling studies in the field of oral health.
The second research gap is the need to ensure the quality of prediction modelling
studies. In recent years, researchers have developed methodological guidelines such as
CHARMS (CHecklist for critical Appraisal and data extraction for systematic Reviews
of prediction Modelling Studies) (Moons et al., 2014) and PROBAST (Prediction model
Risk Of Bias ASsessment Tool) for conducting prediction modelling studies (Moons et al.,
2019). Additionally, reporting checklists such as TRIPOD (Transparent Reporting of
a multivariable prediction model for Individual Prognosis Or Diagnosis) (Collins et al.,
2015) have also been developed to guide researchers on the reporting of findings from
this type of study. However, the use of these guidelines is sparse in oral health prediction
modelling research. Implementation of the PROBAST strategy suggests there is a need
to address the common types of biases arising from prediction modelling studies which
include, for example, measurement error and anomalies arising from missing data.
1.3 Aims
The overall purpose of this research was to establish a better understanding of prediction
modelling studies in oral health, thereby contributing to new knowledge that may be
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useful in dental practice. This thesis presents the findings of the research conducted in four
separate but interrelated studies.
Studies 1 and 2 comprise the first half of this thesis and formed the basis of the
remaining chapters. Studies 3 and 4 form the second half of this thesis and demonstrate
the incorporation of multiple sources of bias and the applications of machine learning
methods in oral health prediction. The research aims and objectives are:
Aim of Study 1: To investigate the quality of prediction modelling studies in pe-
riodontology, one of the major disciplines of oral health.
Aim of Study 2: To identify the best available evidence addressing the overall
quality of oral health prediction modelling research and to present optimal contemporary
methodological standards and reporting guidelines for conducting prediction modelling
studies.
• Objective 1: to examine the risk of bias of recent oral health prediction modelling
studies, using the PROBAST instrument.
• Objective 2: to examine the completeness and transparency of reporting of these
studies using the TRIPOD instrument.
Aim of Study 3: To account for some of the identified biases (missing data, unmeasured
predictors) in the existing literature, and to demonstrate the conduct of a prediction
modelling study designed to predict the survival probability for patients with oral and
pharyngeal cancers.
• Objective 1: to develop prediction models and a web-based calculator for estimating
the three- and five- year disease-specific survival of oral and pharyngeal cancer
patients, using cancer registry data.
• Objective 2: to compare the predictive capability of Cox proportional hazard regres-
sion, a traditional statistical method, with machine learning methods (e.g., survival
tree and random survival forest).
Aim of Study 4: To account for some of the potential biases in model development when
using multilevel oral health data by conducting a predictive case study of predicting acute
and persistent pain following root canal treatment.
• Objective 1: to use a prospective cohort data set (containing sociodemographic and
clinical characteristics) to develop models for predicting the postoperative pain for
patients who received root canal treatment.
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• Objective 2: to demonstrate the conduct of predictor selection using multilevel
machine learning algorithms.
• Objective 3: to demonstrate the use of precision-recall curves for assessing the per-
formance of prediction models when the distribution of outcome data is imbalanced.
• Objective 4: to increase the research focus on effective strategies to incorporate
sociodemographic variables when developing clinical prediction models.
1.4 Original contributions
The major contributions of this research work can be outlined as follows:
1. The best available evidence in prediction modelling research in the major fields of
oral health has been identified and collated. Moreover, the quality of existing studies
has been evaluated by applying two validated and accepted quality assessment tools
to these studies.
2. This work has led to the publication of a number of relevant papers and presentations
at (inter)national conferences. These focus attention on the need for researchers
to improve the quality (including reliability and reproducibility) of oral health
prediction modelling studies.
3. This research clearly identifies that multiple types of biases (e.g., inappropriate
handling of missing data, unmeasured predictors, modelling uncertainty) can arise
during the prediction modelling process. Using two empirical case studies, this
research demonstrates how these biases can be avoided in prediction modelling and
how the results from such analyses can be presented and reported.
4. Models have been developed for predicting the outcome of various oral diseases, such
as the disease-specific survival of oral and pharyngeal cancers and pain following
a common endodontic treatment. This thesis describes the application of machine
learning algorithms for oral health prediction purposes and has provided a potentially
useful translation of the research findings into clinical practice by developing a user-
friendly, web-based application.
1.5 Thesis Structure
This thesis is a result of a PhD project funded by the Adelaide University China Fee
Scholarship at the University of Adelaide, carried out by Mi Du under the supervision of
Dr. Murthy Mittinty, Dr. Dandara Haag, and Prof. John Lynch.
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This thesis has been structured in publication format and comprises eight chapters.
Peer-reviewed papers published or submitted for publication have been included in relevant
chapters. Additional chapters including the Introduction, Research Context, Methodology,
Discussion and Conclusion have been provided to give the readers a clear description of
the research undertaken.
The remainder of this thesis is organised as follows:
• Chapter 2 provides a comprehensive review of prediction epidemiology in oral health
and reviews the commonly used practices and their limitations for the development
of clinical prediction models.
• Chapter 3 describes the various research methods used in each of the four studies in
this thesis, as well as the data sources used in the empirical analysis.
• Chapter 4 identifies the existing prediction models in periodontology, one of the
major oral health areas. A systematic review published in the Journal of Clinical
Periodontology is included in this chapter.
• Chapter 5 examines the overall quality (including methodological bias and report-
ing transparency) of prediction modelling studies in oral health. A review article
published in the Journal of Dental Research is included in this chapter.
• Chapter 6 reports the use of multiple statistical and tree-based machine learning
methods to develop prediction models for estimating the three- and five-year survival
probability of patients with oral and pharyngeal cancers. An original research article
published in Cancers is included in this chapter.
• Chapter 7 presents the use of multilevel machine learning models, incorporating
sociodemographics and clinical information, to predict acute and persistent pain
following root canal treatment. This chapter is presented in publication format
submitted to the Journal of Dental Research.
• Chapter 8 presents a discussion of the main findings, strengths, limitations, and
implications of the research, as well as an overall conclusion.






This chapter presents a summary of descriptive epidemiology in the context of major oral
health conditions along with a detailed literature review of predictive epidemiology in the
oral health field.
There are eight sections in this chapter. Section 2.1 presents a brief review of the major
burden of the three most prevalent oral diseases – dental caries, periodontal diseases, and
oral cancers. Sections 2.2 and 2.3 introduce the general concepts of clinical prediction
modelling research, followed by their contributions to oral health promotion in Section
2.4. Section 2.5 reviews the step-by-step procedure for conducting a clinical prediction
modelling study: from data preparation to model performance evaluation. Of special
interest, with the advancement of machine learning methods, we also look at the current
application and evolution of machine learning algorithms in oral health-related prediction
research in Section 2.6. Section 2.7 provides guidelines on choosing between statistical
models and machine learning algorithms for prediction purposes. We then investigate the
potential limitations of the commonly used practices in clinical prediction modelling in
Section 2.8. In alignment with the guidelines - PROBAST instrument, this section starts
by understanding potential bias during clinical prediction modelling (e.g., selection bias,
measurement error, overfitting/underfitting) and ends by discussing current efforts and




• What is the major burden of oral diseases worldwide?
• What role does prediction modelling research play in promoting oral health?
• How are clinical prediction models developed?
• What are the limitations of the existing methods for conducting clinical prediction
modelling?
• Why does bias matter in prediction modelling?
• How does bias arise during prediction modelling?
• What are the common sources of bias in prediction modelling study?
• How can researchers reduce these biases?
2.1 Overview of oral diseases burden
Most oral diseases do not cause death but have been identified as a major public health
burden worldwide due to their high prevalence and adverse impact on the quality of life.
The top three most prevalent oral conditions are periodontal diseases, dental caries (tooth
decay), and oral cancers. According to the estimates by the Global Burden of Disease
study 2017 (James et al., 2018):
• About 2.3 billion people (1/3 of the global population) suffer from caries of perma-
nent teeth. The plaque on the surface of a tooth can lead to dental caries and destroy
the teeth over time. Risk factors for dental caries include bacteria deposits, poor
oral hygiene, frequent exposure to sugar contained diets, developmental defects of
tooth enamel, family history of caries, poor oral health habits (e.g., inadequate tooth
brushing or dental care).
• Two common types of periodontal disease are gingivitis and periodontitis. Peri-
odontal diseases affect the tissues that surround the teeth, therefore they are usually
characterised by swollen or bleeding gums, causing teeth to become loose and even
fall out. Gingivitis is a common oral condition in children and adolescents and it
can be prevented by improving oral hygiene. Periodontitis has several forms, with
aggressive periodontitis occurring more commonly in children and adolescents while
chronic periodontitis is more prevalent in adults. Severe periodontitis is affecting
almost 10% of the global population. The common risk factors for periodontal
diseases include smoking, systemic conditions such as diabetes, stress, and human
immunodeficiency virus (HIV) (Scannapieco and Gershovich, 2020).
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• Oral and pharyngeal cancers represent the eighth most prevalent cancer worldwide
among the male population and are one of the three most common cancers in some
countries of Asia and the Pacific. According to the American Cancer Society, the
estimated new cases and deaths due to oral oropharyngeal cancers are 54,010 and
10,850 in the US for 2021 (American Cancer Society, 2021). Based on the Interna-
tional Disease Classification (ICD) 10th edition, oral and pharyngeal cancers (ICD
C00-C14) usually include cancers of the lip, tongue, salivary glands, oropharynx,
hypopharynx, nasopharynx, and other surrounding sites in the mouth. Risk factors
for oral and pharyngeal cancers include smoking, tobacco consumption, alcohol
consumption, viruses such as human papillomavirus (HPV), and recurrent oral
inflammation (Shield et al., 2017).
Despite considerable progress being made to understand the causes of the major oral
diseases, the burden of oral conditions worldwide persists and may have even become more
severe (Kassebaum et al., 2017; Watt et al., 2019). To reverse the trend, clinical dentistry
adopts a treatment/intervention-dominated approach to care. All of these interventions
and clinical activities rely on evidence-based dentistry, which requires joint efforts from
dental practitioners, epidemiologists, biostatisticians, ethicists, and others. These efforts
have multiple aims, covering the causal exploration, disease prevention, early detection,
treatment decision, and treatment effect evaluation. Among most of those aims, predictive
modelling research can play important roles, such as identifying the risk factors for a
disease, early detection of the occurrence of an adverse health outcome, and predicting the
treatment effect of a specific therapy.
2.2 What are clinical prediction models?
Clinical prediction models (also named clinical prediction rules or risk scores) are mathe-
matically derived tools that predict the health outcomes of interest and inform evidence-
based clinical decisions (Kuhn et al., 2013). Since 2000, the number of studies describing
the development (and the validation) of clinical prediction models has been increased.
A well-known example for clinical prediction models is QRISK for cardiovascular risk
(Anderson et al., 1991; Hippisley-Cox et al., 2008). Models such as this are being im-
proved constantly to predict outcomes covering numerous disease areas, including cancers,
obstetrics, diabetes respiration diseases, and oral conditions.
What is prediction modelling in the first place? Over decades, the discussion of
explanation versus prediction has been actively pursued in the philosophy of science,
however, since statistical modelling can be and is used for each of these goals, there has
been confusion between causal explanation and empirical prediction. Statistical models
are initially and mostly used for causal explanation and inference (the ultimate goal of
scientific research). Models with high explanatory (causal) power are often assumed
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to possess predictive power, which may not necessarily be the case. Depending on the
focus of a study (explanatory or predictive), there are important differences in the design
and data analysis methodology for explanatory and prediction modelling. The work by
(Shmueli, 2010) ‘To Explain or to Predict?’ provides a detailed discussion/guidance on
this. Similar to Shumeli, Hernán (Dickerman and Hernán, 2020; Hernán et al., 2019)
and van Geloven and colleagues (van Geloven et al., 2020) also highlight the difference
between (factual/observed) prediction and counterfactual prediction (causal inference)
in European Journal of Epidemiology. Based on these works, we briefly summarise the
differences between explanatory and prediction models in Table 2.1. More considerations
on factual/observed prediction v. counterfactual prediction (causal inference) can be found
in Chapter 8.
Table 2.1: Distinction between explanatory and prediction models.
Explanatory Models Prediction Models
Goal Establish causal relationships
(estimating the distribution of
an outcome under hypothetical
interventions)
Estimate the probability of an
event in binary or categorical
outcome variable or estimate
the conditional mean of a con-
tinuous outcome variable
Candidate variables Expert-specified risk factors and
confounders (common causes)
identified through an explicit
causal diagram
A larger set of potential pre-
dictors; Causal relationship
not required











Model estimates of in-
terest
Size of β coefficients;
Effect size measures (e.g., odds
ratios)
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[1]AUROC: Area Under the Receiver Operating Characteristic curve
2.3 Types of clinical prediction modelling studies
The studies used to develop, validate, and test the effect of clinical prediction models
are called clinical prediction modelling studies. It is common to classify multivariable
prediction modelling studies into four groups: (i) predictor finding studies; (ii) model
development studies; (iii) external validation studies; and (iv) model impact studies. Most
clinical prediction modelling studies describe both the development and internal/external
validation of new models. Relatively fewer studies investigate the evidence of models’
impact (e.g., improving patients’ outcomes) and widespread implementation of these
developed models (clinical application) is rare. The four types of multivariable prediction
modelling studies can be defined as follows, and this thesis covers the second and third
categories:
1. Predictor finding studies:
These studies, alternatively known as predictor importance studies, allows identifying
which variables (also namely predictors, characteristics, covariates, factors, features,
markers, etc.) from a number of possible predictors contribute to the prediction of a health
outcome (Altman and Lyman, 1998; Hayden et al., 2008; Moons et al., 2009). However,
identifying the ‘significant’ predictors does not translate to its ability to discriminate
‘cases’ and ‘non-cases’.
2. Model development studies:
The process of model development can be summarised as follows: 1) selecting
predictors from a candidate set; 2) assigning the weights for each predictor (e.g., the β
coefficients) in some kind of multivariable analysis; and then 3) combining them by a
mathematical function to yield accurate forecasts when new observations are given. The
main difference between the Predictor finding studies and Model development studies is
that the latter builds a final multivariable predictive model using the predictors identified
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by the former (Royston et al., 2009; Sterne et al., 2009).
3. External validation studies:
Once the model is developed using the above procedure, the next step is to validate
this model in two different ways, internal and external, with and without model updating.
The aim of these studies is to test the performance of the existing models using new data
from new participants that were not used in the model development process (Altman et al.,
2009; Bedogni, 2009; Efron, 2020; Janssen et al., 2008; Royston et al., 2009; Sterne et al.,
2009). Let’s see one particular situation of external validation without model updating.
In this scenario, we apply the coefficient values from the developed model to the new
data from external sources. For example, let’s say we have developed an oral cancer
screening model using data from New Zealand. Then using the same model, we select
similar variables from the Australian cancer registry and use the data from the Australian
Cancer registry to validate this model. If the model performance is similar to that of New
Zealand, the model does not require any update. However, in some cases, when there was
a poor predictive performance in the external validation cohort, there is a need to update
the model based on validation data to improve the models’ transportability in new data
sets, by, for example, adding new predictors.
4. Model impact studies:
The aim of this type of prediction modelling study is to evaluate the impacts of using
such a diagnostic or prognostic prediction model on the behaviour of patient or clinicians
or patient health outcomes, compared to not using the model (Altman et al., 2009; Reilly
and Evans, 2006; Toll et al., 2008).
2.4 The significance of prediction modelling research
in promoting oral health
To better understand how oral health care can benefit from predictive modelling research,
it is important to understand the various applications of predictive models in oral health
care. This can be explained from three perspectives: clinical dentistry, public oral health,
and oral epidemiology. Examples are shown in (Table 2.2).
• From clinical dentistry point of view
Reducing unpredictability and uncertainty is important in clinical activities.
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Table 2.2: Illustrating potential applications of risk prediction models in dentistry and oral health.
Domain Example question regarding
risk
Potential decision made accord-
ing to the prediction
Clinical dentistry Is the loose tooth preservable? Systematic periodontal therapy
or tooth extraction
Public oral health How many children are esti-
mated to have deciduous dental
caries in South Australia next
year?
Quantity and location of dental
services
Oral epidemiology How many survivors from oral
cancers do I expect in my clini-
cal trial?
Recruit more or fewer partici-
pants
Everyone is a patient at one point in time, and we always expect the ‘best’ medical
care and assume that all their decisions are evidence-based. However, that may not
always be the case. Unpredictability and uncertainty exist in many medical activities.
Therefore, forecasts are needed to improve our decisions regarding future events in
the field of medicine. Usually, the lower their uncertainty and the more accurate
that we can predict the future, the higher our confidence that our decisions may be
correct.
To achieve this, prediction modelling research helps to estimate the uncertainty using
statistical analysis. In determining the risk of having certain outcomes among a
population, prediction modelling research takes various factors into account, such
as individual’s health behaviours, living environment, lifestyles, disease history,
socioeconomic characteristics, and even genetic information. With these elements,
a profile can be generated among the population group that predicts their health
outcomes and lays the basis for addressing risk factors accordingly (Moons et al.,
2012). In other words, prediction models quantify the average risk for a population
or subgroup of a population of experiencing an adverse outcome either currently
(diagnostic model) or in the future (prognostic model), by learning patterns from
the training data and then applying to the test data. In the clinical dentistry sector,
prediction modelling research allows dental practitioners to use predictive tools
to make more accurate diagnoses, carry out the best treatment, and forecast the
prognosis of oral diseases in order to make relevant supportive therapy.
By risk prediction modelling, each individual in a population can be assigned a
probability representing their risk of having the adverse outcome. However, it
does not answer questions like ‘What is the individual risk of having the predicted
outcome?’, but it answers questions like ‘What is the average risk of having the
predicted outcome for population like this individual?’ Though there are claims
about personalised risk prediction following the -omic information such as the
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sequencing of the human genome, we argue that individualised/personalised risk
prediction is unlikely to be achievable. First, the predicted value is based on the mean
estimation over a population or over many repetitive estimations for an individual
(Rockhill et al., 2000). Therefore, decisions of health care made based on risk factors
are general among a population who is similar to the specific individual rather than
tailored. Second, at the individual level, the outcomes will vary because other risk
factors besides genetics have not been suggested as a guide to change lifestyles
(Marteau and Weinman, 2006). Therefore, the predicted risk might be modified
by adding more predictors such as environmental factors. Detailed discussion on
‘population-level risk prediction’ versus ‘individual-level risk prediction’ can be
found in Chapter 8.
• From a public health point of view
Public oral health emphasises early detection, surveillance, and prevention
of oral conditions. With prediction modelling research, scientists can estimate and
monitor the prevalence, incidence, and changing patterns of oral conditions over a
period of time among a specific population at a specific location.
In addition, risk prediction modelling research will facilitate public health policy de-
cisions. Population-based prediction modelling research usually uses a large amount
of health data including geographic, sociodemographic, and systemic medical infor-
mation (Dash et al., 2019). These population-based prediction modelling studies can
generate health patterns of a community and provide suggestions/guidance to health
policymakers on where to make interventions, such as ‘dental fluoridation’.
• From an oral epidemiology point of view
The discipline of Epidemiology investigates the distribution and determinants of
diseases and focuses on causal inference (Frérot et al., 2018). In order to make an
effective intervention, precision prediction and identification of high-risk populations
should be prior made. Based on risk assessments, oral epidemiological studies aim
to identify the risk factors and prevent oral diseases at the population level, then
ultimately intervene to lower risk of oral conditions.
In summary, risk prediction modelling plays important role in dentistry, public oral
health, and oral epidemiology. The results from a specific clinical prediction modelling
study can be used to inform decision-making by patients, dental practitioners, health
policymakers, and academics. In this thesis, we discuss the application of prediction
modelling research in clinical dentistry (the diagnosis and prognosis of clinical oral
conditions).
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2.5 General practices for clinical prediction modelling
Given the significance of clinical prediction models in oral health, researchers have called
for rigorous development and validation of these models (Kundu et al., 2017). People
may think developing a prediction model is easy, using existing data (collected for various
purposes) and a well-packaged statistical method. Obviously, this is an oversimplification,
but in fact, prediction modelling is a complex process requiring sound clinical judgement
and careful statistical analyses (Lee et al., 2016). Currently, there is no agreement on the
best practices for developing, validating, and updating clinical prediction models, several
studies and books (Hastie et al., 2009; James et al., 2013; Steyerberg et al., 2019) have
published frameworks and recommendations for methodological approaches, with Harrell
and Steyerberg being key leaders in this field. Overall, a prediction model can be developed
by the following steps: (i) consideration of the research question; (ii) data collection (or
inspection) and pre-processing; (iii) model generation; (iv) model validation and evaluation;
and (v) model presentation. Figure 2.1 illustrates the general process of conducting a
prediction modelling study. The following sections present detailed explanations of the
process step by step.
2.5.1 Consideration of the research question
Before developing a prediction model, some key background questions should be set
up:
• What would be the intended use of the developed model?
• What outcomes need to be predicted, in whom and how?
• Why is the model needed? Is there any similar prediction model currently being
used in practice?
• What would be the predictors?
• Is the study a model development or model validation study, or a combination of
both?
Before we apply a developed prediction model in clinical practice, more questions
should be asked:
• Is this model easy to use?
• Has this model been validated by more than one cohort?
• What are the differences between the cohorts used for model development and model
validation?
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• Is there any evidence that the patients’ health outcomes can be improved by using
this prediction model?
Figure 2.1: Flowchart of conducting a prediction modelling study.
In this figure, the left column is the preparation stage, at this stage, background
questions should be set up: what the target outcome is to predict, who the target
receiver is, and who the target user is. Following this, data collection and pre-
processing are conducted, for example, cross-sectional data can be collected to
predict prevalent events, longitudinal cohorts can be used to predict incident events.
The middle part of this figure shows how to build the model. Usually, the data are
split into two parts, the data to be used to develop the model are named development
data, and the remaining data are named test data, which are to be used for testing the
model’s prediction performance. For a proposed model, a performance test is needed
to understand the model’s predictive ability. The commonly used performance
measures include measures for model calibration and discrimination. Following this,
prediction models can be presented as web-based calculators, or as applications for
mobile phones. However, it is very common for a proposed model to perform well
in the development cohort, but accuracy almost always decreases when the model is
applied in other settings. There are several reasons, such as different baseline risk
distributions, and different measurement systems. Therefore, for predicting a new
subject with new data, if poor prediction is obtained, we can move back and adjust
the model (model updating), till it performs well both in the original and future data.
Following the model’s performance test, another path is conducting model impact
studies to determine whether the model would ultimately improve patients’ health
outcomes, in order to facilitate the model’s clinical utility.
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2.5.2 Data acquisition and pre-processing
As said by George Box in 1976 ‘All models are wrong, but some are useful’, a
common agreement is that there is no such thing as a perfect model and perfect data.
Researchers could use different types of data sets (e.g., registry data, administrative data),
depending on the research questions. In general, a clinical prediction modelling study has
three key components: outcome data, predictor data, and a model that links the relationship
between the two.
• Outcome data: The health outcome that we want to predict, for example, tooth loss.
• Predictor data: Data involved the models to make a prediction, for example, patients’
clinical symptoms, demographical characteristics, etc.
• Modelling: A mathematical function that links the predictors and the outcome
data and discovers the relationships between them, for example, logistic regression
analysis, machine learning algorithms (e.g., neural network, decision trees, etc).
The outcome of a prediction model can be any event that might happen in the future,
such as the probability of having a tooth loss, or the chance of surviving from cancers at
a particular time point. It is noteworthy that the outcome measures and definitions are
sometimes debatable. For example, there are various definitions of chronic periodontitis.
Based on the definitions by the Centers for Disease Control and Prevention - American
Association of Periodontology (CDC/AAP) (Eke et al., 2012; Page and Eke, 2007), mild
periodontitis is defined as: there are ≥ 2 interproximal sites having ≥ 3mm clinical
attachment loss and ≥ 2 interproximal sites having ≥ 4mm pocket probing depth or
one site having ≥ 5mm probing depth. Moderate periodontitis is defined as: there are
≥ 2 interproximal sites having ≥ 4mm clinical attachment loss or ≥ 2 interproximal
sites having probing depth ≥ 5mm; Severe periodontitis is defined as: there are ≥ 2
interproximal sites having ≥ 6mm clinical attachment loss and ≥ 1 interproximal site(s)
having ≥ 5mm probing depth. However, according to the definitions by the European
Federal of Periodontology (EFP) (Tonetti and Claffey, 2005), incipient periodontitis is
defined as: there are ≥ 2 non-adjacent teeth having proximal attachment loss of ≥ 3mm;
Severe periodontitis is defined as: there are ≥ 30% of teeth having proximal attachment
loss of ≥ 5mm. Therefore, we raise researchers’ attention on using consistent outcome
definitions and measurement systems when developing a prediction model.
Handling of continuous and categorical variables With regards to data pre-processing,
we can group variables into continuous or categorical variables. The type of the outcome
variable(s) can be used to determine the methods for model generation. For example,
continuous outcome variables, presented by numerical values, can be predicted by re-
gression models (e.g., linear regression). Categorical outcome variables, described by
20 Research Context
two or more classes, can be predicted by classification models (e.g., logistic regression).
There are also studies aiming to not only predict/classify a particular outcome but also
account for the time period for this outcome to happen. This is known as time-to-event
analysis (e.g., survival analysis). For this type of analysis, Cox proportional hazards
regression and Kaplan-Meier curves can be used (Efron, 1988; Walters, 2012). For pre-
dictor variables, researchers have more and more realised that we should not categorise
continuous predictors at the initial stage of model development (Royston et al., 2006).
However, though categorisation decreases the heterogeneity and individualisation in the
population, at times interpretation of continuous values is not easy, categorisation might
provide more meaningful interpretations. For instance, it may not be useful to use body
mass index (BMI) as a continuous measure, BMI as a categorical variable is more useful
as the pre-specified categories (underweight (≤ 18.5), normal (18.5 - 24.9), overweight
(25.0 - 29.9), and obese (≥ 30) BMI categories) may convey more information or be easier
to interpret. These subtleties need to be thought through with relevance to the study and
communication of results from the study. Moreover, in oral health prediction research,
when the investigated outcomes are chronic (e.g., dental caries, chronic periodontitis)
and the target population is among adults, the ‘risk’ of getting certain outcome does not
change too much by one year age differences, instead, it is quite stable within an age
group, thus categorising age by five-year interval should not introduce much bias but be
more interpretable. Therefore, handling predictors should be done in light of the target
population and investigated outcome.
Handling of missing data The management of missing data is another important part of
data pre-processing. Missing data is unavoidable in most data analyses, leading to loss of
information and bias. Missing data occurs for various reasons, such as missingness during
collection, not applicable, dropout, or ‘unknown reason’. Three common missingness
mechanisms are: 1) ‘missing completely at random’ (MCAR), 2) ‘missing at random’
(MAR), and 3) ‘missing not at random’ (MNAR) (Rubin, 1976). To address this issue,
researchers may use singularly-imputed data, multiply-imputed data and complete case
analysis (CCA), etc. (see Table 2.3 for definitions and examples). The selection guidance
of an appropriate method to account for missing data can be found here (Hughes et al.,
2019).
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When there is no systematic differ-
ence between the missing data and
the observed data, it is MCAR.





When the observed information can
explain the systematic differences
between the missing and the ob-
served data, it is called MAR.
If a child does not attend an educa-
tional assessment because the child
is (genuinely) ill, this might be pre-
dictable from other data we have





When the observed information can-
not explain the systematic differ-
ences between the missing data and
the observed data, it is MNAR.
An adolescent took drugs the night
before he/she might not attend a
drug test, because they might not
want the information to be passed




Analysis conducted among the indi-
viduals with complete information




In MI, the missing values will be re-
placed by the ‘imputed values’, and
multiple imputed data sets are cre-
ated to account for the uncertainty
due to imputation. Then the separate
analysis is conducted using these
data sets and Rubin’s rules are used
to combine the multiple results.
2.5.3 Model generation
According to the discussion by Efron (Efron, 2020), in general, statistical tasks can be
categorised into three: (i) predicting the new cases, (ii) estimating the regression parameters
(e.g., coefficients), and (iii) assigning significance to each of the predictors. For prediction
purposes, there are many ways to generate the model, we can choose either statistical
methods or ‘pure prediction algorithms’ (e.g., machine learning algorithms). A statistical
model is using statistical analysis to represent and/or infer any relationships between
variables. Machine learning is using mathematical algorithms to learn the underlying
patterns of the data without relying on rules-based programming or pre-defined assumptions
in order to make predictions of the unknown (Murphy, 2012). A detailed review of their
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application in oral health and the difference between statistical models and machine
learning algorithms can be found in section 2.6.
2.5.4 Model performance evaluation
The study of performance measures has matured over the past two decades. For
example, the binary classification tasks have two objectives: minimising the number of
False Positives (e.g., where a disease is mistakenly diagnosed) as well as the number of
False Negatives (e.g., where a diagnosis of the disease is missed). The binary classifiers
can trade-off one type of misclassification against another. It is common to represent this
trade-off by a Receiver Operating Characteristic (ROC) curve (see the following section).
Efforts have also been made to put this ROC curve into a simple value that would allow
for comparisons across different classifiers, known as the Area Under the ROC curve
(AUROC). When two cases (a positive and a negative case) are selected at random, the
AUROC reflects the probability of the classifier assigning a higher risk score to the positive
case (Hanley and McNeil, 1982). Besides AUROC, many metrics are nowadays available,
such as sensitivity, specificity, etc. These measures are detailed and reviewed elsewhere
(Alba et al., 2017; Li and Wang, 2019; Steyerberg et al., 2010). In brief, a good prediction
modelling study should not only assess model fit but also assess and evaluate the model’s
discrimination and calibration as well as compare the performance of different prediction
models.
Model discrimination
Discrimination refers to the models’ ability to classify cases v. non-cases (e.g., dead v.
alive). A commonly used measure of discrimination is the AUROC, which sometimes
refers to the concordance (C)-statistic, and their extensions. The AUROC is equal to the
probability that an event is given a higher risk score than a non-event across all possible
thresholds. When a threshold is set, the individuals whose risks estimates are lower or
higher than the threshold are assigned different levels of risk. For example, if the threshold
is 0.3, then the individuals whose estimated risk≥ 0.3 are assigned to the higher risk group,
and vice versa. Then the sensitivity and specificity for this threshold can be calculated. In
the calculation of an AUROC, the thresholds vary from 0 to 1. Therefore, a ROC curve is
plotted over a wide variety of sensitivity and specificity. An AUROC value of 0.5 indicates
a random chance. However, when outcomes are infrequent, measures of overall accuracy
can be misleading: if there are only 5% of patients experiencing a positive outcome,
the model that predicts 0% positives obtain an accuracy of 95%, however, such a 95%
accuracy does not mean a ‘strong’ predictive ability. To overcome this limitation, sensitivity
and specificity were created as alternate properties for evaluating models’ performance.
However, when the proportion of positive and negative outcomes is imbalanced, alternate
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measures were proposed and found to be more useful (Saito and Rehmsmeier, 2015).
One alternative is the Area Under the Precision Recall Curve (AUPRC), which uses
information on sensitivity (referred to as recall) and positive predictive values (referred to
as precision). The AUPRC is more informative for evaluating the model’s discrimination
because it identifies the joint probability of being positive in both the predicted world
and the observed world, meaning AUPRC focuses on the performance of a classifier on
the positive (minority class) only. Therefore, AUPRC is more suitable for imbalanced
data where the positive observations are less. Let’s take binary outcome prediction as an
example, the confusion matrix of the predicted and observed positives can be expressed by
a 2×2 table.
Table 2.4: Confusion matrix of the binary outcomes
Observed distribution of the binary outcome Total
Predicted distribu-
tion of the outcome
1 0
1 N11 (True positive) N10 (False positive) N1.
0 N01 (False negative) N00 (True negative) N0.
Total N.1 N.0 N
The calculations of these measures are as follows:

























Sensitivity(Speci f icity)d(Speci f icity) (2.6)
• PRC: Plot of Recall (TPR) v. Precision (PPV).
To calculate the AUPRC, we can follow two steps: 1) Calculate precision-recall value from
multiple confusion matrices for different thresholds. For example, if the threshold is 0.8, all
the participants whose predicted probability greater than 0.8 are considered as cases. For
threshold = 0.8, we can calculate the precision-recall values based on the true positives,
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true negatives, false positives and false negatives. 2) Similarly, we can also calculate the
precision-recall values for the other thresholds. Once we have these precision-recall values,
we can calculate the AUPRC using an integral. Mathematically, it can be expressed as






Model calibration measures the agreement between the predicted probabilities/risk v. the
observed probabilities/risk. Let’s say we have a cohort with 100 participants, among
which 10 patients having a positive outcome. If our model predicts 10% of the population
developing the outcome, then we believe that our model has ‘good’ calibration because the
predicted probability matches the observed frequency.
A common way to evaluate the model calibration is called the Hosmer-Lemeshow
(H-L) test (Hosmer et al., 2013). The H-L test measures the correspondence between the
prediction and observation in two steps: first, dividing the ranges of the predicted and
observed probability (0-1) into n subgroups (usually n = 10), second, comparing their
difference by calculating a chi-square value and a p-value. Another way for measuring
model calibration is to generate a calibration curve (Almeida et al., 2002). The calibration
curve can be constructed in three steps: 1) ranking the predicted probabilities, 2) categoris-
ing these probabilities into n subgroups (usually n = 10) and 3) plotting the mean of the
predicted probabilities v. the mean of the observed probabilities for each subgroup.
Interpreting performance
The performance of a particular model only should be interpreted with comparison to
another (an existing) one. For example, a prediction model with an accuracy of 70% is
useful if the accuracy of the currently-used models is just better than a random classifier
(with an accuracy of 50%). In contrast, a model with an accuracy of 80% may not be
useful if the existing models can predict the outcome correctly 90% of the time. Therefore,
models’ performance can only be meaningful when compared with others.
2.5.5 Model validation
For evaluating model performance, different metrics have been proposed in the
above paragraphs. However, those measures do not provide guidance on the model
adoption. Because there is a possibility that models overly adapted to the development
data set may perform well in that particular data set but have poor predictive performance
using new observations (Steyerberg and Vergouwe, 2014). Therefore, it is important to
determine under what circumstances the model can be used, and how well is the model’s
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transportability (Altman and Royston, 2000). Model’s transportability refers to the idea
that the model’s results from one population can be exchangeable with a different source
of population. Models’ reproducibility and transportability can be evaluated in internal and
external validation studies, respectively. The typical life cycle of clinical prediction models
thus includes multiple stages of model development and model validation. Validation
refers to the process of testing whether the results from a prediction modelling study can
be generalised to data that were not used in the previous study.
The importance of splitting data into a training and test data set
Talking about ‘good’ predictive performance, it is important to evaluate models’ perfor-
mance on both the training and the test data that was not seen by the model during the
generation process. This ensures that the models are not overfitting or underfitting, which
might result in poor performance in new observations. An example of a training and test
data set can be found in Figure 2.2.
Figure 2.2: Example of training and test data sets.
Say we have a data frame with 100 observations (S1 to S100) and 10 predictors (X1
to X10) and outcome Y. We randomly pick a proportion (e.g., 80%) of the rows
(green box) to training set and the rest 20% (pink box) go to test set. We train our
model with training data set, while test data are only used for the evaluation of the
model’s performance.
Internal validation
Generally, we should distinguish the internal and external validation. Internal validation
refers to the process where we split the data into a development data set (for model
generation) and a test data set (for model validation). It tests whether the models’ predictive
ability remains at a similar level in the similar underlying population (not exactly the same
as the specific population used to develop it). Several methods are available to do internal
validation including split-sample validation, k-fold cross-validation, etc.
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Split-sample validation referring to randomly splitting a single data set into two parts.
For example, we use 70% of the available data for training and 30% for validation. The
problem with split-sample validation is that we can never know whether the estimate is a
realistic estimate of the model or due to a ‘lucky’ randomisation, therefore, it is important
to try several split proportions (e.g., 9:1, 8:2, 7:3, 5:5, 4:6, etc.) with many iterations (e.g.,
setting different seeds to allow for repetitions).
Another approach for internal validation is k-fold cross-validation, where the data is
stratified into k folds. Figure 2.3 box bar shows the example of 10 folds, the yellow box
represents validation fold and the blue boxes are training folds. We use one fold as the
test set once (the yellow box goes from the first to the last fold) to complete one iteration.
Such iteration should be repeated many times (usually at least 50). There were two aims
to use cross-validation, the first is to limit overfitting, the second is to tune the models.
For example, when we develop a random forest, we can set different parameters for the
model such as the number of trees. The tuning process would pick the forest with the best
predictive ability. Finally, our models can be evaluated in the test sets. We illustrate the
use of k-fold cross-validation for modelling training in Figure 2.3.
Figure 2.3: Schematic overview of 10-fold cross-validation.
Researchers have also argued that bootstrapping-validation is another effective version
of internal validation, as it can avoid using the development data for estimating models’
prediction performance (Gerds et al., 2008). Differing from cross-validation that splits the
available data to create multiple data sets, bootstrapping works by performing sampling
from the original data set with replacement, and assuming that the data that have not
been chosen are the test data set. For this nature, bootstrapping can avoid the possibility
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that a single model fit of the original data might overestimate the models’ prediction
performance. Therefore, bootstrapping can be viewed as a method that we fit the model
once, then evaluate it many times on various resampled data sets, i.e., bootstrapping has
dual purposes: estimating the variance of the parameters of interest and building ensemble
models then testing the models’ performance. Cross-validation is a method where we fit
the model many times using each of real sub-data sets, each time evaluate it against the
real data, i.e., cross-validation is more about testing the models’ validity.
External validation
Having excellent model discrimination, high accuracy, and good model fit using data on
hand does not ensure that the model will have ‘good’ performance when tested on new
patient cohorts. We here take the Framingham risk score as an example. Framingham
risk score is a commonly used method for assessing the risk of cardiovascular diseases.
Though it obtains high accuracy in general, it is found to underestimate the risk of sub
clinical atherosclerosis in some women (Michos et al., 2005). Thus this comes to a further
test - evaluating the predictive performance of a model under external validation. External
validation is different from what is given in Figure 2.2. It refers to the validation process
where two different data sets are used. One is used for model generation and a new data
set is used for validation. If we obtain ‘good’ performance metrics on multiple external
data sets, this indicates ‘good’ transportability and generalisability of the model and
further strengthens the acceptance of the model. External validation of a model requires
open and transparent reporting of the original study, such as the patients’ inclusion and
exclusion criteria, data pre-processing steps (e.g., handling of missing data, etc.), and
model performance metrics, etc.
2.6 Application of machine learning-based algorithms
for prediction purposes in oral health
This section is an extension of the subsection ‘model generation’. As mentioned above
in subsection 2.5.3, the approaches used for predictive model generation are generally
classified into two categories: statistical models and machine learning-based algorithms.
The term ‘machine learning’ refers to the idea of applying algorithms to learn the structures
in the observed data, therefore, allows for predicting the outcome using unseen data.
Examples of machine learning-based algorithms include bagging, boosting, recursive
partitioning, random forests, support vector machines, and neural networks, etc.
To understand the trends of the application of machine learning in oral health, elec-
tronic searching was carried out using the PubMed database. We searched keywords
including ‘machine learning’, ‘deep learning’ and ‘artificial intelligence’. Other items such
as ‘dentistry’ and ‘oral health’ were used as conjunctive search terms. The distribution of
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the number of articles can be found in Figure 2.4. We found that though the term ‘machine
Figure 2.4: Number of articles on machine learning in the field of oral health (searched on PubMed
on 5th February 2021).
learning’ was coined in the 1950s, its application in dentistry and oral health was not seen
until the late 1990s. In recent years, its applications have evolved rapidly, and most of the
existing machine learning algorithms were used to address various clinical issues in the
fields of dental medicine. We here present its applications using recent examples:
• In endodontics, machine learning has been applied to detect dental caries. For
example, using information relating to dental caries history and periodontal health
from parents, a decision tree was ‘grown’ to detect dental caries in children (Dima
et al., 2018). In addition, using radiology images, a study has shown the reliability
of using machine learning to find the minor apical foramen in order to determine the
working length for patients undergoing root canal treatment (Saghiri et al., 2012).
The accurate evaluation of endodontists was 76%. The artificial neural network
found correct anatomic positions in 96% of the teeth and was more accurate than
endodontists’ markings.
• In periodontics, machine learning algorithms were applied to better understand
periodontal diseases. For example, a study has presented the classification of peri-
odontitis using decision trees and neural networks (Ozden et al., 2015). Moreover,
a large number of radiographs was analysed by the convolutional neural network
models for the diagnosis of periodontally-compromised teeth (Lee et al., 2018b).
Additionally, under the help of the microbial profiles of subgingival plaque, sup-
port vector machine models were applied to classify the aggressive and chronic
periodontitis (Feres et al., 2018).
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• In prosthodontics, a study by Chen et al. (Chen et al., 2016) was conducted to
describe a clinical decision support system for the design of removable partial
dentures. Moreover, a machine learning system was also used for predicting the
colour of the teeth after the bleaching procedure (Thanathornwong et al., 2016).
The system needed two input components: patients’ data and pre-bleaching colour.
Based on these information, the developed system can predict the post-treatment
colour and colour change obtained with a whitening system.
• In the management of other oral conditions such as oral cancers, the last two decades
have also seen the evolution of machine learning in these fields. In 1995, it was first
proposed to use a machine learning-based approach to identify individuals who are
at high risk of developing oral cancers (Speight et al., 1995). More recently, based
on the clinical, pathological, and genomic markers, (Chang et al., 2013) applied
machine learning methods for feature selection and prognosis of patients with oral
cancers.
In summary, there are a variety of machine learning applications in dentistry and oral
health, but we only present a small part using the above-mentioned examples. From
these examples, we conclude that machine learning algorithms offer new supportive
diagnostic and prognostic tools for various oral diseases with high accuracy and facilitate
the development of a clinical decision support system. We see there is a significant uptake
of machine learning in oral health research. An important driver for this uptake is that in
research that involves the analysis of a vast amount of data (e.g., electronic health records,
including clinical data, behavioural data, imagery data, etc.), machine learning-aided
models are capable of analysing these data efficiently.
Health care data are rather heterogeneous as it includes data in various types such
as demographic data, clinical data, behavioural data, -omics information, etc. Obviously,
it is difficult for humans to infer the data and to make decisions. While data analysts are
working towards providing clean, curated, and structured data, machine learning has been
proposed for a better understanding of data, making the best use of the various types of
data, and allowing to grasp their interactions.
2.7 The choice between statistical models and
machine learning algorithms for health care
prediction purposes
There have been several vague statements on the difference between statistical models
and machine learning algorithms. Generally, the statistical models depend on statistical
hypothesis testing, which tries to identify whether the observed patterns match our assumed
data generating mechanism. Before we start collecting data and performing research, we
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will need to formulate our hypothesis. The original aim of statistical methods is to make
inferences on the predictors so as to intervene on the outcomes.
One of the advantages of machine learning is that many forms are non-parametric,
data-driven, more flexible, and do not rely on prior assumptions. Meaning, there is no
specific requirement for the hypothesis that the independent predictor X is associated
with dependent outcome Y . Instead, the primary hypothesis for machine learning is that
there is a pattern in the set of predictors that will identify the outcome, therefore they
allow models to identify the underlying relations between variables. Second, statistical
modelling aims to produce the simplest and explainable models that fit the data. So the
predictors are generally assumed to be independent of one another. However, machine
learning algorithms consider all possible interactions between variables.
Though there are many published comparisons/differences of statistical models and
machine learning algorithms, these comparisons do not help researchers to choose an
appropriate approach for their prediction modelling studies. Based on Harrel’s suggestions
(Harrell, 2020), we here describe some general guidelines in order to help researchers
choose between these two approaches.
Statistical models may be a better choice when
• We want to find out the (causal) effects of a number of predictors on the outcome.
• Predictors mostly affect the outcome in an additive way, or the interactions between
predictors are ‘small’ and/or can be pre-specified.
• Sample size is inadequate for the alpha level and analyses chosen (i.e., statistical
models typically require 20 events per candidate predictor).
• One wants to isolate the effects of a specific predictor(s) such as treatment or a risk
factor.
• The interpretability of the model is one of the major pursuits.
Machine learning algorithms may be more suitable when
• The algorithms can be trained on a number of replications.
• Obtaining ‘high’ prediction accuracy is the main purpose while describing the impact
of any particular predictor (e.g., treatment) is less of a concern.
• The interaction between variables and/or non-additivity can be strong and cannot be
isolated.
• The sample size is large (i.e., machine learning algorithms usually require > 200
events per candidate predictor).
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• One does not pursue the interpretability of the model (i.e., the model is a ‘black
box’).
2.8 Bias in prediction modelling research
Whenever we discuss model prediction, it is important to understand prediction errors (bias
and variance). Like many other types of research, the low risk of bias has always been a
pursuit for prediction modelling research. Understanding the nature of bias is important
for understanding and interpreting a model’s prediction ability. In this section, we talk
about what bias is, how bias occurs, and why bias matters in prediction modelling studies.
2.8.1 What is bias
Generally speaking, in data science, bias refers to a deviation from expectation in
the data. In the context of risk prediction, we have defined the risk of bias to occur when
systematic errors of a model’s estimates or predictive performance are led by the limitations
in the study design, conduct or data analysis, etc. However, the error is often subtle and
neglected. So, the first question is how does bias occur?
2.8.2 How bias occurs
By understanding the general steps to develop a clinical prediction model in the
last paragraphs, it is not hard to find that there are many chances for bias to occur. To
understand this, we mapped the relationship between the real world, the observed world,
and the predicted world in Figure 2.5.
Figure 2.5: Overview of how bias arises in the process of developing a prediction model.
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As shown in Figure 2.5, the real world contains the true values that we are interested
in, however, these true values are never known. If we could know ‘everything’ about all
the individuals in the real world and could store and identify all of this information, our
data and model would have no bias. Therefore, to understand the true values, we usually
collect data by sampling and measuring random observations from the real world, thus an
observed world can be obtained. Next, we conduct modelling procedures to identify the
data generating mechanism and develop the prediction models. Finally, we estimate the
unobserved outcomes/parameters of interest using these models and we thereby obtain the
predicted world.
Notably, in prediction modelling research, bias refers to the differences between the
predicted value and the true value of the parameters being estimated (indicated by the blue
curve). Therefore it is obvious that uncertainties that happen during sampling, measuring
(red circle in Figure 2.5), and the modelling process (green circle in Figure 2.5) may bias
our prediction. In short, bias occurs because of sampling, measurement, and estimation.
2.8.3 Why does bias matter in prediction modelling studies
Prediction models observe the real world through the data used for training. When
the data used for model development are biased, models’ prediction accuracy and estimates
are compromised, because the model will not only learn those biases but will end up
amplifying them (Mehrabi et al., 2019). Being aware of these risks allows us to better
eliminate bias. Mathematically, let’s define the true outcome and predictors as Y and X, and
the predicted outcome value is Ŷ . Let’s suppose that the data is generated from Equation
2.8:
Y = f (X)+ ε (2.8)
Where the random error, ε has a mean E(ε) = 0 and is independent of X . Variance of
the error is Var(ε) = σ2. Let’s define the prediction error as the difference between the
observed outcome (Y ) and the predicted outcome (Ŷ ). Now the mean square error (MSE)
of an estimate Ŷ of an observation Y is defined by Equation 2.9:
MSEŶ = E[(Ŷ −Y )
2] (2.9)
Note that MSE measures the average squared difference between the estimator Ŷ and the
true value Y , and MSE can also be expressed as the following equations:
MSEŶ = E(Ŷ −Y )
2 = E(Ŷ 2)+Y 2−2Y E(Ŷ ) (2.10)
= E(Ŷ 2)− [E(Ŷ )]2 +[E(Ŷ )]2 +Y 2−2Y E(Ŷ ) (2.11)
=Var(Ŷ )+ [E(Ŷ )]2 +Y 2−2Y E(Ŷ ) (2.12)
=Var(Ŷ )+ [E(Ŷ )−Y ]2 (2.13)
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=Var+Bias2 (2.14)
Hence, bias and variance are the two sources of imprecision in prediction models.
2.8.4 Common sources of bias in prediction modelling research
Recently, substantial efforts have been made to improve the reproducibility and
reliability of scientific findings in health research. These efforts include the development of
guidelines for designing, conducting, and reporting preclinical studies (ARRIVE), clinical
trials (ROBINS-I, CONSORT), observational studies (STROBE), and systematic reviews
and meta-analyses (PRISMA). Given the use of prediction has increased in health sciences,
guidelines such as PROBAST have been recently published for the conduct and risk of
bias assessment for prediction modelling studies. As suggested by PROBAST (Moons
et al., 2019), common types of bias could be classified into four domains, relating to
Participants, Predictors, Outcome, and Analysis. We summarise the actions that may
introduce bias in Table 2.5, and these actions are avoidable.
Table 2.5: Actions introducing bias in prediction modelling studies.
Domain Actions should be avoided
Participants
• Selection bias, e.g., lack of specification of inclusion/exclusion
criteria, lack of sampling and/or data collection methods.
Predictors
• Measurement error. Poor measurement of predictors is likely
to degrade their predictive power. This usually happens when
inconsistent measures were used across all the participants.
• Categorising continuous variables.
• Lack of consideration on unmeasured predictors. In external val-
idation studies, this usually happens when omitting unavailable
predictors.
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Outcomes
• Unclear definition.
• Measurement error. This usually happens when inconsistent mea-
sures were used across all the participants.
• Incorporation of predictors. This usually happens when the pre-
dictors include part of the information captured by the outcome.
For example, using bleeding to predict gingivitis.
Analysis
• Selecting predictors based on univariate analyses.
• Lack of consideration on overfitting. This usually happens when
lacking internal validation (e.g., k-fold cross-validation).
• Lack of appropriate missing data handling.
• Insufficient evaluation of the model’s prediction performance. This
usually happens when lacking either assessment of discrimination
or calibration.
2.8.5 Efforts to improve the quality of clinical prediction modelling studies
Here we define that the quality of a clinical prediction modelling study can be
influenced by two aspects: the methodology that is used to reduce biases in the study
and completeness of reporting of the study. There has been lots of progress in recent
years to improve the quality of prediction modelling studies, including the publication of
several books, various series of papers in PLOS Med and BMJ (Hemingway et al., 2013;
Hingorani et al., 2013; Riley et al., 2013; Steyerberg et al., 2013), the CHARMS checklist
in 2014 (Moons et al., 2014), the TRIPOD statement in 2015 (Collins et al., 2015), and
the PROBAST guidelines in 2019 (Moons et al., 2019). The efforts to reduce bias and
improve the reporting completeness are discussed in the following paragraphs.
Efforts to reduce bias To standardise methodological principles, the earliest efforts were
from the PROGnosis RESearch Strategy (PROGRESS) group, this group has proposed the
methods that can be used in predictive models in particular using a series of publications
(the so-called PROGRESS series). More recently, CHARMS checklist was designed for
two purposes: 1) to provide explicit guidance to help reviewers and users of diagnostic or
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prognostic models framing the right (review) questions, and 2) to provide a data extraction
list with guidance on which items to be extracted from prediction modelling studies.
CHARMS can be applied to all types of primary model development studies, for all types
of target population, outcomes, predictors, and regardless of the used statistical methods.
However, CHARMS does not evaluate the risk of bias in the studies. To address this
gap, PROBAST was introduced in 2019 as an updated tool to assess the risk of bias in a
multivariate prediction modelling study. We would not reiterate the details in PROBAST
documents (Moons et al., 2019; Wolff et al., 2019), however, key guidance to reduce bias
according to PROBAST are summarised in Table 2.6.
Table 2.6: Key suggestions to reduce bias in prediction modelling research.
Suggested practices Cautions
Prioritising precision and transparency
when working on a prediction task.
Approaches for solving a prediction prob-
lem can be different from causal inference.
Considerations on the methods for feature
selection.
Using p values from bivariable compari-
son or step-wise procedures to select pre-
dictors might introduce bias and overfit-
ting.
Transparently report the presence and han-
dling of missing data. Approaches to han-
dle missing data are suggested to be able
to improve models’ prediction capability.
CCA [1] may not always be a good practice
to handle missing data.
Conduct external validation to test the gen-
eralisability of a model.
External validation should use exactly the
same model developed (same predictors,
same modelling approaches, etc.).
Seek a reference model/comparator other
than ‘no model’ when evaluating and in-
terpreting model performance.
Relying on the AUROC [2] alone may lead
to an in-comprehensive understanding of
the model’s predictive performance.
Follow checklists such as TRIPOD [3] for
the purpose of reporting completeness and
transparency.
[1]CCA: Complete Case Analysis. [2]AUROC: Area Under the Receiver Operator
Characteristic curve. [3]TRIPOD: Transparent Reporting of a Multivariable Predic-
tion Model for Individual Prognosis or Diagnosis.
Although the criteria of risk assessment for clinical prediction modelling studies are
in infancy, when we use them to assess the previous literature, we can obtain the changes
and progress during the past years and the investments on standardising the methodological
issues in prediction modelling studies will surely increase the quality of models.
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Efforts to improve transparent reporting With regards to reporting principles of a
prediction modelling study, there were no defined reporting guidelines of predictive
modelling studies for researchers to follow until the development of TRIPOD statement
in 2015. The TRIPOD statement lists 22 items (covering title, abstract, introduction,
methods, results, conclusion, and supplements) that are considered crucial to effectively
report a clinical prediction modelling study. There are two groups working towards
standardising the reporting of a clinical prediction model (Collins et al., 2015; Hemingway
et al., 2013). These groups and their reports take important steps towards outlining ways
that the results of this type of study can be effectively communicated in the research
community so that these prediction tools can be validated and might improve decision-
making. Moving forward, the dental and oral health journals should require that clinical







Chapter 3 comprises the methodologies used in the thesis. It consists of four sections:
Section 3.1 gives a brief summary of the adopted methods in this thesis. Section 3.2
describes the methods for conducting systematic reviews (Chapters 4 and 5). These
methods include framing a review question, registering a protocol, defining study selection
criteria, formulating search strategy, critical appraisal for the studies included, and evidence
synthesis and study reporting. Section 3.3 briefly describes the data sources and aspects
of data management used in each of the empirical analyses included in later chapters
(Chapters 6 and 7). Section 3.4 presents statistical methods used in each of the studies
undertaken in relevant chapters.
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3.1 Summary of the methods used in this thesis
The term, ‘evidence-based medicine’, was introduced to generate high-quality evidence in
medical research and using that evidence to make better clinical decisions (Sackett, 1997).
A milestone in ‘evidence-based medicine’ was the development of systems for classifying
the ‘level of evidence’ (Hill et al., 1979). Based on the traditional hierarchy of evidence for
therapeutic studies, systematic reviews are positioned at the top, followed by randomised
controlled trials, then observational studies such as cohort studies and case–control studies,
then case studies, then laboratory studies and ‘expert opinions’ (Greenhalgh, 1997). When
coming to the field of prediction modelling studies, the highest level of evidence can be
provided by the ‘high-quality’ prospective cohort studies with ‘sufficient’ predictive power
or systematic reviews of these studies (Burns et al., 2011).
In this thesis, two types of research were conducted: systematic reviews and empirical
analyses using observational cohorts. Table 3.1 summarises the methods used in each of
the four studies included in the current thesis.
Table 3.1: Summary of the adopted methods in each of the included publications
Publication Title Methods adopted
Publication 1
(Chapter 4)
Prediction models for the inci-
dence and progression of peri-
odontitis: A systematic review
Systematic review + narrative report.
Publication 2
(Chapter 5)
Examining bias and reporting
in oral health prediction mod-
elling studies
Systematic review + narrative report.
Publication 3
(Chapter 6)
Comparison of the tree-based
machine learning algorithms
to Cox regression in predicting
the survival of oral and phary-
ngeal cancers: Analyses based
on SEER database
Prediction modelling approaches:
1. Cox proportional hazard regression
2. Random Forest for survival
3. Survival Tree
Handling of missing data:
1. Substantive Model Compatible Imputa-
tion
2. Random Forest for survival
Publication 4
(Chapter 7)
Application of multilevel ma-
chine learning for predicting




Variable selection approaches: LASSO [1]
Handling of missing data:
MICE [2] + missing indicator
[1]LASSO: Least Absolute Shrinkage and Selection Operator; [2]MICE: Multiple Imputa-
tion with Chained Equations.
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3.2 Methods for systematic reviews on prediction
modelling studies
In this thesis, available guidelines were followed regarding the steps in conducting
systematic reviews of prediction modelling studies. These steps include framing a review
question, literature searching (Geersing et al., 2012; Ingui and Rogers, 2001; Wong et al.,
2003), study selection (Steyerberg et al., 2013), data extraction, critical appraisal of
prediction modelling studies (Moons et al., 2014; Wolff et al., 2019), and evidence syn-
thesis and reporting. A brief description of each step can be found in the following sections.
3.2.1 Registering a protocol and framing the review question
Usually, a systematic review starts with a protocol describing the review question,
background, aims, study design, methodology (e.g., literature searching, study inclusion
and exclusion criteria), and statistical analysis (if applicable) of the study. Two review
questions that are of interest in this thesis are:
• Chapter 4: Are there any prediction modelling studies for the incidence and progres-
sion of periodontitis in adults?
• Chapter 5: Whether the oral health prediction modelling studies in the recent litera-
ture were conducted following the methodological and reporting recommendations?
According to the International Prospective Register of Systematic Reviews (known
as PROSPERO), once the review questions are framed, systematic reviews should be
registered at inception using public platforms, in order to avoid unplanned duplication. A
typical PROSPERO protocol has 39 items, which defines various aspects of a systematic
review, including the aim of the systematic review, the timeline for conducting the study,
searching strategies, the criteria for selecting studies, the planned approaches for data
analysis. In this thesis, we registered two protocols on PROSPERO, details can be found
by ID numbers CRD42018085437 and CRD42019122274.
3.2.2 Formulating the search strategy
Following the recommendations by Moons et al. (Moons et al., 2014), the search
strategies for our systematic reviews were framed according to the PICOTS system (popu-
lation, intervention, comparator, outcome(s), timing, setting). The definitions and details
of PICOTS items applied to our two systematic reviews are described in Tables 3.2 and
3.3.
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Table 3.2: PICOTS system
• Population — The target population (model receivers) on which the prediction
model(s) will be used.
• Intervention (Model) — The prediction model(s) to be reviewed.
• Comparator — ‘C’ means comparison group, sometimes it is not applicable in
systematic reviews for prediction modelling studies. In systematic reviews for
intervention studies, the ‘C’ represents confounding.
• Outcome(s) — The outcome(s) that the model is to predict.
• Timing — The time period between the record of predictors and the occurrence
of the outcome.
• Setting — Under what circumstances or settings is the prediction model to be
used.
Table 3.3: Framing a systematic review search strategy by use of the PICOTS∗ system
Publication 1 (Chapter 4) Publication 2 (Chapter 5)
Population Adults (aged 18 and over) Adults (aged 18 and over)
Intervention
(Model)
Models to predict the future
incidence and progression of
periodontitis
Models to predict the risk of
any oral conditions
Outcome Periodontitis incidence and
progression
Any investigated oral condi-
tions
Time span Predictors measured after age
18, outcome measured at ad-
equate time after the occur-
rence and progression of pe-
riodontitis
Predictors measured after age
18, outcome measured at ad-
equate time after the occur-
rence of oral conditions
Settings of using
the model
Generally healthy adults who
are free of systematic condi-
tions, e.g., intellectual disabil-
ity, HIV, drug dependent and
alcohol dependent
Relevant only to adults (aged
18 and over)
∗ The ‘C’ (Comparator) in the PICOTS system was not used in our studies.
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3.2.3 Searching
Here we present a summary of electronic searching, the detailed search strategies
can be found in the relevant chapters (Chapters 4 and 5). For the systematic review
of prediction models for periodontitis (Publication 1), six databases (PubMed, Embase,
DOSS, Scope, Web of Science, Proquest) were reviewed to identify the existing literature
without time restrictions. Additionally, to avoid missing out on potential papers/reports, we
reviewed the bibliography of the included full-text articles. In our second systematic review
(Publication 2), assessing bias and reporting transparency in predictive modelling, our
search was limited to ‘high-impact’ journals, including oral health, dentistry, epidemiology
and biostatistics. The reason why we only searched these journals is that these journals are
believed to provide the best available evidence in the field of oral health, and the findings
from these studies are believed be generalised to a broader area of oral health prediction
modelling studies.
3.2.4 Critical appraisal and information extraction
The quality of a systematic review depends not only on the methodology used in the
review but also on the quality and reliability of the studies included. Therefore, critical
appraisal (also referred to as the risk of bias assessment) is essential in any systematic
review. In Chapters 4 and 5, studies’ quality was critically appraised using tools such
as CHARMS published in 2014 and PROBAST published in 2019 (the most updated
tool by the time when the systematic review was conducted). CHARMS assesses the
potential risk of bias in five domains: participant selection, predictor, outcome, attrition,
and analysis for model development, while PROBAST assesses the study quality in four
domains: participants, predictor, outcome, and analysis.
Following the critical appraisal, another important step in a systematic review is to
extract information from the included studies. This information are to be used for evidence
synthesis. In this thesis, CHARMS was also used for information extraction in Chapters
4 and 5. A standard CHARMS checklist outlined 11 items that need to be extracted
from a study: setting, source of data, population characteristics, follow-up period, sample
size, outcomes, predictors, missing value, variable selection, modelling approach, model
presentation, interpretation and performance evaluation (e.g., discrimination, calibration).
3.2.5 Evidence synthesis across studies
Researchers should adopt an appropriate and ‘tailored’ approach to synthesise the
extracted evidence across the reviewed studies. In Chapters 4 and 5, narrative reports
and qualitative synthesis of findings were provided, focusing on the description of study
characteristics and the presentation of study quality, respectively.
Usually, evidence from a systematic review can be synthesised into two types: nar-
rative and quantitative. When the quantitative analysis is conducted, the estimates of
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model performance measures (e.g., models’ sensitivity, specificity) can be extracted and
meta-analysed (Snell et al., 2016). However, when quantitative analysis is not conducted
then studies need to qualitatively synthesise the information. Collating evidence from
qualitative synthesis is challenging as distinguishing linguistic statements can be time-
consuming and the interpretation of the qualitative evidence may vary across different
investigators. We argue that the synthesis of the available evidence should be conducted in
light of the review question and the specific context of studies. For example, in our first
systematic review (Chapter 4), we aimed to identify the existing prediction models for the
incidence and progression of periodontitis, therefore, we emphasised the identification
and description of the commonly used predictors and modelling approaches. Moreover,
the aim of our second systematic review (Chapter 5) was to examine the quality of the
included studies. We therefore highlighted the findings from critical appraisal and adopted
tables and Gantt charts to provide an understanding of the limitations and overall quality
of those studies, in a visual-friendly manner.
3.2.6 Reporting and presentation
Communicating and presenting the results from systematic reviews (and meta-
analysis) in sufficient details are important. The PRISMA statement (Moher et al., 2009)
was originally developed for reporting systematic reviews (and meta-analysis) of interven-
tion studies, with many items being suitable to report systematic reviews of prediction
modelling studies. Therefore, these two systematic reviews were reported and presented
following the PRISMA statement.
3.3 Data used in the empirical analysis in this thesis
Data for this thesis were drawn from two open-access databases: the Surveillance, Epidemi-
ology, and End Results (SEER) program and the Dental Practice-Based Research Network
(DPBRN) in the US. The US states covered by the SEER program and the DPBRN project
are mapped in Figure 3.1).
3.3.1 Data used in Chapter 6: SEER program
The SEER program collects information on cancers prevalence, incidence, mortality
and survival covering over 30% of the population in the US (Hankey et al., 1999). There
are 18 registration stations across the country (states can be found in Figure 3.1). These
registration stations collect data using SEER*STAT software and submit the information
to the National Cancer Institute for data aggregation and statistical analysis. The data
collected contains information on patients’ sociodemographics (e.g., sex, age) and clin-
ical characteristics (e.g., tumour site, tumour size, differentiation stage at diagnosis and
treatment). In addition, SEER registries follow up with the participants for vital status
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Figure 3.1: The US states from which the data for studies in the thesis were drawn.
States coloured in blue are covered by the SEER program. States coloured in pink
are covered by the DPBRN. State(s) coloured in green is covered by both SEER and
DPBRN.
to provide survival information. Because of its broad coverage and comprehensive data
collection, the SEER data were used in this thesis to serve as a basis for the survival
prediction modelling using machine learning. SEER releases data submissions annually,
containing new incidences and updated information for existing cases. Our study (Chapter
6, Publication 3) is based on the data from 1973 to 2015, released in November 2017. The
Data-Use agreement for SEER 1973-2015 file can be found in Appendix A.
Outcome and predictors in Chapter 6 A summary of predictors and outcome variables
and their descriptions can be found in Table 3.4. Among these variables, ‘Survival months’
and ‘Death status’ were used as outcome data.
Table 3.4: Description of the predictor and outcome variables used in SEER study
Variable Description Type
Age Age at time of diagnosis Continuous
Sex Male or female Binary
Race White, Black, American Indian/Alaska na-
tive, Asian or pacific islander, Others
Categorical
Marital status Marital status at diagnosis Categorical
Grade Tumour grading and differentiation Categorical
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Derived AJCC [1] Stage
Group, 6th ed (2004+)
Tumour stage - based on T, N, and M [2] Categorical
Derived AJCC T, 6th ed
(2004+)
AJCC component describing tumour size Categorical
Derived AJCC N, 6th ed
(2004+)
AJCC component describing lymph node
involvement
Categorical
Derived AJCC M, 6th ed
(2004+)
AJCC component describing tumour dis-
semination to other organs
Categorical
Histology Histology type Categorical
CS tumour size (2004+) Information on tumour size Categorical
No. of lymph nodes re-
moved
Information on the involvement of lymph
nodes
Categorical
Surgery Whether or not the patient underwent a
surgery
Binary
Survival months Number of months that patient is alive
from date of diagnosis
Count
Death status Alive or death Categorical
[1]AJCC: American Joint Committee on Cancer, [2]TNM: Tumour size, lymph Node
involved, Metastasis
3.3.2 Data used in Chapter 7: the DPBRN endodontic study
In Chapter 7 (Publication 4), a data set based on patients’ electronic dental records was
used. It was derived from an endodontic study involving 62 dental practitioner-investigator
from the DPBRN who recruited 708 patients - over 6 months - receiving initial root canal
treatment. The DPBRN is research networking between a group of dental practices in the
US that share expertise and work together on research questions.
Study design and participants in Chapter 7
We employed a prospective cohort where data were collected at four time points: pre-
operation, intra-operation, one-week and six-month after operation. As shown in Figure
3.2, data collected at time points coloured in yellow were used as predictors and data
collected at time points coloured in green were used as outcomes. Further, the one-week
postoperative information was also used for predicting the six-month outcome.
Outcome and predictors in Chapter 7
Outcome The outcome measures of pre-operative, intra-operative and postoperative pain
were assessed using the Graded Chronic Pain Scale (GCPS). (Smith et al., 1997; Von Korff
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Figure 3.2: Time points for data collection in the root canal treatment cohort.
et al., 1992). The intensity of the one-week postoperative pain is defined by ‘In the past
one week, on average, how intense was your tooth pain rated on a 0 to 10 scale?’. If the
patient answered ‘≥ 7’, then we defined the individual as a positive observation for the
one-week cohort. The six-month outcome measure of persistent tooth pain is defined by
‘On how many days in the last one month have you had tooth pain in the root canal treated
tooth?’. If the patient answered ‘≥ 1 day’, then we defined the individual as a positive
observation for the six-month cohort.
Predictors Based on the electronic health records, a total of 76 variables, obtained from
questionnaires answered by patients and dentists, were used as predictors. These predictor
variables can be grouped into the following categories:
• Patient sociodemographic characteristics (e.g., sex, age, insurance status)
• Pain measures (e.g., pre-operative pain intensity, the experience of intra-operative
pain)
• Psychosocial variables (e.g., dental anxiety, dental fear)
• Medical characteristics (e.g., diabetes)
• Procedural characteristics (e.g., type of root canal, pulp status, presence of periapical
periodontitis, number of appointments, use of rubber dam, procedural difficulty)
3.4 Analytic approaches
The adoption of prediction modelling approaches usually depends on the data type of the
outcome variables. In this thesis, two common types of outcome data were included in
Chapters 6 and 7, respectively: a time-to-event outcome and a binary outcome.
Overview of the analytical methods used in Chapters 6 and 7 To understand the
methodology of a prediction modelling study, it is common to answer the following
questions: ‘What is predicted, in whom, for whom, and how?’, i.e., What is the outcome(s)?
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Who are the model users? Who is the target population? and How to conduct this study?
Methods used in Chapters 6 and 7 are presented in Table 3.5.
Table 3.5: What is predicted, in whom, for whom, and how in Chapters 6 and 7?
Research scenario Examples in Chapters 6 and 7
Specification of aim
Chapter 6: Predict the 1-5 year survival probability for patients
with oral and pharyngeal cancers
Chapter 7: Inform clinicians and patients about the risk of devel-
oping pain following root canal treatment.
Outcome (What is
predicted?)
Chapter 6: Three- and five-year disease-specific survival of the
patients with oral and pharyngeal cancers
Chapter 7: One-week and six-month pain following a root canal
treatment
Target population
Chapter 6: Adults patients diagnosed with oral and pharyngeal
cancers








Chapter 6: Predictors were collected based on previous literature
Chapter 7: Multilevel LASSO [1]
Models used in anal-
ysis
Chapter 6:
1. Cox proportional hazard regression
2. Survival Tree
3. Random Survival Forest
4. Conditional Inference Forest




1.Substantive model compatible imputation
2. Random survival forest
Chapter 7: Multiple imputation with missing indicator method
Other considerations
Chapter 6: Effects of unmeasured predictors on models’
performance
Chapter 7: Evaluation for models’ prediction performance when
the outcome is imbalanced (AUROC [2] and AUPRC [3])
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[1]LASSO: the Least Absolute Shrinkage and Selection Operator; [2]AUROC: Area Under
the Receiver Operating Characteristic curve; [3]AUPRC: Area Under the Precision Recall
Curve
3.4.1 Chapter 6: Right-censored data and survival analysis
Right-censored data
In Chapter 6 (Publication 3), the outcome variable is time of death among patients with oral
cancers. As illustrated in Figure 3.3, the observations in the data set can be distinguished
into three types. The first type is that we observe the ‘event’ (i.e., death occurs before
time t, as shown for Patients 1 and 2). The second type is that we observe the patient
being alive at time t, all we know is that his/her death time is after his/her censored time
t. The phenomenon is called right censoring, as the unknown event time is on the ‘right’
side of censored time t (as shown for Patients 3 and 4). The third type is that, if a patient
drops out before time t, then we will never know his/her outcome status at t (as shown for
Patients 5 and 6), this is called left censoring. In our study, we exclude the left-censored
observations due to the unknown outcome status. The observations with ‘X’ in Figure 3.3
were included, the observations with ‘×’ were excluded.
Figure 3.3: Illustration of the ‘event’, the left- and right-censored observations.
Survival prediction: Cox proportional hazard regression
For the usual time-to-event data setup, a commonly used analytical method is the Cox
proportional hazard regression model (David et al., 1972). A Cox model computes the
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impact of a given predictor(s) on the hazard (i.e., risk) of an event occurring (e.g., death).
For the ith individual, let’s denote the predictors being x(x1,x2, ...xk) and the death/event
time being yi. In the Cox model, it is assumed that:
h(t|x) = h0(t)exp(∑
j
x jβ j) (3.1)
where h(t|x) is the hazard at time t given the predictor values of that individual, and h0 is
the baseline hazard function.
Though the Cox model has been widely adopted for survival analysis due to fast
computation and straightforward interpretation, this method has some shortcomings. For
example, Cox models rely on the pre-specified assumptions: the hazard of a patient is a
linear function of the baseline hazard of the population and of the static predictor values
over time of that patient. Additionally, Cox regression is unable to model nonlinearities
and interactions between variables. To overcome these limitations, machine learning has
provided alternate solutions, and are being increasingly used in survival prediction.
Survival prediction: tree-based machine learning algorithms
While methods such as support vector machine and neural networks can be used for survival
prediction, real data experiments have shown that they require larger computational power
and have similar efficiency when compared to the methods that do not have the same
computational burden, such as tree-based methods (e.g., random forest) (Fouodo et al.,
2018; Kvamme et al., 2019). For this reason, we were specifically interested in the use
of ‘tree-based machine learning algorithms’. In Chapter 6 (Publication 3), three tree-
based machine learning approaches (survival tree, random survival forest and conditional
inference forest) were adopted along with Cox regression. A detailed description of
tree-based models can be found in Chapter 6.
A survival tree:
In the terminology of tree models, one node would split the data into two children nodes
based on a pre-defined splitting rule. For the purpose of growing and pruning the tree, one
needs to define a splitting statistic (e.g., log-rank) that handles the dependence of failure
times and a performance metric (e.g., C-index) to evaluate the predictive ability of the tree.
In the survival tree, the split rule was defined using the ‘log-rank’ test (Damato and Taktak,
2007). For the purpose of predicting a new observation, the if-then rules was followed
using predictor values of that observation until coming to the terminal node. A step-by-step
procedure for growing a survival tree is shown in Algorithm 1.
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Algorithm 1 The development of a basic survival tree
Start
Create an initial survival tree with a root node k0
Create a stack S of open nodes
while S is not empty do
k = k0 + k1
if the stopping criterion is met for k; then
end
else
Find the splitting node that maximises the survival difference between the children
nodes
Partition data into two children nodes of k
end
end
Calculate the tree’s prediction performance
A random survival forest:
The implementation of a basic random survival forest follows three steps: 1) The basic
survival trees are fully grown using a bootstrapped sample of the original data. 2) The
tree nodes are split using the best splitting criterion among a number of candidate criteria.
Usually, the one that maximises the survival difference between two children nodes is
selected. 3) The prediction from a random survival forest is calculated as the average of the
individual survival trees. A step-by-step procedure for growing a random survival forest is
shown in Algorithm 2.
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Algorithm 2 The development of a basic random survival forest
Start
Define the number of survival trees (ntree) to develop
for i = 1 to ntree do
Create a B bootstrap sample (usually two thirds of the original data set), one third is
left as out-of-bag (OOB) data Develop a survival tree model using this sample
for each split do
Randomly select k (< K) of the candidate predictors
Select the predictor from the k predictors that can give the optimal estimates (e.g.,
highest homogeneity within children node)
for each splitting point of the best k do
Compare the survival curves of the two groups using one splitting rule among
the multiple splitting rules
Select the best splitting rule that maximises the survival difference between
two children nodes
Partition the data
(for determining splitting rule)
end
(for determining one split in one tree)
end
Using tree stopping criterion to test whether the development of a tree is completed.
Using OOB data, the prediction performance is calculated and recorded.
(for developing one tree)
end
The performance metrics of individual trees are then averaged to obtain the ensemble
performance of this forest.
In Chapter 6, a handful of predictors was selected following the previous literature.
However, in much of the real-world data settings, some data complexities need to be
considered before modelling, such as the selection of predictors from a large set of
candidate variables and the nesting of information. To demonstrate how to take these
complexities into account in prediction modelling, a data set with a ‘small’ number of
samples and a ‘large’ number of variables was used. Additionally, this data set has a
two-level structure, which allows the use of multilevel modelling. Detailed explanations
can be found in the following paragraphs.
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3.4.2 Chapter 7: Multilevel data and multilevel models
Multilevel data
As shown in Figure 3.4, our data have a nested (clustered) structure: 708 patients were
grouped by 62 dental practitioners across six states in the US. Data with such a hierarchical
structure is called multilevel data.
Figure 3.4: Schematic structure of the data set.
Multilevel models
When the data a two- (or multi-) level structure and also it is believed that the total variation
is made up of the variation of level-1 and level-2, then one may consider using multilevel
models (also refer to mixed effect models or random effect models) (Mason, 2001).
Multilevel models can recognise the hierarchies in the data set by accounting for variance
components at each level in the hierarchy. In our study, a two-level logistic regression
model accounting for the clustering of patients’ outcomes within dental practitioners was
used. In this study, the practitioner residuals represent the ‘random effect’, referring to the
unobserved practitioner characteristics that affect patients’ outcomes. It is the unobserved
characteristics that led to correlations between the outcomes for different patients treated
by the same dental practitioner. More details of the two-level model can be found in
Chapter 7 (Publication 4).
3.4.3 Variable selection in Chapter 7: the Least Absolute Shrinkage and Selection
Operator (LASSO)
In Chapter 7, variable selection was an important criterion as the data set had a smaller
sample size (number of participants = 708) and a large number of variables (number of
variables = 152). The reasons for conducting variable selection are three:
1. Removing the irrelevant variables that do not add to the models’ prediction perfor-
mance can make the models easier to interpret.
2. Variable selection can speed up the training of an algorithm, especially for high-
dimensional data sets.
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3. If we do not select variables in this study there is a chance that the determinant(s)
of the variance-covariance matrix equates to zero thus resulting in unstable effect
estimates, commonly referred to as overfitting.
To select variables in a study one may use methods such as backward or forward
selection in training and test data sets. However, these methods are not free from limitations
(Greenland et al., 2016). Alternatively, several machine learning algorithms are available
for variable selection, and in this study we used the LASSO introduced by (Tibshirani,
1996). The idea of conducting LASSO is to constrain the sum of the model parameters (e.g.,
the sum of variables’ coefficients) to be less than a fixed value. To do so, the LASSO applies
a shrinking function to penalise the variables’ coefficients and shrink some of them towards
zero. Then the variables with non-zero coefficients following the shrinking function are
selected into the final model. Given that our data has a two-level structure, a two-level
logistic regression was used for model development. To be compatible with the intended
model, multilevel LASSO was therefore conducted to select predictors (Schelldorfer et al.,
2011). This method is discussed in detail in Chapter 7.
3.5 Model performance measures
3.5.1 Measures for models’ discrimination
Chapter 6: Discriminating measures for survival prediction models
There are a number of measures being constantly developed for evaluating the accuracy
of survival predictions, of which some are reviewed by (Bøvelstad and Borgan, 2011),
including the log-rank test, the Harrell’s C-index (also known as C-index), and the Brier
score. Following the literature which evaluates survival prediction models in medical
research (Austin et al., 2017; Chen et al., 2012; Choodari-Oskooei et al., 2012; Graf et al.,
1999; Nasejje et al., 2017; Pencina et al., 2012; Rahman et al., 2017; Schemper and Stare,
1996; Schmid and Potapov, 2012), C-index and the Integrated Brier Score (IBS) were used
to measure models’ discriminative ability in Chapter 6 (Publication 3). The definitions and
calculation of C-index and IBS can be found in Chapter 6.
• In time-to-event analysis, say we have a pair of patients (i, j), and the ith patient
has an event (e.g., death) prior to the jth patient. If the model predicts that the ith
patient having a higher risk score than the jth patient, then this is a concordant pair.
The C-index is calculated as the proportion of concordant pairs divided by the total
number of possible pairs. It measures the probability of successfully predicting the
sequence of events for a random pair of cases. A C-index of 0.5 or lower indicates
the model predicting an outcome no better than random chance and a higher C-index
indicates a higher predictive ability.
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• The Brier score was first introduced in 1950 by (Brier, 1950) as a method of assessing
the prediction error of weather forecasts. For binary prediction models, the Brier
score is calculated as the mean squared prediction error. In the study by (Graf et al.,
1999), the Brier score was adopted as a performance measure for predicting survival
up to sometime t, and was given the name ‘IBS’. For models based on time-to-event
data, the Brier score is defined as: at a given time point t, the average squared
distances between the predicted survival probability and the observed survival status.
The IBS represents an overall estimate of the models’ prediction error at all available
time points. Similar to the C-index, the IBS is a number between 0 and 1, with 0
being the best value.
Chapter 7: Discriminating measures for binary classification models
In Chapter 7, two measures were used to evaluate the discriminative ability of binary
classifiers: the AUROC and the AUPRC. We here define what these two measures are,
describe why they are suitable for our study, and present how to interpret these measures.
What are AUROC and AUPRC?
• For a binary classification problem, when two cases (a positive and a negative case)
are selected at random, the AUROC reflects the probability of the classifier assigning
a higher risk score to the positive case (Hanley and McNeil, 1982). In a plot of a
ROC, the x-axis is the sensitivity (recall) and the y-axis is 1-specificity (false positive
rate). Therefore, AUROC is calculated as the average sensitivity, regarding all values
of the specificity as equally likely (Hand, 2009).
• In a plot of a PRC, the x-axis is the sensitivity (recall) and the y-axis is the precision
(positive predictive value). Therefore, AUPRC is calculated as the average positive
predictive values, regarding all values of the sensitivity as equally likely (Saito and
Rehmsmeier, 2015).
Besides AUROC, why was AUPRC used as an additional measure?
For binary classification tasks, the two outcome categories are often labelled as positives
(e.g., diseased) and negatives (e.g., disease-free). Sometimes the interest of a study would
be to get the prediction of both the outcomes correct (i.e., positives, ‘1’ and negatives, ‘0’),
else the interest can be in getting the prediction correct only for the positives. Moreover,
when the outcome distribution is imbalanced (the negatives being more than the positives),
then predicting the positives become more important. The AUPRC is used as a performance
metric when the outcome data are imbalanced and the investigators care a lot about
recognising the positives. If we are interested in how the model performs on both the
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positive and the negative categories, then AUROC is a good choice. A typical example
is for classifying images between dogs and cats. In this case, there is no distinguishing
between the positives and negatives, we thus want the model to perform equally well in
both the dogs and cats categories. However, if we are not interested in how well the model
performance is on the negatives (i.e., the true negatives are less of a concern), but just
focus on positive prediction (i.e., we want a high value of sensitivity and to have as many
of the positives classified as positives as possible), then AUPRC is a better choice. For
example, in our case for predicting pain following root canal treatment, the proportion of
developing one-week and six-month pain were 24% and 11%, respectively, we considered
it as a data set with imbalanced outcome distribution. And for this research question, we
care less about how many of the negative predictions (non-pain cases) are correct, but we
want to ensure none of the positive observations (pain cases) missed out, and that most of
the positive predictions are correctly classified.
How to interpret AUROC and AUPRC?
There are similarities and difference between the interpretation of AUROC and AUPRC.
While the higher values for both AUROC and AUPRC indicate the better models’ perfor-
mance, they differ in terms of what is considered as a ‘good’ baseline value. Differing to
AUROC where a baseline value always being 0.5, the baseline value of AUPRC is equal
to the proportion of positive observations (Saito and Rehmsmeier, 2015), calculated as
Positives/(Positives+Negatives). Thus, models built on different data sets have different
AUPRC baselines. For example, a data set with 10% positives has an AUPRC baseline of
0.1, so if a model obtains an AUPRC of 0.3, then it means using the model is better than
not using the model. However, for a data set with 80% positives as baseline, a model with
an AUPRC of 0.7 maybe viewed as worse than not using the model.
3.5.2 Measures for models’ calibration
Besides discrimination, the performance of prediction models also relates to the
agreement between the predicted and the observed probabilities, and this is called models’
calibration (Van Calster et al., 2016). In this thesis, calibration curves were adopted to
present the models’ calibration ability for both empirical examples. Specifically, in Chapter
7, we used a method to create a confidence belt for the calibration curve (Nattino et al.,
2016). Compared to the standard calibration curve, the calibration belt can spot the range









The primary aim of this chapter is to identify existing prediction modelling studies in the
field of periodontology. Additionally, this chapter is included in this thesis to achieve the
second aim: to demonstrate a systematic approach for collecting evidence on the prediction
modelling research in the field of oral health. We were interested in periodontitis because
it is one of the most prevalent oral diseases and prediction modelling research around this
discipline has been largely investigated. This paper acts as our first step to gain insights
into clinical prediction models in oral health.
This chapter contains the first of a series of four studies contributing to this thesis.
Details of this publication are:
Du M., Bo T, Kapellas K, Peres M. Prediction models for the incidence and progression
of periodontitis: A systematic review. Journal of Clinical Periodontology. 2018;45:1408-
1420. https://doi.org/10.1111/jcpe.13037.
The accepted version of the published paper is reproduced as follows.
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Aim: To comprehensively review, identify and critically assess the performance of models
predicting the incidence and progression of periodontitis.
Methods: Electronic searches of the MEDLINE via PubMed, EMBASE, DOSS, Web
of Science, Scopus and ProQuest databases, and hand searching of reference lists and
citations were conducted. No date or language restrictions were used. The Critical
Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies
checklist was followed when extracting data and appraising the selected studies.
Results: Of the 2,560 records, five studies with 12 prediction models and three
risk assessment studies were included. The prediction models showed great heterogeneity
precluding meta-analysis. Eight criteria were identified for periodontitis incidence and
progression. Four models from one study examined the incidence, while others assessed
progression. Age, smoking and diabetes status were common predictors used in modelling.
Only two studies reported external validation. Predictive performance of the models
(discrimination and calibration) was unable to be fully assessed or compared quantitatively.
Nevertheless, most models had ‘good’ ability to discriminate between people at risk for
periodontitis.
Conclusions: Existing predictive modelling approaches were identified. However,
no studies followed the recommended methodology, and almost all models were
characterized by a generally poor level of reporting.
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4.2 Introduction
Periodontitis has become a significant global healthcare problem with increasing costs for
both the individual and society (Tonetti et al., 2017). Periodontitis is one of the leading
causes of tooth loss and ranks as the sixth most prevalent disease globally (Kassebaum
et al., 2017). Early identification of people at risk of periodontitis and early treatment
are important to retain teeth and improve oral health-related quality of life (Ramseier
et al., 2017; Tan et al., 2016). In order to improve prevention, efforts in epidemiology
have shifted from identifying new risk factors to developing viable algorithms to assess
individuals at risk (Page and Beck, 1997). The American Academy of Periodontology
(AAP) stated: ‘the use of risk assessment will become a component of all dental and
periodontal evaluation as well as part of all periodic dental and periodontal examination’
(American Academy of Periodontology, 2008). Criteria and measures of periodontitis
and progression vary across the literature (Savage et al., 2009). The World Workshop
on the Classification of Periodontal and Peri-Implant Diseases and Conditions recently
agreed on a new classification and case definition system based on a multidimensional
staging and grading system, which not only reflects the severity of disease, but also
accounts for the risk of aggressiveness and progression (Tonetti et al., 2018). Previously,
several risk assessment tools for periodontitis were based on a list of single factors
developed to delineate different risk levels, and often risk portrayed the extent and severity
of periodontal status (Lang et al., 2015). That is, people with fewer risk factors and
presenting little periodontal destruction are assumed to be at ‘low’ risk for developing
and worsening of the disease, whereas those deemed as ‘high’ risk are considered to
have a high probability of future disease. Despite these tools fitting the definition of ‘risk
assessment’ as defined by the AAP (American Academy of Periodontology, 2008), most
are qualitative assessments, as they do not calculate the accurate probability required by
prediction studies (Collins et al., 2014) .
Prediction in medicine includes both studies of the presence of disease (diagnosis) or
an event in the future course of disease (prognosis). A prediction model contains more
than two predictors and aims at converting observed values in individuals to absolute and
objective probability, going beyond correlation coefficients and risks (Steyerberg and
Vergouwe, 2014). Beside the goodness of fit, a prediction model should be evaluated in
terms of discrimination, which is a model’s ability to distinguish individuals with and
without an outcome event; and calibration, which is the agreement between predicted
and observed outcomes (Harrell et al., 1996; Steyerberg et al., 2010; Vergouwe et al.,
2002). Prediction is not new in medicine, and there are a range of prediction models
existing in the fields of cardiovascular diseases (Shariat et al., 2008), cancers (Altman,
2009; Shariat et al., 2008), stroke (Counsell and Dennis, 2001), diabetes (Collins et al.,
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2011; Damen et al., 2016), and reproductive medicine (Leushuis et al., 2009). Compared
to subjectively made predictions, prediction models provide more accurate and fewer
variable estimates of risk (Kattan et al., 2013; Ross et al., 2002). However, systematic
reviews evaluating the methodology and reporting of prediction modelling studies all
conclude that these studies are deficient in study design, statistical approaches, and
suffer from poor reporting (Bouwmeester et al., 2012; Collins et al., 2013; Jaja et al., 2013).
Several models aiming at predicting periodontitis prevalence, incidence, progression,
and tooth loss have been developed, but their performance, validity, and clinical
applicability raise concerns (Schwendicke et al., 2018). In addition, a universally accepted
objective method/model for calculating the probability of prospective development or
deterioration of periodontitis does not exist. A review of all existing prediction models
is lacking, particularly in terms of their methodological quality, validity and clinical
reliability.
Thus, the aim of this study was to comprehensively review, identify and critically
appraise studies presenting prediction models for periodontitis incidence and progression.
Specifically, the review question was: ‘What models with clustered risk factors predict the
incidence and progression of periodontitis in adults? Moreover, the existing modelling
approaches are of special interests’.
4.3 Methods
The protocol for this review was prepared according to Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009). Regis-
tration of the protocol was on PROSPERO (No.CRD42018085437) on 13rd March 2018,
prior to the formal commencement of this systematic review, and an update on 26th April
2018 was made to formally include the Checklist for Critical Appraisal and Data Extraction
for Systematic Reviews of Prediction Modelling Studies (CHARMS) (Moons et al., 2014)
criteria into the evaluation methodology. Structure of this systematic review was prepared
based on Cochrane Handbook of Systematic Reviews of Intervention (5.1 version) (Higgins
and Green, 2011) and Joanna Briggs Institute Reviewers’ Manual (4th edition) (Aromataris
and Munn, 2017).
4.3.1 Inclusion and exclusion criteria
The predictors include, but are not limited to: tooth-related factors (initial peri-
odontal status), oral health-related factors (tooth brushing, interdental cleaning, pattern
of dental visits), subject-related factors (smoking, diabetes, alcohol consumption, over-
weight/obesity), inherited factors (family history of periodontitis), psychological factors,
and socioeconomic/demographic factors.
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Studies were eligible if they met the following criteria: (1) Described the development,
validation or assessment of a model that was constructed to predict the incidence or
progression of periodontitis used in the general population; (2) Population-based cohort
studies with samples selected probabilistically; (3) Targeted on adults aged 18 years or over;
(4) The outcomes were periodontitis incidence or progression; (5) The model contained at
least two risk factors as predictors.
Studies were excluded if they were: (1) Not original data, such as review article,
meta-analysis, letter to editor, editorials or comments on prediction studies; (2) With
participants younger than 18 at baseline; (3) Targeting on specific populations like those
with chronic diseases, pregnant, intellectual disability, HIV, drug-dependent person and
alcohol-dependent person; (4) Models including a single predictor, test, or marker; (5)
With no probabilistic sample; (6) Not peer reviewed.
4.3.2 Search strategy
Six electronic databases (MEDLINE via PubMed, EMBASE, DOSS, Web of Science,
Scopus, and ProQuest) were used for article searching and collection (supporting informa-
tion included in Appendix B Supplement 1). The primary search strategy was constructed
based on four domains (‘periodontitis’ AND (‘prediction’ OR ‘risk factors’ OR ‘risk
assessment’) AND (‘incidence’ OR ‘progression’) AND general aspects for longitudinal
studies). No time and language restrictions were used. Additional searches were performed
by reviewing the bibliography and citation of the retrieved full-text articles.
4.3.3 Study selection
Two reviewers (MD, TB) independently scanned titles and abstracts in parallel and
selected the articles that meet the inclusion criteria, then full texts of the selected articles
were read. There was disagreement for three studies, where the referees (MP, KK) were
called and an agreement was reached.
4.3.4 Data extraction
Two reviewers (MD, TB) collected key characteristics of the study and quantitative
data related to results by pre-defined data-abstraction forms. The CHARMS (Moons et al.,
2014) (Appendix B Supplement 2) was used for data extraction.
Study characteristics included data such as author/publication year, setting/context,
type of study, participant characteristics (mean age at baseline, sex, study inclu-
sion/exclusion information), sample size, outcomes to be predicted, periodontitis classifica-
tion criteria or definition for the outcome, predictors. Quantitative data extraction focused
on the two most common statistical measures of predictive performance: discrimination
and calibration. In terms of model development, type of model, missing values, selection
of candidate predictors and selection of final predictors were extracted. In terms of model
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performance, the reported concordance (C) statistic, sensitivity, specificity, false-positive
and false-negative proportions were extracted; other data related to model evaluation (exter-
nal/internal validation), model presentation (formula/ score chart), and model interpretation
were extracted. If a model presented several cut-off scores, the one that represented the
highest sensitivity model was selected (Verstraete et al., 2015).
4.3.5 Risk of bias assessment
The CHARMS checklist for critical appraisal of prediction modelling studies was
used to assess the risk of bias that may occur in participant selection, predictor, outcome,
attrition, and analysis for model development. CHARMS defines the risk of bias as ‘low’,
‘moderate’ and ‘high’ level. Cohort studies were assessed by the Newcastle-Ottawa Scale
(NOS) in three domains: selection, comparability, and outcome. Detailed criteria of the
CHARMS checklist and NOS are provided in Appendix B Supplements 3 and 4.
4.3.6 Data synthesis and reporting
Due to study heterogeneity, it was deemed inappropriate to conduct a meta-analysis.
Therefore, a narrative report of findings is provided.
4.4 Results
4.4.1 Studies searches and selection
2,560 titles and abstracts were identified, of which 41 papers were examined in full
text, however, no grey literature was identified. Reasons for exclusion are shown in S5,
common reasons included tooth- and site-level studies, and validation study of a risk
assessment tool. Finally, seven studies were included in the analysis (Figure 4.1). Three
papers reported risk assessment models, three papers proposed prediction models, and one
reported both.
4.4.2 Characteristics of studies and data extraction
Overview
The characteristics of studies are shown in Tables 4.1 and 4.2. Three studies were from the
USA, one each was from Brazil, Italy, Spain, Sweden, and Switzerland.
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Figure 4.1: PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) flow
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For risk assessment tools, in 2002, Page et al. introduced the Periodontal Risk
Calculator (PRC) (Page et al., 2002), and in 2007, they added disease status score to the risk
score (PreViser) (Page, 2007), which became a component of the Oral Health Information
Suite. Based on 11 parameters: age, smoking, diabetes, history of periodontal surgery,
periodontal probing depth (PPD), bleeding on probing (BOP), furcation involvement (FI),
root restorations or sub-gingival calculus, radiographic bone height and vertical bone
lesions, the risk score and disease severity score can be calculated to establish both risk
assessment as well as disease severity. The Periodontal Risk Assessment (PRA) model,
proposed by Lang et al in 2003, is a multifactorial graphic composed of six vectors
representing six systemic and clinical factors: systemic and genetic aspects, diabetes,
cardiovascular disease, smoking, percentage of sites with BOP, prevalence of residual
pockets > 5mm (residual pocket > 4mm), number of tooth loss, loss of periodontal
support in relation to the patient’s age. In contrast to PRC, the targeted population are
patients during the supportive periodontal treatment. Moreover, PRA was designed to
classify patients as either low-, moderate- or high-risk profile. Some validation and
updating studies were conducted related to PRC and PRA (Table 4.1). The simplified risk
assessment model (UniFe) proposed by Trombelli et al. (Trombelli et al., 2009) included
the five key parameters: smoking, diabetes, BOP, number of sites with PD > 5mm, and
radiographic bone loss-to-age ratio. Patients are assigned to five risk categories: score 1
(low), 2 (low-medium), 3 (medium), 4 (medium-high), and 5 (high). In general, all of
these risk assessment tools share several common attributes. They all aimed at assigning
patients into one of those risk categories, but did not provide the predicted probability of
getting the outcome. For prediction modelling studies, they varied in derivation cohort,
follow-up period, type of predictors, and the definition of outcome (Table 4.2). Of the five
prediction modelling studies, one acted as a validation study, while the other four were
model development studies, without (n = 3) or with (n = 1) external validation. Twelve
prediction models were identified, of which three were based on tooth level and nine
were on individual level. Two models were explicitly developed only for white or black
populations in the US.
Study design and participant sampling
While prediction model development and validation can be achieved from nested case-
control or case-cohort data sets, prospective cohort studies are the preferred option (Moons
et al., 2009). Four studies used prospective cohort data while one utilised data from a
retrospective cohort study. Participant recruitment was well-described in all five studies.
Three studies involved participants from clinical settings with an average age of 59.5 years,
and two used cohort data sets from general populations. Of the cohort studies, one was
a birth cohort, which recruited their sample at age 24 years while the other investigated
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people aged 65 years and over longitudinally. Follow-up times ranged from 3 to 20 years.
Study samples sizes ranged from 183 to 3985 participants.
Outcome
The outcome definition of periodontitis varied across studies, and ultimately eight criteria
were identified (Table 4.2). Four models from one study predicted the occurrence of
periodontitis using four alternate case definitions; three models from one study predicted
the incidence of attachment loss of 3mm or more, the other three studies with five models
predicted periodontitis progression, of which tooth loss was mostly selected as one of the
outcomes of progression.
4.4.3 Development, presentation, and performance of the prediction models
Candidate predictors and selection of final predictors
Figure 4.2 and Appendix B Supplement 6 list > 30 variables included across the prediction
models. Most incorporated the well-established periodontitis risk factors age, smoking and
diabetes. Other common predictors included oral examination parameters such as BOP,
clinical attachment loss (CAL), and degree of tooth loss. The number of predictors in
the studies varied between four and 11 and were selected based on clinical knowledge or
literature. Two studies applied predictor selection in multivariable analyses: one reported
criterion for predictor selection was p-value = 0.05 in univariate analysis (Beck, 1994),
whilst the other used variables in nodes of the first two leaves from the decision tree
analysis (DTA) (Leite et al., 2017). Both reported using automated variable selection
(forward and/or backward selection and stepwise) regression procedures to decide the final
variables.
Missing values
Three studies handled missing data by excluding subjects lost to follow-up from the
analyses, while the other two studies did not provide a description of how missing data
was managed.
Development and performance of the models
Models within a particular study used the same model generation method however, none
of the five studies used the same statistical methods. At least one measure of predictive
performance was reported for all the 12 models. Discrimination was reported in the form
of C-statistics, Area under the receiver operating characteristic curve (AUROC), sensitivity
+ specificity, positive/negative predictive value (PV+, PV-), but none of these models
reported calibration. Detailed information is listed in Tables 4.3 and 4.4.
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Figure 4.2: Frequency of identified risk predictors in the final prediction models.
BL: bone loss; BMI: body mass index; CAL: clinical attachment loss; FI: furcation
involvement; PPD: periodontal probing depth. Others includes education, race,
gingival recession, alcohol, bruxism, patient awareness, therapist’s experience, stress-
related factor. Bacterial includes plaque, calculus, and/or presence of periodontal
pathogens. Frequency for “Tooth brushing or mouthwash”, “Family history”, “Dental


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.4: Model Performance and evaluation.
Study
R2




























Model 1 0.75 0.62 0.88 No
Model 2 0.65 0.54 0.75 No
Model 3 0.64 0.70 0.58 No





0.53 0.86 0.71 0.76 0.83 0.79 External
valida-
tion



























[1]AUROC: Area under the receiver operating characteristic curve, [2]Sen: Sensitivity,
[3]Spec: Specificity, [4]PV+: Positive prediction value, [5]PV-: Negative prediction
value, [6]Accu.: Accuracy.
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4.4.4 Quality and risk of bias assessment
The risk of bias of prediction modelling studies is shown in Figure 4.3 and Appendix
B Supplement 7. Of all selected prediction studies, participant-related bias occurred in
two, no predictor-related and outcome-related bias occurred, however, all studies have a
bias in sample flow-related and statistical analysis-related area. Newcastle-Ottawa Scale
scoring is presented in supporting information Appendix B Supplement 8. Among five
cohort studies, two showed ‘Good’ quality, and three showed ‘Poor’ quality. No study was
excluded because of quality or bias.
Figure 4.3: Bias assessment of the prediction modelling studies according to CHARMS.
L: low risk of bias; M: Medium risk of bias; H: high risk of bias.
Model presentation and interpretation
The presentation of the prediction models varied from narrative and graphical to detailed,
quantitative formulas (Table 4.3). Among five studies, one used a 7×7 table (Morelli et al.,
2018), two prediction models are available online as web-based tools (Lindskog et al.,
2010; Martinez-Canut et al., 2018), while the other two did not report the presentation.
Beck (Beck, 1994) used an ordinal logistic regression model to predict whether the
individual will develop CAL > 3mm, with a low sensitivity of 56% and a specificity of
74%. The study distinguished prediction (where the model included risk predictors, such
as degree of tooth loss), with risk (whereby the model only contained risk factors). Leite et
al. (Leite et al., 2017) established four multivariable logistic regression models to predict
the occurrence of periodontitis. Choice of classification influenced the prediction accuracy
with sensitivity varying between 41.4% to 69.8%, and specificity variability ranging from
4.5 Discussion 79
58.2% to 88.5%. Lindskog et al. (Lindskog et al., 2010) validated a web-based algorithm
for predicting periodontitis progression, radiographic marginal bone loss, and tooth loss,
with accuracy of 79%, sensitivity of 86%, specificity of 71%, PV+ of 76%, and PV- of 83%
at the patient-level; and with accuracy of 65%, sensitivity of 66%, specificity of 64%, PV+
of 73%, and PV- of 55% at the tooth-level. Generalized linear mixed regression was used
by Martinez-Canut et al. (Martinez-Canut et al., 2018) to predict the dichotomous event:
tooth loss due to periodontal disease (TLPD+ or TLPD-). The predictive models for molars
and non-molars achieved an AUROC of 93% and 97%, a sensitivity of 39% and 43%, a
specificity of 98% and 99%, a positive predictive value of 72% and 60%, and a negative
predictive value of 94% and 98% respectively. In the model by Morelli et al. (Morelli
et al., 2018), the latent class analysis was used to calculate the Index of Periodontal Risk
(IPR) score and classify individuals or teeth into different classifications. This IPR score
can predict the 10-year tooth loss with C-statistics of 0.72. No study conducted internal
validation. External validation was conducted in Martinez-Canut’s and Morelli’s model,
but only Morelli’s model reported the model performance with C-statistics of 0.72 and
0.75 for 3-year attachment loss and 5-year tooth loss, respectively.
4.5 Discussion
4.5.1 Summary of main findings and quality of the evidence
In this systematic review, we distinguished the risk prediction, estimating the
probability of an event, from risk assessment, stratifying the risk levels, and we provided
an overview of the currently available prediction models of periodontitis incidence and
progression based on clustering of risk factors and predictors. Fifteen models from
seven studies were identified, of which three were risk assessment tools, and 12 were
prediction models. Despite concerted efforts to develop and improve periodontitis
prediction modelling, the overall results have not been ideal. Risk assessment tools were
designed either qualitatively, classifying patients into low, medium, and high-risk level,
or quantitatively, converting the disease status and risk status into risk scores. More
review articles about the status of periodontal risk assessment are available in the literature
(Heitz-Mayfield, 2005; Kye et al., 2012; Lang et al., 2015). The 12 prediction models
varied in derivation cohort, type of predictors, outcome, statistical approaches, model
performance, and model presentations. Each model had its merits and limitations. Some
are able to calculate the exact probability of periodontitis development or tooth loss
while others are more suited to predicting periodontal health. Nonetheless, it is difficult
to determine which models stood out when it comes to predictive performance and
clinical usefulness. Most studies were of ‘good’ quality concerning participant selection,
predictors, and outcomes. However, prediction models were deemed to be of ‘high’ risk of
bias due to poor handling with missing data, statistical methods for model development,
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and the lack of validation.
Variables covered the common risk factors and indicators for periodontitis (Albandar,
2002), the most frequent were age, smoking, diabetes, and sex. Some other clinical
parameters such as number of teeth lost and plaque-related factors also were included in
risk prediction studies. All models selected candidate variables based on the published
literature, but two studies selecting final predictors based on statistical significance, may
lead to a model fitting the data too closely (Bedogni, 2009; Collins et al., 2015). Eight
identified criteria for periodontitis incidence and progression showed the absence of
consensus, resulting in variation across data collection of longitudinal studies (Leite
et al., 2017). Two previous prominent definitions from AAP/CDC and EFP were not
given priorities in existing prediction models, and the change of PPD, CAL, bone loss, or
tooth loss have been used to investigate the disease progression. The prediction models
commonly reported performance on discrimination but cannot be compared quantitatively,
because they reported performance in the original derivation cohort only. However, the
reported performance could give an indication about the maximum potential predictive
performance in other populations, because accuracy usually decreases in future external
populations (Collins et al., 2015; Steyerberg et al., 2013).
Overall, risk assessment/scoring systems cannot replace the need of prediction models.
Generalizability of the prediction models in other settings with different population and
socioeconomic compositions remains unclear. Periodontitis incidence and progression has
been differently defined for epidemiological purposes (Holtfreter et al., 2015), complicating
prediction. Assessment of methodological quality revealed that improvements are clearly
needed, both in conducting studies and eventual reporting, in-line with conclusions made
previously (Bouwmeester et al., 2012). The recently published transparent reporting of a
multivariable prediction model for individual prognosis or diagnosis (TRIPOD) statement,
may lead to improvements in conducting and reporting of future studies (Collins et al.,
2015). We showed that nearly half of the items considered essential in the TRIPOD
statement were either not or inadequately reported (Appendix B Supplements 9 and 10).
4.5.2 Strengths and potential limitations
The strengths of this study include the very first perspective of prediction modelling
studies for periodontitis, comprehensive literature search, adherence to rigorous systematic
review methodology, and adherence to recommended guidelines for reporting. However,
this study is not free of limitations. The broad inclusion criteria could allow the inclusion
of studies not meant to concern accurate probability, but only qualitatively evaluating the
risk levels. Outcomes included tooth loss though it was not a part of this systematic review
since periodontitis progression and tooth loss are somewhat linked. Finally, high study
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heterogeneity precluded overall comparisons of prediction models despite most containing
the same performance measures.
4.5.3 Implications for future research
In order to develop high-quality prediction models for periodontitis, a standard
methodology for model generation should be adopted (Moons et al., 2012). Several
strategies may be adopted to improve the performance and usability of the available
and further models. First, a comprehensive external validation of existing models in an
independent eligible population will allow a model-to-model comparison and identify the
strength and weakness of each model. Second, the predictive performance of a model
might improve by accounting for new and better predictors such as gingival crevicular
fluid and salivary markers (e.g., interleukin-1, and matrix metalloproteinase-8) (Giannobile
et al., 2009; Gursoy et al., 2011) or microbiology information. Models should predict
specific events accurately and be relatively easy to use. If a prediction model provides
inaccurate estimates of future-event development, it may mislead healthcare professionals
and provide inappropriate management of patients. In contrast, if a model has good
predictive ability but is hard to apply (e.g., with complicated examinations or questions),
time-consuming, or costly, it will not be commonly used (Pencina et al., 2008). Therefore,
an ideal prediction model should achieve a balance between predictability and simplicity.
Third, different modelling methods can be employed such as machine-learning approaches,
tree-based algorithms, and neural networks (Goldstein et al., 2017; Peissig et al., 2014).
In the field of healthcare, machine learning algorithms have outperformed conventional
regression models in predictive ability in identifying patients at high risk for developing
disease (Singal et al., 2013). Lastly, using consistent outcome definitions will enhance not
only the reporting, but also the generalizability and comparability of models. The novel
classification of periodontal manifestations and conditions of AAP and EFP is strongly
recommended for further studies (Tonetti et al., 2018).
4.6 Conclusion
This is the first systematic review of prediction modelling studies for periodontitis inci-
dence and progression. It revealed several methodological and reporting shortcomings of
published prediction models and indicated further research is required. Logistic regression,
generalized linear mixed regression, and latent class analysis were used as predictive
modelling approaches. Existing models covered the most likely predictors for periodontitis
development in adults and achieved acceptable predictive accuracy, but the absence of
consensus regarding periodontitis measurement and classification complicates modelling.
In the future predictive modelling studies, it is essential to conduct cross-validation and/or
out-of-sample estimation and/or validation with a second data set, both for variable selec-
tion, and for measures of prediction accuracy, in order to avoid overfitting. More efforts
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can be made in taking into account new predictors, such as microbiological information,
biological markers, and machine learning approaches, such as decision tree, or neural
network.
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Examining bias and reporting in oral health
prediction modelling studies
Preface
In Chapter 4, we identified that the quality of most prediction models in the discipline
of periodontology is poor. Based on these findings, Chapter 5 takes a further step to
obtain more information on the methodological quality and reporting transparency of
prediction modelling studies in oral health, regardless of their investigated outcomes. In
this chapter, we review the recent prediction modelling studies published in major dental,
epidemiological and biostatistical journals. We find that oral health prediction modelling
studies suffer from various potential biases, such as selection bias, measurement errors.
These biases lead to a lack of reproducibility and non-transparent reporting of the existing
models. To solve these issues, suggestions and achievable steps are provided in this
chapter to improve the reliability of future oral health prediction modelling research. This
is the first study of this nature in oral health field.
This chapter contains the second of a series of four studies contributing to this thesis.
Details of the publication are:
Du M, Haag D, Song Y, Lynch J, Mittinty M. Examining bias and reporting in oral
health prediction modelling studies. Journal of Dental Research. 2020;99(4):374-387.
https://doi.org/10.1177/0022034520903725.
The accepted version of the published study is reproduced as follows.
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Background and aims: Recent efforts to improve the reliability and efficiency of
scientific research has caught the attention of researchers conducting prediction modelling
studies. Use of prediction models in oral health has become more common over the past
decades for predicting the risk of diseases and treatment outcomes. Risk of bias (ROB)
and insufficient reporting present challenges to the reproducibility and implementation of
these models. A recent tool for bias assessment—PROBAST (Prediction model Risk Of
Bias Assessment Tool) and a reporting guideline—TRIPOD (Transparent Reporting of a
multivariable prediction model for Individual Prognosis Or Diagnosis) have been proposed
to guide researchers in the development and reporting of prediction modelling studies, but
their application has been limited.
Methods: Following the standards proposed in these tools and a systematic re-
view approach, a literature search was carried out on PubMed to identify oral health
prediction modelling studies published in dental, epidemiological and biostatistical
journals. ROB and transparency of reporting was assessed using PROBAST and TRIPOD.
Results: Among 2,881 papers identified, 34 studies containing 58 models were
included. The most investigated outcomes were periodontal diseases (42%) and oral
cancers (30%). 75% of the studies were susceptible to at least four (out of 20) sources of
bias,including measurement error in predictors (n = 12) and/or outcome (n = 7), omitting
samples with missing data (n = 10), selecting variables based on univariate analyses (n =
9), overfitting (n = 13), and lack of model performance assessment (n = 24). Based on
TRIPOD, at least five (out of 31) items were inadequately reported in 95% of the studies.
These items included sampling approaches (n = 15), participant eligibility criteria (n = 6),
and model-building procedures (n = 16).
Conclusion: There was a general lack of transparent reporting and identification
of bias across the studies. Application of the recommendations proposed in PROBAST
and TRIPOD can benefit future research and improve the reproducibility and applicability
of prediction models in oral health.
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5.1 Introduction
In general, over 85% of the health research is unreliable due to the lack of reproducibility
(Chalmers et al., 2014). In order to improve the transparency and reliability of health re-
search, collaborative efforts (e.g., EQUATOR network: http://www.equator-network.org/)
have been made to produce measures for quality assessment of various types of studies.
These measures include guidelines for reporting preclinical studies (ARRIVE) (Kilkenny
et al., 2012), clinical trials (CONSORT) (Schulz et al., 2011), observational studies
(STROBE) (von Elm et al., 2014), and systematic reviews and meta-analyses (PRISMA)
(Moher et al., 2009). Additionally, bias assessment tools have also been developed, such
as Cochrane risk-of-bias (for randomised studies), ROBINS-I (Risk of Bias in Nonran-
domized Studies of Interventions), and QUIPS (Quality In Prognosis Studies). In health
research, prediction modelling studies are used to identify population at high risk of a
particular health condition, and determine the benefit from a care management plan
The primary goal of prediction models is to improve the accuracy with which a
particular outcome can be predicted given a set of observed predictors. However, a
difference between the predicted and the observed outcome always exists due to random
or systematic error or both (Rothman, 2008). Systematic error, which also refers to bias,
is the difference between the expected and the true value of the parameters of interest in
the population. Random error occurs due to variations in a given population and is largely
influenced by sample size (Rothman, 2008).
One key aspect of the quality of prediction modelling studies is related to the potential
of bias in data collection and modelling processes, which involves misclassification,
selection of participants, missing information and unmeasured covariates (Lash et al.,
2014). Therefore, inaccurate prediction due to systematic errors can be avoided or at least
reduced if appropriate methodology concerning data collection and analytical procedures
are used.
Additional issues concerning the quality of prediction modelling studies include
transparency and completeness of reporting of a prediction modelling study. Insufficient
reporting of data sources and cleaning, as well as model development processes hinders
study replication and inhibits the assessment of the reliability of such studies.
Systematic reviews have shown that prediction models have been developed to assess
the risk of multiple oral conditions among various populations. These conditions include
dental caries (Senneby et al., 2015), periodontal diseases (Lang et al., 2015), and oral
cancers (Sharma and Om, 2013). Most of these systematic reviews are interested in
estimating the effect size or to understand the importance of certain predictors, rather than
assessing the overall quality of the included prediction modelling studies. Therefore, the
present study aims to assess the ROB (using PROBATS) and reporting transparency (using
TRIPOD) of recent oral health prediction modelling studies.
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5.2 Methods
5.2.1 Protocol and registration
This study was prepared in accordance with the PRISMA guidelines (Moher et al.,
2009). The review protocol was registered on PROSPERO (No. CRD42019122274).
This is not a typical systematic review, since we limited our literature search to certain
journals and publication times, however strictly adhere to the guidelines of conducting and
reporting a systematic review.
5.2.2 Inclusion and exclusion criteria
Studies were included if they met the following criteria: 1) diagnostic and prognostic
multivariable prediction modelling studies; 2) for prognostic purposes, study designs
included observational cohorts, case-control, and RCTs. For diagnostic purposes, cross-
sectional designs were also included; 3) outcomes were oral health-related and clearly
defined, including but not limited to diagnosis (incidence, occurrence, prevalence) and
prognosis (outcome of treatment, progression, survival).
Studies were excluded if they: 1) were not original research (e.g., review articles,
letters, editorials); 2) were not human research (e.g., cell- and molecular-level); 3) were
not multivariable modelling studies; 4) did not include oral health outcomes (e.g., study
investigating periodontitis as a predictor for type 2 diabetes).
5.2.3 Literature search and study selection
To reflect the ‘good-quality’ research and best available evidence in oral health
prediction modelling studies, 14 dental journals, eight epidemiology journals and seven
biostatistical journals were fully searched on PubMed from 2016/01/01 to 2018/12/31,
following the development of TRIPOD in 2015 (ranking based on Thomson Reuters
Journal Citation Reports, Google scholar, and Scopus). Figure 5.1 shows the flowchart of
study selection. Two authors (MD and YS) screened all the titles and abstracts based on
inclusion and exclusion criteria in parallel, then full-text reading of all selected articles was
performed for eligibility assessment. In cases of disagreement, a third referee (DH) was
involved. Detailed search strategy and journals selection criteria are provided in Appendix
C Supplements 1, 2, and 3.
5.2.4 Data extraction
Key information extracted from each eligible study include: setting, study design,
population characteristics, follow-up period, sample size, outcomes, predictors, missing
data, variable selection, modelling approach, model presentation, interpretation, perfor-
mance (discrimination and calibration) and evaluation.
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(14 dental/oral health journals, 8 general epidemiological 
journals, and 7 bio-statistical journals)
Search for prediction modeling studies:
































Title and abstract screened 
(n = 2881)
Records excluded based on 
criteria (n = 2692)
Full-text articles assessed for 
eligibility 
(n = 50)
Full-text articles excluded, with 
reasons (Appendix Table 9)
(n = 16)
Predictive model development & evaluation studies (n = 34)
Journal of periodontology,
n=6




Clinical oral investigations, 
n=1




Journal of dental research,
n=2




Clinical oral implants research,
n=3 












Figure 5.1: PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) flow
diagram of the studies search and selection.
5.2.5 Application of PROBAST and TRIPOD
A pilot study on applying each PROBAST item was conducted and agreement was
achieved among MD, DH, JL, and MM. Two authors (MD and DH) applied PROBAST
across all selected studies and a third referee (MM or JL) was involved in cases of doubt.
Following PROBAST recommendations (Moons et al., 2019), we classified studies into
high, low and unclear ROB, and recorded the answer of ‘Yes (Y)’, ‘Probably Yes (PY)’, ‘No
(N)’, ‘Probably No (PN)’, or ‘No Information (NI)’ for 20 signalling questions (Appendix
C Supplement 4) along with supportive background (Appendix C Supplement 5). TRIPOD
was applied by one author (MD) with experience on this tool (Du et al., 2018) and doubts
were resolved with the involvement of a second reviewer (DH or JL or MM). A score for
each study was then calculated in order to quantify the completeness and transparency
of reporting (maximum 31 items with a score of 1 for item met and a score of 0 if the
item was not met). Detailed PROBAST and TRIPOD criteria are provided in Appendix C
Supplements 6, 7, and 8.
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5.3 Results
5.3.1 Literature search, study selection and general characteristics of the included
prediction modelling studies
Out of the 2,881 searched articles, 50 were included following title and abstract
screening. After reading the full-text, 34 studies were included in the review (exclusion
reasons are provided in Appendix C Supplement 9). There were 24 studies emphasising
model development for risk assessment, and ten studies focusing on model validation with
(n = 1) or without (n = 9) updating. Study characteristics are summarized and presented in
Tables 5.1 and 5.2. Details of the investigated outcomes, predictors used, model deviation
methods and model presentations are provided in Appendix C Supplements 10 and 11.








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































108 Examining bias and reporting in oral health prediction modelling studies
5.3.2 Identification of main sources of bias in the included prediction modelling
studies
Figure 5.2A shows the proportion of Y, PY, N, PN and NI for each PROBAST item.
Figure 5.2B presents the proportion of studies with potential biases according to four
domains of PROBAST (Participants, Predictors, Outcomes, Analysis), and Figure 5.2C
presents the ‘biased’ domain(s) identified in each study. Overall, 76% of the studies were
susceptible to at least four (out of 20) sources of bias (e.g., measurement error, missing
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110 Examining bias and reporting in oral health prediction modelling studies
Bias related to participants
Selection bias may be present when the association between the predictors and the outcome
is different between those who were part of the study versus those who should have been
theoretically eligible but were not part of the study (Rothman, 2008).
Overall, six of the studies showed unclear ROB due to lack of specification of
inclusion/exclusion criteria. Among the 22 studies which utilised existing data sets (e.g.,
electronical health records, disease registries), 14 did not specify the sampling and/or data
collection methods nor referenced previous studies that did so, making it impossible for
us to judge the potential for selection bias in these studies. According to PROBAST, one
study (Alonso et al., 2017) showed high ROB due to convenience sampling, as convenience
samples may not be generalized to the target population. Another study (Rao et al., 2016)
showed high ROB because the baseline risk/outcome frequency was not adjusted when
using a non-nested case-control design.
Bias related to predictors
The identified potential bias related to predictors include (i) measurement error (n = 12),
(ii) lack of blinding to the outcome when assessing predictors (n = 6), and (iii) unmeasured
predictors (n = 2). Overall, 27 studies showed low ROB and 7 studies showed high ROB
in the predictor section.
Twelve studies used data from multiple medical/dental centres (Martinez-Canut
et al., 2018; Rao et al., 2016; Ritter et al., 2016) , different periods (n = 7) and different
studies (Eke et al., 2016; Martinez-Canut and Llobell, 2018). Measurement error for
predictors is likely to exist in these studies if the predictors were assessed in various ways
across the centres or time periods. Another seven studies clearly specified that different
examiners/observers were calibrated to minimize measurement errors.
Lack of blinding of predictors assessors to outcome information may increase the
predictor-outcome association and lead to a biased prediction (Moons and Grobbee, 2002).
While this does not represent a problem in prediction modelling studies using data from
RCTs and prospective cohort studies, lack of blinding to the outcome could not be achieved
in prediction modelling studies using data from retrospective cohorts and cross-sectional
designs, as the predictors and outcomes were assessed at a similar time (n = 6).
Though the included prediction models cover multiple well-known risk factors, we
should be aware that unmeasured predictors always exist, e.g., genetic information. For
external validation studies, omitting unavailable predictors that presented in the derived
model (Prince et al., 2016; Schwendicke et al., 2018) can result in validation of another
model rather than the intended model.
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Bias related to outcomes
Bias related to outcomes refer to factors that can influence the outcome assessment, such
as (i) unclear definition, (ii) measurement error and (iii) incorporation bias, which usually
occurs when the predictors share the same or part of the information captured by the
outcome, and is usually observed when the outcome is a manifest/latent variable. Overall,
9 studies showed high ROB related to outcomes, with some of them being suspected to
multiple biases. Three out of the 34 identified studies did not use a pre-specified or clear
outcome definition (Martinez-Canut et al., 2018; Prince et al., 2016; Su et al., 2017).
Similar to predictor measurement error, inconsistent outcome measurement (e.g.,
registry data, multiple-centre study) was likely to exist due to variations in assessments
among professionals from multiple health care facilities (n = 2) (Martinez-Canut and
Llobell, 2018; Rao et al., 2016) and across different time periods (n = 7). Seven studies
stated that the agreement or consistency between various examiners was verified and
achieved, thus reducing the chance of outcome measurement error.
Incorporation bias was observed in eight studies. One example can be found in the
study by (Su et al., 2017), where the objective was to verify the accuracy of the Community
Periodontal Index (CPI) in predicting periodontitis. However, the outcome under study
(CPI score) is based, among other factors, on the periodontal pocket depth, which is the
most important criteria for the definition of periodontitis.
Bias related to analysis
Overall, 23 studies were identified to be high ROB on the analysis due to categorization of
continuous variables (n = 16), omission of samples with missing data (n = 10), selection of
predictors based on univariate analyses (n = 9 out of 24), lack of over-fitting consideration
(n = 13 out of 24), and insufficient model performance assessment (n = 24).
Twelve out of the 16 studies which categorized continuous variables classified age
into 5-year age groups (n = 7) or larger categories (n = 5). Three studies categorised pocket
probing depth and/or level of bone loss (Martinez-Canut et al., 2018; Martinez-Canut
and Llobell, 2018; Schwendicke et al., 2018), and two studies categorised laboratory test
results such as low-density lipoproteine (OuYang et al., 2017; Peng et al., 2018).
Half of the studies (n = 17) did not provide information on missing data handling.
Among the remaining 17 studies, 13 studies conducted ‘complete-case’ analyses (ten and
three studies had missing information proportion greater and less than 5%, respectively),
two studies used mean/median imputation (Bersani et al., 2017; Lee et al., 2018a), one
used conditional mean imputation (Ritter et al., 2016) to assign missing data and one study
reported there was no missing data (Jover-Espla et al., 2018).
Over a third of the model development studies (n = 9) adopted ‘univariate analyses’
with various criterion (e.g., p-value < 0.05) to select predictors. Seven studies used variable
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selection methods such as backward elimination and stepwise forward-entry. The predictor
selection process was unclear in six model development studies.
Our review found a good consideration of data complexity (e.g., censoring) in survival
predictions (n = 7), where all the studies have applied time-to-event analysis (e.g., Cox
regression). Among the 24 model development studies, five conducted external validation
with an independent dataset, and 13 studies conducted an internal validation of developed
models. Out of these 13 studies, two used a split-sample procedure (Kayaoglu et al., 2016;
Lee et al., 2018a), five used cross validation (Bersani et al., 2017; Canullo et al., 2017, 2016;
Papantonopoulos et al., 2017; Ritter et al., 2016), and six adopted bootstrap resampling.
Bootstrapping, however, is a form of estimating variance using a computational approach
as opposed to an analytical approach, and should not be considered as a way of internal
validation.
Insufficient model performance assessment (e.g., discrimination and calibration) was
observed in the majority of the studies (n = 24). While 28 studies assessed the discrimina-
tive ability of the prediction models, only seven studies assessed their calibration, out of
which five presented it graphically and two performed Hosmer-Lemeshow test. The Area
under the receiver operating characteristics curve (n = 19) was the most-adopted discrimi-
nation measurement, followed by specificity (n = 17), sensitivity (n = 16), positive/negative
predictive value (n = 9), and accuracy (n = 8).
5.3.3 Transparent reporting of the included prediction modelling studies
Reporting of individual TRIPOD items are presented in Figure 5.3, and reporting of
TRIPOD for each study is shown in Figure 5.4. Overall, at least five (out of 31) items were


























































































































































114 Examining bias and reporting in oral health prediction modelling studies
The TRIPOD items most often reported included title (item 1), abstract (item 2), and
introduction (item 3) across all studies. Methods, results and discussion items are reported
separately for model development and validation below:
Model development studies
TRIPOD scores varied from to 20 to 28 (out of 31) in the 24 studies.
A) Methods: Although all the studies reported the data source (e.g., study design, key
study dates etc.) (item 4), lack of reporting on data collection procedures (e.g., sampling
approaches, data entry, data cleaning), inclusion and exclusion criteria (item 5b), and
treatment (item 5c) were identified in more than half of the studies. No study reported
blind assessment of predictors (item 6b) and outcomes (item 7b). 30% of the studies did
not report how the sample size was arrived at (item 8). In addition, missing data handling
(item 9) was not reported in 60% of studies (n = 14).
B) Results and Discussion: 63% of the development studies did not report unadjusted
associations between each candidate predictor and outcome (item 14b). Other aspects
regarding description of participants (item 13), model development procedure (item 14a),
models’ predictive performance (item 16), study limitations (item 18), model interpretation
(item 19), and study implications (item 20) were reported in at least 80% of the studies.
Model validation studies
Ten model validation studies yield a range of 20 to 27 TRIPOD scores (total 31).
A) Methods: Similar to model development studies, only 10% of the validation studies
reported blind assessment of predictors (item 6b) and outcomes (item 7b). Information
regarding model updating (e.g., recalibration) (item 10e) was reported in 40% of the
studies. 60% of the studies reported information on sample size calculation (item 8) and
missing data handling (item 9). Only 70% of the validation studies provided a comparison
of the distribution of important characteristics of the population (e.g., age distribution, sex)
between the model development and validation studies (item 12).
B) Results and Discussion: Insufficient reporting of the updated model metrics (item
17) lead to a lack of discussion on comparison of model performance between development
and validation cohorts (item 19a) in 60% of the studies. Similar to model development
studies, many aspects regarding description of participants (item 13), model predictive
performance (item 16), study limitation (item 18), model interpretation (item 19), and
study implication (item 20) were reported in at least 90% of the studies.
5.4 Discussion
Bias and non-transparent reporting were identified across all the included studies. Three
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Figure 5.4: Completeness of TRIPOD (Transparent Reporting of a multivariable prediction model
for Individual Prognosis Or Diagnosis) checklist for 34 prediction modelling studies.
Reported (green), Not reported (pink), Not applicable (black). Right columns are the
least reported items, and the bottom studies represent the ‘least-reported’ studies.
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measurement error in predictors and/or outcome, omitting samples with missing data,
selecting variables based on univariate analyses, overfitting, and lack of model performance
assessment. Similarly, 95% of the studies presented inadequate reporting in at least five
(out of 31) TRIPOD items, especially regarding sampling approaches, eligibility criteria,
and model-building procedures.
5.4.1 Summary of main findings and quality of the evidence
• To allow selection bias assessment, studies using data from existing cohorts, data
registries, experiments and surveys are required to provide detailed information
regarding sampling process, data collection and cleaning procedures. In case data
are from case-control studies, the prediction model should adjust for the baseline
risk (Moons et al., 2019) to reduce the variability of the starting difference among
the two groups as well allows for re-calibration when this model to be externally
validated in another population (Ahmed et al., 2014). When using medical records,
information on record collection, data entry, and data cleaning should be provided.
• Measurement error has the potential to influence the overall performance of a risk
prediction model (Rosella et al., 2012) therefore consistent assessment criteria
should be followed when measuring both predictors and outcomes. When multiple
data sources are used, it would be a good practice if model developers explained
transparently/clearly the methods used for assessing the predictors and outcomes.
• The most commonly categorised variable in the included studies was age (n = 12). The
degree of loss of information caused by categorising continuous variables may vary
according to the population and outcomes under study. For example, among adults,
the risk of periodontal diseases (Eke et al., 2015) and dental caries (Slade, 2007) is
fairly stable within 5-15 year age groups, however the risk of dental caries varies
greatly from one year to another among children (Gradella et al., 2011). Therefore,
categorising age into age groups among children when predicting dental caries could
lead to bias whereas it may not be a concern among adults and when outcomes, such
as periodontal diseases are studied.
• Missing data occurs both in longitudinal and cross sectional studies. The missing data
problem at the item level needs to be tackled from three aspects: the missing data
mechanisms, the proportion of missing data, and patterns of missing data.
A common approach to handle missing data in oral health prediction modelling
studies is complete-case analysis, while the use of multiple imputation (MI)
is sparse. Complete cases analysis are unbiased if the missing mechanism
is missing completely at random (MCAR). Usually this is not the case in
real life, hence missing data can be imputed using MI if the missing data
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are missing at random (MAR) to retain the sample size and reduce biased
prediction due to complete-case analysis (Madley-Dowd et al., 2019). Bias
caused by missing data when they are missing not at random (MNAR) can be
addressed by sensitivity analyses examining the effect of different assumptions
about the missing data mechanism (Sterne et al., 2009).
Regarding the proportion of missing data, there is no set cut off from the literature
regarding an acceptable percentage of missing data. However, following
(Schafer, 1999) and (Little and Rubin, 2002), missing information less than
5% is inconsequential, and complete-case analysis and single imputation can
be used along with estimating variance due to single imputation.
• Univariate analyses are discouraged to be used for predictor selection (Rothman, 2008),
because (i) if two predictors are highly correlated with each other and with the
response, then the univariate analysis will identify both as ‘significant’, and (ii)
some variables are only ‘significant’ when we adjust other covariates. We suggest
researchers select predictors based on the clinical knowledge (but not relying on
p-values) and on the availability of such information when the models intend to be
used.
• Lack of internal validation may lead to over-fitting because quantifying the predictive
performance of a model on the same data from which the model was developed tends
to give optimistic estimates of performance, that is, the model is over adapted to
the development data set. We thus suggest that any form of internal validation such
as k-fold cross-validation be applied before moving to external validation, which is
necessary before implementing prediction models in clinical practices.
• As suggested by PROBAST item 4.7, assessment of both discrimination and calibration
is essential to make models predictive ability (model performance) known.
These abovementioned suggestions are not an exhaustive list. To avoid potential
threats to reproducible prediction modelling studies (Appendix C Supplement 12), more
efforts could be made, such as making the data used in the research accessible (if no confi-
dential agreements exist), providing statistical codes used in analysis, and pre-registering
RCTs.
5.4.2 Strengths and potential limitations
To our knowledge, this is the first study that has comprehensively appraised the
methodological and reporting quality of multivariable prediction modelling studies in oral
health research. A main strength of this study is the adoption of PROBAST and TRIPOD
guidelines as benchmarks, although an ‘acceptable TRIPOD score’ still is lacking, and
some PROBAST criteria are not tailored for oral health prediction research.
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Limitations
The current review is limited to studies published in pre-specified journals over the
past three years, leading us to underestimate the number of studies with high
ROB and poor reporting.
It must also be said that the tools that were used are not free from limitations.
For example, PROBAST emphasizes MI for handling any missing data (e.g.,
MCAR, MAR, MNAR); this is incomplete. Even though PROBAST is very
instructive in regard to the method of MI, methods such as single imputation
can be used when the proportion of missing information is less than 5% with
a detailed description of variance estimation methods. Moreover, when the
missing data are MNAR, methods such as pattern mixture models can be more
appropriate than the MI.
5.5 Conclusion
The majority of the prediction modelling studies identified in this review fell short in
addressing bias due to missing data (85%), overfitting/underfitting (54%), categorising
continuous variables (46%), univariate variable selection (41%) and measurement error
(35%). None of the included study rigorously followed the TRIPOD recommendations for
study reporting, especially in reporting model performance metrics (70%) and missing data
handling (47%). To improve the overall quality of prediction modelling studies, PROBAST
criteria need to be taken into account to address the potential of bias during modelling
procedure, and TRIPOD checklist is encouraged to be provided to reviewers and readers
for the assessment of the study reporting transparency. Our suggestions and proposed
achievable steps towards improving the reproducibility of prediction modelling studies can
be wider adopted in oral health research.
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Comparison of the Tree-Based Machine
Learning Algorithms to Cox Regression in
Predicting the Survival of Oral and Pharyngeal
Cancers: Analyses Based on SEER Database
Preface
Chapter 5 identified the existence of multiple sources of bias in the current oral health
prediction modelling studies. In this chapter, we conduct a case study to address some of
the identified bias, as well as to demonstrate the adherence to the reporting guidelines
of clinical prediction modelling study. We choose to predict the survival of oral and
pharyngeal cancers (OPCs), for two reasons: 1) OPCs are the only fatal oral disease
and predicting the survival of patients with OPCs has the potential to benefit patients’
lives; 2) time-to-event data is a common type of outcome data in health research, and
we use this chapter as an example to demonstrate how to develop models for survival
outcomes. Following the growing trend in the application of machine learning methods
in cancer research, we present the use of tree-based machine learning algorithms and
compare their predictive performance to the standard Cox proportional hazard regression.
We have used a real-world cancer registry data set, which includes various prognosis
factors and is subjected to different forms of biases such as missing data and unmeasured
predictors. Moreover, it is criticised to handle missingness in the time-to-event data
using multiple imputation based on standard multivariate normal distribution. For
this reason, we demonstrate the use of a compatible method – substantive model
compatible fully conditional specification (SMC-FCS) approach for handling missing
data for Cox regression. SMC-FCS allows for compatibility between the imputation
model and the final prediction model. Additionally, a web-based calculator is pre-
sented in this chapter for estimating the 3- and 5-year survival probability of OPCs patients.
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Database
This chapter contains the third of a series of four studies contributing to this thesis.
Following the requirements of the journal, we describe the results of this study prior to the
methods, and this chapter is organized in a different order compared to previous chapters:
Abstract, Introduction, Results, Discussion, and Methods. Details for this publication are:
Du M., Haag, D. G., Lynch, J. W., Mittinty, M. N. Comparison of the tree-based
machine learning algorithms to Cox regression in predicting the survival of oral and
pharyngeal cancers: Analyses based on SEER database. Cancers. 2020;12(10), 2802.
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Comparison of the Tree-Based Machine Learning Algorithms to Cox Regression in
Predicting the Survival of Oral and Pharyngeal Cancers: Analyses Based on SEER
Database
Abstract
Aims: This study aims to demonstrate the use of the tree-based machine learning
algorithms to predict the 3- and 5-year disease-specific survival of oral and pharyngeal
cancers (OPCs) and compare their performance with the traditional Cox regression.
Methods: A total of 21,154 individuals diagnosed with OPCs between 2004 and
2009 were obtained from the Surveillance, Epidemiology, and End Results (SEER)
database. Three tree-based machine learning algorithms (survival tree (ST), random forest
(RF) and conditional inference forest (CF)), together with a reference technique (Cox
proportional hazard models (Cox)), were used to develop the survival prediction models.
To handle the missing values in predictors, we applied the substantive model compatible
version of the fully conditional specification imputation approach to the Cox model,
whereas we used RF to impute missing data for the ST, RF and CF models. For internal
validation, we used 10-fold cross-validation with 50 iterations in the model development
data sets. Following this, model performance was evaluated using the C-index, integrated
Brier score (IBS) and calibration curves in the test data sets.
Results: For predicting the 3-year survival of OPCs with the complete cases, the
C-index in the development sets were 0.77 (0.77, 0.77), 0.70 (0.70, 0.70), 0.83 (0.83, 0.84)
and 0.83 (0.83, 0.86) for Cox, ST, RF and CF, respectively. Similar results were observed
in the 5-year survival prediction models, with C-index for Cox, ST, RF and CF being
0.76 (0.76, 0.76), 0.69 (0.69, 0.70), 0.83 (0.83, 0,83) and 0.85 (0.84, 0.86), respectively,
in development data sets. The prediction error curves based on IBS showed a similar
pattern for these models. The predictive performance remained unchanged in the analyses
with imputed data. Additionally, a free web-based calculator was developed for potential
clinical use.
Conclusion: Compared to Cox regression, ST had a lower and RF and CF had a
higher predictive accuracy in predicting the 3- and 5-year OPCs survival using SEER data.
The RF and CF algorithms provide non-parametric alternatives to Cox regression to be of
clinical use for estimating the survival probability of OPCs patients.
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6.1 Introduction
Globally, oral and pharyngeal cancers (OPCs) are ranked as the ninth most prevalent type
of cancers (Bray et al., 2018). As the only life-threatening diseases in oral health, OPCs
have an estimated incidence of 834,860 new cases worldwide in 2018 (Bray et al., 2018),
and have shown an increasing incidence trend over the past two decades (Du et al., 2019).
Despite the advances in multiple types of therapies for OPCs, such as tumour removal
surgery, chemo(radio)therapy and molecular-targeted therapy (Kioi, 2017), the current
5-year overall survival rate of OPCs remains 64.8% in the United States. In response to
the need for improving medical care delivery in the oral health field, there are clinical
decision support tools being developed to aid the early detection, diagnosis, treatment and
prognosis of oral diseases, including OPCs (Patton, 2017). These clinical decision support
tools are all developed based on clinical prediction modelling research, which aims to yield
the most accurate outcome prediction by capturing patterns in the available data (known as
data-generating mechanisms) and minimizing the difference between the predicted and
observed outcome (known as bias). However, following the up-to-date bias assessment
criteria (PROBAST - Prediction model Risk Of Bias ASsessment Tool) (Wolff et al., 2019)
and reporting guidelines (TRIPOD - Transparent Reporting of a multivariable prediction
model for Individual Prognosis or Diagnosis) (Collins et al., 2015), the overall quality
of oral health prediction modelling studies was found to be less than optimal due to the
presence of multiple sources of bias (e.g., measurement error, unmeasured predictors) and
lack of reporting transparency (Du et al., 2020).
The traditional method of survival prediction for OPCs has been building nomograms
using Cox proportional hazard (Cox) regression analysis based on available clinical and
sociodemographic predictors (Chen and Asch, 2017; Wang et al., 2018). Such models are
generally based on the assumptions that each predictor is linearly associated with OPCs
survival outcomes. Thus, there is a possibility that these models may oversimplify complex
relationships, which potentially include both non-linear associations, non-linear interac-
tions and effect modification (Breslow, 1975; Chen and Asch, 2017). To overcome this
limitation, the evolution of machine learning provides an alternative to (semi)parametric
modelling by relaxing the hypothesis of the data-generating mechanism and considering
all possible interactions and effect modification between variables (Ryo and Rillig, 2017).
Among the commonly used machine learning algorithms, tree-based methods (e.g., deci-
sion tree, random forest) are well-known for the ease of use, interpretability and the nature
of preventing overfitting (Duda et al., 2012).
To date, despite machine learning algorithms being used for predicting OPCs progno-
sis (Kim et al., 2019; Tseng et al., 2015), they rarely accommodate the potential systematic
bias arising from data collection (e.g., missing data, measurement error) and modelling
process (e.g., unmeasured predictors). Moreover, very few outputs from prediction mod-
124
Comparison of the Tree-Based Machine Learning Algorithms to Cox Regression in
Predicting the Survival of Oral and Pharyngeal Cancers: Analyses Based on SEER
Database
elling research have been implemented to assist clinical practice. Therefore, this study was
performed to contribute to the clinical decision support system in the field of OPCs by
1) developing and validating various models to predict the 3- and 5-year disease-specific
survival of OPCs; 2) comparing the predictive accuracy of the tree-based machine learning
algorithms and the standard parametric Cox method; and 3) developing a web-based
calculator to estimate the individual survival probability of OPCs patients. Additionally,
this study demonstrated the conduct and reporting of a clinical prediction modelling study,
following up-to-date guidelines (PROBAST and TRIPOD). The significance of this study
not only lies in the development of prediction models and an online calculator for OPCs
survival, but also includes a call for action to improve the quality (reduce bias) of prediction
modelling studies in the field of oral health. Specifically, this study demonstrates how




A total of 54,955 primary OPC patients diagnosed between 2004 and 2009 were
collected from the Surveillance, Epidemiology, and End Results (SEER) database; 27,569
records were excluded based on inclusion and exclusion selection criteria. Patients with
survival months of less than 1 month were excluded (n = 771). Left censored samples for 3-
year (n = 157) and 5-year (n = 260) cohorts were also excluded. For complete case analysis,
patients who had missing values (n = 13,455, 49.49%) on any of the examined variables,
including race (n = 327, 1.2%), marital status (n = 1745, 6.42%), tumour size (n = 7654,
28.15%), lymph node involvement (n = 2131, 7.84%), tumour (T), node (N), and metastasis
(M) categories (n = 515, 1.89%), clinical stage (n = 4729, 17.39%), differentiated grades (n
= 5803, 21.35%), surgery history (n = 262, 0.96%) and ICD (International Classification of
Disease) classification (n = 437, 1.61%) were excluded. Due to the different number of left
censored samples for 3- and 5-year cohorts, we ended up with 21,154 patients (21,000 for
5-year survival) and 11,888 patients (11,870 for 5-year survival) for final imputation and
complete case analysis, respectively. Figure 6.1 shows the flowchart of patient selection.
6.2.2 Characteristics of the patients
Here we only describe the characteristics of patients without missing information
in Tables 6.1 and 6.2. Detailed characteristics of patients in the imputed data sets can be
found in Appendix D Supplements 1 and 2.
Of the 11,888 (11,807 for 5-year survival) patients, the overall disease-specific sur-
vival rates for all patients in the 3- and 5-year cohorts were 65.0% and 60.1%, respectively.
Mean survival times were 66.7 (SD = 44.1) and 66.8 (SD = 44.3) months for 3- and 5-year
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Figure 6.1: Flowchart of study design and patient selection.
cohorts. In the 3-year cohort, patients had a mean age of 59.0 (SD = 12.3) years. Of
the 11,888 eligible patients, 8774 (73.8%) were male, 10,020 (84.3%) were white and
6997 (58.9%) were married at diagnosis. Overall, 7293 (61.3%) tumours arose from the
oral cavity (C00-06) and tumours were poorly differentiated or undifferentiated. T3-T4
tumours accounted for 31.1% of all tumours and positive neck lymph nodes and distant
metastases accounted for 44.8% and 2.9%, respectively; 7189 (60.5%) patients underwent
surgery. The 5-year cohort consisted of 11,807 patients, of which 73.9% were male, 84.3%
were white and 58.9% were married at diagnosis. Similar to the 3-year cohort, over half of
the tumours (61.2%) arose from the oral cavity, while 39.6% tumours were poorly differ-
entiated or undifferentiated. T3-T4 tumours accounted for 31.2% of all tumours, lymph
nodes were removed in 44.8% cases and distant metastases occurred in 2.9% tumours;
60.4% patients received surgery.
126
Comparison of the Tree-Based Machine Learning Algorithms to Cox Regression in
Predicting the Survival of Oral and Pharyngeal Cancers: Analyses Based on SEER
Database
Table 6.1: Demographic characteristics of patients with oral and pharyngeal cancers in SEER
(Surveillance, Epidemiology, and End Results) cohorts.
Characteristics 3-year cohort (n = 11,888) 5-year cohort (n = 11,807)
Death Status
Alive 7731 (65.0%) 7092 (60.1%)
Dead 4157 (35.0%) 4715 (39.9%)
Survival months
Mean (SD) 66.7 (44.1) 66.8 (44.3)
Median [min, max] 77.0 [2.00, 143] 78.0 [2.00, 143]
Age(Years)
Mean (SD) 59.0 (12.3) 59.0 (12.3)
Median [min, max] 58.0 [18.0, 103] 58.0 [18.0, 103]
Sex
Female 3114 (26.2%) 3086 (26.1%)




55 (0.5%) 54 (0.5%)
Asian or Pacific Islander 762 (6.4%) 750 (6.4%)
Black 1051 (8.8%) 1046 (8.9%)
White 10020 (84.3%) 9957 (84.3%)
Marital status
Divorced 1532 (12.9%) 1526 (12.9%)
Married (including com-
mon law)
6997 (58.9%) 6951 (58.9%)
Separated 135 (1.1%) 133 (1.1%)
Single (never married) 2218 (18.7%) 2198 (18.6%)
Widowed 1006 (8.5%) 999 (8.5%)
Table 6.2: Tumour-related characteristics of patients with oral and pharyngeal cancers in SEER
cohorts.




1535 (12.9%) 1521 (12.9%)
Moderately differenti-
ated; grade II
5667 (47.7%) 5626 (47.6%)
Poorly differentiated;
grade III
4434 (37.3%) 4410 (37.4%)
Undifferentiated;
anaplastic; grade IV
252 (2.1%) 250 (2.1%)
T category
T1 3956 (33.3%) 3917 (33.2%)
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T2 4204 (35.4%) 4171 (35.3%)
T3 1562 (13.1%) 1556 (13.2%)
T4 2132 (17.9%) 2129 (18.0%)
TX 34 (0.3%) 34 (0.3%)
N category
N0 4659 (39.2%) 4615 (39.1%)
N1 2416 (20.3%) 2404 (20.4%)
N2 4386 (36.9%) 4362 (36.9%)
N3 391 (3.3%) 390 (3.3%)
NX 36 (0.3%) 36 (0.3%)
M category
M0 11,447 (96.3%) 11367 (96.3%)
M1 348 (2.9%) 347 (2.9%)
MX 93 (0.8%) 93 (0.8%)
Stage
I 2183 (18.4%) 2160 (18.3%)
II 1540 (13.0%) 1522 (12.9%)
III 2356 (19.8%) 2341 (19.8%)
IV 5809 (48.9%) 5784 (49.0%)
Lymph nodes re-
moved
None 6557 (55.2%) 6515 (55.2%)
Yes 5331 (44.8%) 5292 (44.8%)
Tumour size
0∼1cm 1420 (11.9%) 1404 (11.9%)
1∼2cm 2806 (23.6%) 2783 (23.6%)
2∼3cm 3120 (26.2%) 3104 (26.3%)
3∼4cm 2097 (17.6%) 2081 (17.6%)
4∼5cm 1369 (11.5%) 1363 (11.5%)
5∼6cm 561 (4.7%) 559 (4.7%)
6∼7cm 253 (2.1%) 252 (2.1%)
7∼8cm 128 (1.1%) 127 (1.1%)
8∼9cm 55 (0.5%) 55 (0.5%)
9∼10cm 41 (0.3%) 41 (0.3%)
>10cm 38 (0.3%) 38 (0.3%)
Surgical therapy
Surgery not performed 4699 (39.5%) 4673 (39.6%)
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Table 6.2 continued from previous page
Surgery performed 7189 (60.5%) 7134 (60.4%)
Tumour sites (ICD
code)
Lip (C00) 540 (4.5%) 536 (4.5%)
Base of tongue (C01) 2192 (18.4%) 2177 (18.4%)
Other parts of tongue
(C02)
2400 (20.2%) 2378 (20.1%)
Gum (C03) 412 (3.5%) 410 (3.5%)
Floor of mouth (C04) 786 (6.6%) 783 (6.6%)
Palate (C05) 318 (2.7%) 314 (2.7%)
Other oral cavity (C06) 645 (5.4%) 639 (5.4%)
Parotid gland (C07) 253 (2.1%) 253 (2.1%)
Other salivary glands
(C08)
39 (0.3%) 38 (0.3%)
Tonsil (C09) 2858 (24.0%) 2840 (24.1%)
Oropharynx (C10) 363 (3.1%) 362 (3.1%)
Nasopharynx (C11) 408 (3.4%) 404 (3.4%)
Pyriform sinus (C12) 391 (3.3%) 391 (3.3%)
Hypopharynx (C13) 283 (2.4%) 282 (2.4%)
6.2.3 Model specification
In this study, a commonly used Cox regression was chosen as the reference model
and three tree-based machine learning algorithms (survival tree (ST), random forest (RF)
for survival and conditional inference forest (CF)) were used to develop prediction models.
These tree-based models were applied because our data set was a mix of continuous and
categorical variables, among which a large proportion had polychotomous values (i.e.,
more than two levels), and a major advantage of tree-based models is that they can handle
this type of data by allowing for multiple splits of a selected node. Additionally, tree-based
models can rank the importance of variables based on their location depth in the tree
structure whereas other popular machine learning algorithms (e.g., neural networks) focus
on outcome prediction with less consideration of the variables’ contribution. Here we
describe the prediction models for 3-year OPC survival for the complete cases. According
to the hazard ratios returned by Cox regression, all the included predictors were identified
as having prognostic value for predicting OPC survival (majority of the hazard ratios with
95% confidence intervals not crossing 1) (Appendix D Supplement 3). The two most
important predictors that determine the 3- and 5-year survival of an individual patient
were tumour site (hazard ratios for ICD being C02—tongue excluding base of tongue,
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Table 6.3: C-index (Median (IQR) in the development and test datasets for various models for
predicting 3- and 5-year disease-specific survival of oral and pharyngeal cancers based on the
complete case analysis.
Modelling approaches Development data set Test data set
Three-year survival cohort
Cox 0.77 (0.77, 0.77) 0.76 (0.76, 0.77)
Survival tree (ST) 0.70 (0.70, 0.70) 0.70 (0.69, 0.71)
Random forest for survival (RF) 0.83 (0.83, 0.84) 0.77 (0.76, 0.77)
Conditional inference forest (CF) 0.83 (0.83, 0.86) 0.76 (0.75, 0.76)
Five-year survival cohort
Cox 0.76 (0.76, 0.76) 0.76 (0.76, 0.76)
Survival tree (ST) 0.69 (0.69, 0.70) 0.69 (0.68, 0.70)
Random forest for survival (RF) 0.83 (0.83, 0.83) 0.76 (0.76, 0.76)
Conditional inference forest (CF) 0.85 (0.84, 0.86) 0.75 (0.75, 0.76)
C04—floor of mouth, C08—other salivary glands, were > 3) and tumour metastasis (hazard
ratio = 2.56). The final ST was with two parameters: the number of the minimum number
of observations that must exist in a node (“minsplit”) = 11 and maximum length from
root node to leaf node (“maxdepth”) = 18. The constructed RF model which returned the
highest value of C-index included the following parameters: number of trees (“ntree”) =
1217, number of variables tested in any split (“mtry”) = 11, the size of random split points
for each “mtry” candidate (“nsplit”) = 3 and split rule/formula (“splitrule”) = “logrank”.
6.2.4 Model performance
The predictive performance of the models was measured using Harrell’s C-index (C-
index) (Tseng et al., 2015), integrated Brier score (IBS) (Mogensen, 2012) and calibration
plots. Values of C-index for each model are presented in Table 6.3. In the main text, we
present results from complete case analysis for the 8:2 split of the model development
and test datasets. Results for the imputed datasets and any other splits can be found in
Appendix D Supplements 4–7.
For 3-year survival prediction, in the complete case analysis (n = 11,888), the C-
indexes in development data sets were 0.77 (0.77, 0.77), 0.70 (0.70, 0.70), 0.83 (0.83, 0.84)
and 0.83 (0.83, 0.86) for Cox, ST, RF and CF respectively. Similar results were found
in 5-year survival cohort: CF yielded the highest values of C-index of 0.85 (0.84, 0.86),
followed by RF (0.83 (0.83, 0.83)), Cox (0.76 (0.76, 0.76)) and ST (0.69 (0.69, 0.70)).
The values of C-indexes in the imputed data were similar to the complete case analysis.
As shown by the over-time C-index in Figure 6.2, RF and CF constantly exhibited the
best C-index throughout the investigated period across all settings. However, this comes
with a computational burden: for example, in the complete case analysis of 3-year cohort,
the average training times for Cox, ST, RF and CF for each iteration were 2.78s, 0.61s,
348.95s and 2513.72s, respectively. In addition to the over-time C-index plots, Figure 6.3
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Figure 6.2: Overtime C-index for predicting disease-specific survival of oral and pharyngeal
cancers with various models (Cox regression, survival tree (ST), random forest for survival (RF)
and conditional inference forest (CF)) based on the complete case analysis.
presents the prediction error curves for each model based on IBS. We found that all models
performed better than the default benchmark Kaplan–Meier model. The RF and CF models
(blue and green curves) had approximately the same values. Compared with the Cox model,
ST showed a higher prediction error while RF and CF showed lower prediction errors in
the test data sets. For the completeness and comparability of prediction models with the
binary family we plotted the time-dependent receiver operator curves (ROC) based on the
cumulative sensitivity and dynamic specificity for Cox models (Kamarudin et al., 2017).
The values of area under the ROC at specific time points (1- to 5-years) were consistent
with the results of over-time C-index plots. Detailed explanation and results can be found
in Appendix D Supplement 8. In terms of calibration, the calibration curves (Figure 6.4)
displayed by all the algorithms in the test data sets appeared close to each other, despite
the weaker calibration exhibited by RF and CF in development data sets.
6.2.5 Model presentation and development of an online survival calculator
In attempt to contribute to clinical decision-making, we have developed a web-
based OPCs survival probability calculator based on a Cox regression model (this online
tool was designed for research only and should not be used clinically until externally
validated). This online tool was developed as a ShinyApp software using R package
shiny (https://dumizai.shinyapps.io/apptest2/). A snapshot of the online calculator can
be found in Appendix D Supplement 9. The potential users of this calculator are OPCs
clinicians, patients and interested researchers. This calculator can 1) present the 3- and
5-year overall survival curves of OPCs cohorts in SEER database; 2) interact with the users
to provide survival curves stratified by each predictor; and 3) interact with the users to
provide survival probability of an individual OPCs patient for 1, 2, 3, 4 and 5 years after
diagnosis.
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Figure 6.3: The prediction error curves for models (Cox regression, survival tree (ST), random
forest for survival (RF) and conditional inference forest (CF)) in predicting disease-specific survival
of oral and pharyngeal cancers based on the integrated Brier score (IBS).
The maximum (observed) survival month was 143 for OPC patients in the SEER
database. Different models are presented by different colours, where the grey curve
represents a default benchmark Kaplan–Meier model. All curves start at time 0
where all subjects are alive and all predictions equal to 1.
6.3 Discussion
By comparing the prediction performance of three tree-based machine learning algorithms
(ST, RF and CF) to the reference method (Cox), our findings suggest that Cox regression
performed robustly as a conventional method for OPCs survival prediction; despite this,
we observed an increase in C-index for RF and CF and a decrease for ST. To facilitate
the translation of our developed model into clinical practice, we developed a web-based
survival probability calculator to allow better visualization and ease-of-use for clinicians.
It can dynamically predict the disease-specific survival probability of OPCs patients at
various time points and help identify patients at high risk of OPC-specific death.
Different C-indexes obtained by Cox and tree-based models led to our further thinking
on the reasons for these differences. In general, conventional statistical models (e.g.,
Cox) attempt to fit the data to an investigator-specified model, whereas machine learning
algorithms allow the data to dictate the form of the model. In our study, Cox regression
examines each predictor’s effect by testing the proportional hazards assumptions, ST
focuses on data partitioning by maximizing the between-node differences, while RF and
CF focus on overall prediction accuracy by reducing the prediction error. Traditional Cox
regression is popular and well-studied, results are easily interpretable and it remains the
most convenient solution for most survival problems. However, it is a (semi)parametric
model and only works when the number of predictors is less than the number of events
(Vittinghoff and McCulloch, 2007). ST, built with “rpart” package (Therneau et al., 2015),
employed a log-rank test statistic (a statistic for comparing the survival curves of two
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Figure 6.4: Example of calibration plots for predicting 3- and 5-year disease-specific survival of
oral and pharyngeal cancers with various models (Cox regression, survival tree (ST), random forest
for survival (RF) and conditional inference forest (CF)).
The 45-degree straight line represents the perfect match between the observed (y-
axis) and predicted (x-axis) survival probabilities. A closer distance between two
curves indicates higher accuracy.
samples) to maximize the between-subgroup heterogeneity. However, the large variance in
the survival time in our study (2 to 143 months) may add complexity when distinguishing
between subgroups. RF, implemented by the “randomForestSRC” package (Ishwaran et al.,
2020) and CF, implemented by the “partykit” package (Mogensen, 2012), are ensemble
methods which aggregate a large number of trees. By combining thousands of trees and
testing multiple node splitting rules, forest took into account all possible link functions
between the outcome and predictors, as well as all possible interactions between variables.
Therefore, it approximates the data-generating mechanism that is in the observed data and
gains the closest predicted value to the observed value (Breiman, 1996). In short, in the
traditional statistical sense, we selected one model (Cox), set up the model’s parameters
and evaluated its accuracy. Obviously, the initial choice of algorithm would limit the
flexibility of the model, while machine learning algorithms (as alternatives for prediction)
have no concerns of non-proportionalities, multicollinearity or nonlinearity; thus, they
may reduce the prediction bias (systematic prediction error) stemming from modelling
uncertainty.
Interestingly, the predictive capabilities represented by the C-index in test data
sets were similar between RF, CF and Cox for predicting OPCs survival based on the
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SEER database, which suggests that the superiority of machine learning is not always
seen but is seen only in situations when the conventional methods meet their limits.
These situations include 1) data sets with large numbers of predictors and relatively small
sample size; 2) datasets with large numbers of uncorrelated candidate predictors (Ishwaran
et al., 2008) (high dimension data sets such as “omics” data); 3) datasets with complex
confounding factors, interactions and nonlinearities (e.g., no clear theory or hypothesis
of the proportional hazard assumption available) (Breiman, 1996); and 4) survival data
sets with high censoring rate, where the predictors were responsible for censoring (Zhou
and McArdle, 2015). Therefore, there are several possible explanations to the comparable
predictive performance between RF, CF and Cox. The first reason is the small number of
predictors used in this study. Though no threshold number of predictors was available,
more variables may enhance machine learning algorithms to outperform the conventional
statistical models. Secondly, the predictors in the SEER program were collected based on
prior clinical knowledge and many of the variables were mostly linearly correlated. Thus,
there is a possibility that although RF and CF are non-parametric methods, they captured
the underlying structure of data which aligned with the hypothesis that we made in the
parametric model (Cox).
In summary, for prediction purposes, it is appropriate to consider a Cox model first
for a given survival data set with a smaller number of predictors. Meanwhile, machine
learning algorithms can also be adopted in combination with conventional methods, so
that one may obtain extra information (e.g., non-linear interactions) in the data that are not
grasped by Cox models. It is also noteworthy that there is a computational burden when
using RF and it cannot match the speed of the computation of Cox regression methods.
The strengths of our study include that according to PROBAST, there are a variety of
systematic biases that can be present in prediction modelling studies, one of which is the
bias due to missing information. In this study, we address this issue using imputed data.
However, when imputing missing data, one might introduce bias by using incompatible
imputation models. For example, with the imputation model being Cox regression and
the final prediction model being RF, this creates incompatibility in the inference as well
as estimation. We show how this can be avoided by adopting the Substantive Model
Compatible Fully Conditional Specification (SMC-FCS) and RF to impute missing data for
the Cox regression and tree-based models, respectively. Another bias which can occur is
due to pre-specified choice of data analysis model. We address this issue by comparing both
parametric and non-parametric models. We also further discuss the possible reasons that
may lead to the differences of C-index between Cox and tree-based models and therefore
guide users to choose different models accordingly. Finally, the web-based prediction tool
for OPCs survival represents an attempt to translate research outputs into clinical practices.
This prognostic tool not only informs clinicians and patients of the possible outcome of
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OPCs survival, but also provides suggestions to clinicians in decision-making, such as
treatment determinations.
There are several limitations in this study. The main limitation of this study is the lack
of records of other well-known predictors for OPCs survival in the SEER program. For
example, for patients with oropharyngeal squamous cell carcinoma, individuals with human
papillomavirus (HPV) positive status are likely to have better prognosis than their HPV-
negative counterparts (Norregaard et al., 2018). Therefore, it is worth noting that including
HPV information and other prognostic factors such as smoking, alcohol consumption and
chemotherapy (Sakamoto et al., 2016) are likely to modify the models’ predictive ability.
Nevertheless, sensitivity analysis was performed using the R package “obsSens” (Snow and
Snow, 2015) to test the impact of unmeasured predictors on our estimates for Cox models.
In the sensitivity analysis, we added another hypothetical unmeasured predictor with a
different effect size (a range of 0.1–2-fold to our included predictors) on the outcome. We
then examined how this added unmeasured factor impacted the estimated hazard ratios
of the existing predictors. Our results showed that the conclusion might change only
when the unmeasured predictor(s) had an (combined) effect on the outcome 2-fold higher
than the existing predictor. This suggests that the lack of an unmeasured predictor may
not inflate the effect of the existing predictors on survival outcome, and we can trust the
hazard ratios and use them for new predictions. Detailed methodology and results can be
found in the Supplementary Materials (Appendix D Supplement 10). In future research,
new methods are needed for incorporating sensitivity analysis for the computed estimates
using the tree-based non-parametric methods. Another major limitation stemmed from
the lack of validation in an external cohort; nevertheless, the replicability of the models
should be sufficient with a 10-fold cross-validation method. Moreover, following the
reviewers suggestions and also the guidance document of handling missing data in SEER,
we presented the results from a complete case analysis in the main document. Additionally,
given in the guidance document by SEER there are occasions where data can be imputed
under the missing at random assumption, it is for this reason we have presented the results
from imputed data in the web supplements. The results from imputed data need to be
interpreted with caution. These data were imputed using the missing at random mechanism,
which implies that missingness can be fully accounted for by variables that have complete
information. However, this assumption might not be appropriate for all variables in the
SEER data as it is linked data from multiple sources with multiple types of missingness.
Therefore, future directions derived from our study include: 1) more comprehensive
models with better predictive performance can potentially be developed by adding more
predictors; 2) external validation of models on another data set (independent of the model
development data set) is required for assessing the models predictive capability; 3) apart
from the tree-based models, multiple types of machine learning algorithms (e.g., support
vector machine, neural networks) could be used for clinical prediction purposes; and 4)
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more research is needed to accommodate multiple sources of bias while developing a
prediction model (e.g., measurement error/misclassification). We have not conducted
sensitivity analysis around all the bias suggested by PROBAST, as it remains unclear how
to incorporate these biases in machine learning algorithms.
6.4 Methods
6.4.1 Data source and study population
Data for this study were obtained from the SEER database (approval number: 15617-
Nov2017), a population-based cancer registry in the National Cancer Institute in the United
States (https://seer.cancer.gov/). The University of Adelaide Human Research Ethics
Committee waived the provision of ethics approval for this de-identified secondary data
analysis.
The five criteria for patient inclusion were listed as follows. The first criterion was
that patients were diagnosed with OPCs as the “Primary and only cancer diagnosis” during
2004 to 2009. The inception year of 2004 was chosen to allow capture of definitions
of T, N and M categories as published in the sixth edition of the AJCC Cancer Staging
Manual. The last year of 2009 was chosen to guarantee the completion of 5-year follow-up
for each patient. The second criterion was defined by the International Classification of
Disease 10th revision (ICD-10) as cancer of lips, tongue, gum, floor of mouth, palate,
cheek mucosa, vestibule of the mouth and retromolar area (C00-C06), salivary glands
(C07-C08), oropharynx (C09-C10), nasopharynx (C11), hypopharynx (C12-C13) (Bray
et al., 2018). The remaining three criteria were that patients had a histologically confirmed
diagnosis and histological examination of squamous cell neoplasms; an active follow-up
with complete dates and a known outcome with “Alive or dead due to cancer”. Patients
were excluded if they had an unknown survival time, had multiple primary cancers, or
were diagnosed by autopsy or death certificate (i.e., unknown date of diagnosis).
6.4.2 Predictors and outcome
Thirteen predictor variables included in this study were age at diagnosis, sex, race,
marital status at diagnosis, AJCC TNM category, overall tumour stage, histologic differ-
entiation grade, tumour site, tumour size, whether surgical therapy was undertaken and
whether lymph node was removed. All variables were categorical except age (continuous).
Specifically, in SEER program, surgical therapy was recorded as “Surgery performed”,
“Not recommended”, “Recommended but not performed, patient refused”, “Recommended
but not performed, unknown reason”, “Recommended, but unknown performed” and
“Unknown”. We have categorized this predictor as “Surgery performed”, “Surgery not
performed” and “Unknown” in this study. Tumours arising from different sites (e.g., oral
cavity, pharynx, salivary glands) were treated separately in our study. Detailed information
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on the categorization of each predictor are shown in Tables 6.1 and 6.2. The primary
outcome of interest was 3- and 5-year disease-specific survival, calculated from the date
of diagnosis to the date of death due to OPCs. “Survival months” and “Death status” as
outcome variables were extracted.
6.4.3 Model development
For this study, patients were randomly assigned to a development or test data set
using a sample of 8:2 proportion, where the development data set consisted of training
and validation data. Proportion ratios of 7:3, 5:5 and 3:7 were also used to assess the
models robustness. Cox regression, survival tree (ST), random forest (RF) and conditional
inference forest (CF) were used to develop prediction models. All models were built
on a development data set using 10-fold cross-validation with 50 iterations. Samples in
each iteration were randomly drawn from observed data using a different seed. After the
final models were obtained, we evaluated, compared and reported the models’ predictive
performance in test data sets. To explain the 10-fold cross-validation, 90% of the devel-
opment data were used for training and the remaining 10% were used for validation. It
was obvious that variation in the models estimates existed due to the different partitions of
the data to form training and validation data sets. We adopted 10-fold cross-validation to
reduce this variance by averaging over 10 different partitions, so the performance estimates
were less sensitive to the random partitioning of the data. For machine learning models,
all 13 predictor variables were used as inputs. The outputs were not different from the
Cox regression model, which were the estimated 3- and 5-year survival probability for
patients with OPCs since diagnosis. Therefore, this was a regression problem based on
time-to-event (censored) data.
Cox regression model
The Cox regression model can be expressed by the hazard function denoted by h(t), which
can be defined as Equation (6.1):
h(t) = h0(t)exp(α1X1 +α2X2 + ...+αkXk) (6.1)
where t represents the survival time, h0(t) is the baseline hazard when all of the predictors
are equal to zero. The coefficients (α1, α2,..., αk) measure the effect size of predictors
(X1,X2,. . . ,Xk).
Survival tree model
A single ST can group observations according to their survival behaviour based on their
predictors. To grow a tree, at each node every candidate predictor is tried for node splitting.
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Within a set of predictors, the one with a split point that maximizes the survival differences
between children nodes is finally chosen as the parent node. The growth of a decision tree
is continued until the tree meets the stopping criteria, which refers to all terminal nodes
containing only a minimal number of unique events which prevents further node splits
(pre-defined by “minsplit”). Additionally, pruning procedures are used to reduce the size of
the tree (pruned hyper parameters for ST can be found in Appendix D Supplement 11). A
step-by-step practical procedure of growing a ST is described in Appendix D Supplement
12.
As for the splitting rule, the log-rank statistic can be applied (Segal, 1988). The










where L(X, C) is the log-rank measure of node separation, X is the predictor, C is the
splitting point, N is the number of individuals in the parent node, i is the it h observation,
di is the number of deaths at time ti in the children nodes, di,1 is the number of death in
children node 1, therefore di =∑ti=1 d(i,t ) , for example, when t = 2, then di = d(i,1)+d(i,2).
Yi are the individuals at risk at time ti and Yi,1 is the number of individuals of Yi in children
node 1, therefore Yi = ∑ti=1 Yi,t
Random forest model
RF is an non-parametric ensemble method that introduces two forms of randomization
into the tree growing process: bootstrap sampling from the data and selection of a limited
number of predictors to construct the tree (known as “mtry”) (Ishwaran et al., 2008). When
growing a tree, a random B bootstrap sample that includes two thirds of the development
data (in-bag data) is used. Based on the B samples, a node splitting process is applied. The
node splitting process works as follows. At each node, according to a splitting criterion
(pre-defined by “splitrule”), the predictor (among all candidate predictors, pre-defined by
“mtry”) with a split point (pre-defined by “nsplit”) that maximizes the survival differences
between children nodes is used for node splitting. The process of tree growing iterates
“ntree” times to obtain a forest for final prediction. For predicting the survival of a new
subject (Snew) at time t in the mt h tree, it eventually falls into a terminal node. The final
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When tuning the forest, the remaining one third of the development data (out-of-bag data)
was used to avoid overfitting and to select the models’ hyper parameters (Appendix D
Supplement 11) which returned the highest prediction accuracy. Details of developing a
RF are described in Appendix D Supplement 12.
Random forest based on conditional inference trees — Conditional inference forest (CF)
As we have stated above, the standard split criterion for a single ST is the log-rank test
statistic, which favors splitting variables with many possible split points. Conditional
inference trees can avoid this bias by using separate algorithms for selecting the best
split-node from that of selecting the best splitting point (Wright et al., 2017). Specifically,
the optimal split-node is obtained by testing the association of all the available predictors
to the time-to-event outcome using a linear rank test based on the log-rank transformation
(log-rank score). Following this, a standard binary split is done for the selected node.
CF is an ensemble model with multiple conditional inference trees. We applied CF
because there were more polytomous predictors than dichotomous predictors (the number
of polytomous and dichotomous predictors was 9 and 3, respectively) in our data set and
CF has been shown as superior in predictive performance to RF on time-to-event data sets
with polytomous predictors (Nasejje et al., 2017).
6.4.4 Missing data
When using multiple imputation (MI) methods, it is important that there is compati-
bility between the imputation model and the analysis model (Allison, 2012). Moreover, it is
criticised to handle missingness in the time-to-event data using multiple imputation based
on standard multivariate normal distribution (Bartlett et al., 2015; White and Royston,
2009). Therefore, we applied different MI methods according to these three prediction
modelling approaches. For Cox regression, the SMC-FCS approach for MI (Bartlett et al.,
2015) was used to impute missing data. Compared to the traditional FCS MI method (also
known as multivariate imputation by chained equations), SMC-FCS can not only specify
an appropriate regression method for imputing each predictor X (depending on the type of
X , e.g., linear regression for continuous variables, logistic regression for binary variables),
but also ensures that each missing value in a partially observed predictor X is imputed from
a model (Equation 6.4) that is compatible with the assumed substantive model (Bartlett
et al., 2015):
f (Xn|Y,X−n,Z) ∝ f (Y |X ,Z) f (Xn|X−n,Z) (6.4)
where Xn refers to nth predictor with missing data, Y is the outcome and X−n refers to the
remaining predictors other than the Xn predictor. The types of regression methods used
to impute each predictor when using SMC-FCS in this study can be found in Appendix
D Supplement 13. For ST, RF and CF models, RF algorithm was used to impute missing
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data because parametric imputation methods (e.g., FCS) may bias our estimation due to
model incompatibility. The underlying two-step imputation strategy of RF is as follows.
Step 1: for each splitting node, missing data are replaced (“imputed”) with values drawn
randomly from the non-missing in-bag data; Step 2: after splitting, the imputed data in
the children nodes are reset to missing (then proceed as Step 1 until terminal nodes are
reached). Therefore, RF imputation is carried out as a tree is being grown and all the
missing values are imputed at the end of one iteration. To accommodate variance due
to imputation, missing data were imputed for five sets in our study. We then performed
modelling on each imputation and the estimates of models prediction performance over
the five imputed data sets were combined using Rubin’s rules.
6.4.5 Model validation and performance evaluation
Validations were conducted internally (in development data sets) and externally
(in test data sets). The discriminative performance of prediction models was evaluated
using an overall C-index (Harrell et al., 1982), as well as a C-index which indicates the
models’ C-index at each point of survival time. For example, for the it h patient, let’s
say the event time is Ti, censoring time is Di and the predicted risk score from a model
is ηi, and let T̃i = min(Ti,Di) denote the censored time or the latest observed time and
ξi = I(Ti < Di) denote event indicator for right censoring. Then the C-index is an estimate
of the probability that, in a randomly selected pair of cases (i, j), the sequence of events
are successfully predicted (Pencina and D’Agostino, 2004):
Concordanceprobability = pr(ηi > η j|Ti < Tj) (6.5)
and the C-index is defined as Equation (6.6):
C− index =
∑i 6= j I(ηi > η j)I(T̃i < T̃j)ξi
∑i 6= j I(T̃i > T̃j)ξi
(6.6)
A C-index of 0.5 or lower finds the model is predicting an outcome no better than random
chance and a higher C-index corresponds to a model with higher prediction accuracy.
Additionally, calibration plots, graphs consisting of two types of curves, a 45-degree
straight line (reference line, indicating perfect calibration) and irregular curves (calibration
curves for each model), were constructed to determine whether the predicted survival
probability and observed survival probability were in concordance. In addition to C-index,
the integrated Brier score (IBS) (Graf et al., 1999) was also applied to assess models’
prediction performance. For binary prediction models, the Brier score is the mean squared
prediction error. For models based on time-to-event data, the Brier score for a single
subject is defined as: at a given time point t, the squared difference between observed event
status (e.g., death) and a model based prediction of survival time t. The IBS represents a
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E[(I(T > t)−S(tZ))2]dFZ(Z) (6.7)
where I(T > t) ∈ [0,1] is the individual survival status at time t and S(t|Z) is the predicted
survival probabilities from the model with covariates Z. The IBS is also known as prediction
error rate, where a value of 0.5 or higher indicates the model’s predictive performance is
no better than a chance and a lower IBS corresponds to higher prediction ability.
6.4.6 Study reporting and software
For reporting the findings of this study, we followed the TRIPOD statement (Appendix
D Supplement 14). All data were extracted from SEER*Stat 8.3.5, statistical analyses
were performed using STATA (Version 15, StataCorp LP, College Station, TX, USA) and
R (Version 3.6.4, R Foundation for Statistical Computing, Vienna, Austria). R package
“smcfcs” and “randomForestSRC” were used for missing data imputation. For model
development, Cox, ST, RF and CF were fitted using R package “mlr” incorporated in
packages “survival”, “rpart”, “randomForestSRC” and “partykit” respectively.
6.5 Conclusion
Based on a cohort from the SEER database, various models were used for predicting 3-
and 5-year OPCs survival, where RF and CF had a higher and ST had a lower predictive
capability than the reference approach (Cox regression). Moreover, a web-based calculator
was developed to predict the OPCs survival probability to potentially assist clinical decision-
making. Even though no major differences in the predictive performance were seen
between the imputation results and the complete case analysis, we recommend using
imputation as it allows a check if there was any information loss due to missing observations.
Additionally, since we are unaware of the true data-generating mechanism, it is good
practice to apply multiple prediction models to check if they all lead to the same answer.
This not only increases the confidence in the estimates but also increases the consistency
in the estimation.
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Application of multilevel machine learning
models for predicting pain following root canal
treatment
Preface
In Chapter 6, we used a real-world cancer registry data to demonstrate how to develop
prediction models for a time-to-event outcome. The analysis in that chapter was carried
out assuming a pre-specified data generating mechanism. In this chapter, we use a
prospective patient cohort to demonstrate how to develop prediction models for a binary
outcome with a multilevel data structure. The outcome we predicted was the pain
following a common treatment in dentistry – root canal treatment. We also aim to
address different types of bias such as missing data and predictor selection. Moreover,
this chapter presents the novel application of precision-recall curves for measuring the
performance of prediction models when the distribution of outcome data is imbalanced
(the negatives being more than the positives). This is a common phenomenon in
real-world health care data. To the best of our knowledge, we are the first to recognise
the issue of imbalanced data and build prediction models on such type of data in oral health.
This chapter contains the last of a series of four studies contributing to this thesis.
Details for the submitted paper are:
Du M., Haag, D. G., Lynch, J. W., Mittinty, M. N. Application of multilevel machine
learning models for predicting pain following root canal treatment. Journal of Dentistry.
(Submitted).
The submitted version of the paper is reproduced as follows.
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Abstract
Aims: This study developed predictive models for one-week acute and six-month
persistent pain following root canal treatment. Additionally, we aimed to study the gain
in predictive efficacy of models containing clinical factors only, over models containing
sociodemographic characteristics.
Methods: We conducted a secondary data analysis of 708 patients who received
root canal treatment. Three sets of predictors were used: 1) combined set, containing
all predictors in the data set; 2) clinical set and 3) sociodemographic set. Missing data
were handled by multiple imputation using the missing indicator method. The multilevel
least absolute selection and shrinkage operator (LASSO) regression was used to select
predictors into the final multilevel logistic models. Three measures, the area under the
receiver operating characteristic curve (AUROC) and precision-recall curve (AUPRC), and
calibration curves, were used to assess the predictive performance of the models.
Results: The selected-in factors in the final models, using LASSO regression, are
related to pre- and intra-treatment clinical symptoms and pain experience. Predictive
performance of the models remained the same with the inclusion (exclusion) of the
socio-demographic factors. For predicting one-week outcome, the model built with
combined set of predictors yielded the highest AUROC and AUPRC of 0.85 and 0.72,
followed by the models built with clinical factors (AUROC = 0.82, AUPRC = 0.66). The
lowest predictive ability was found in models with only sociodemographic characteristics
(AUROC = 0.68, AUPRC = 0.40). Similar patterns were observed in predicting six-month
outcome, where the AUROC for models with combined, clinical and sociodemographic
sets of predictors were 0.85, 0.89, and 0.66, respectively, and the AUPRC were 0.48, 0.53
and 0.22, respectively.
Conclusion: Models containing pre-treatment clinical factors adequately predict
the development of one-week and six-month pain following root canal treatment. Adding
sociodemographic characteristics to the models with clinical factors did not change the
models’ predictive performance or the proportion of explained variance.
Clinical significance: This study presents the use of pre- and intra-operative pain
experience to predict the post-operative pain following RCT. Clinicians could use this
information to better inform patients about pain outcome and possibly use different
treatment strategies to manage their patients.
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7.1 Introduction
Root canal treatment is an invasive procedure that dentists perform to remove the dead
or infected pulp from the pulp chamber and then replace with a rubbery material to
prevent bacteria from entering again. Sometimes patients experience pain after a root canal
treatment due to various reasons, such as post-procedure inflammation, in-adequate/over-
adequate fillings and tooth cracks. Pain following a root canal treatment can be either
acute or persistent. The prevalence of acute pain was reported to vary from 5% to 14%
(Pak and White, 2011), and persistent pain was estimated to have an occurrence of 3%
to 12% (Polycarpou et al., 2005). As known, clinical prediction models usually combine
available data on risk factors into a single index, which conveys some information about the
likelihood of a certain healthcare outcome (Moons et al., 2009). Pre-operative identification
of patients who are at high-risk of pain has the potential to help dentists and improve
post-operative care of patients subject to root canal treatment.
The predictors for pain following root canal treatment include patient-level character-
istics (e.g., sex, age), tooth-level characteristics (e.g., tooth anatomy, type of root canal),
and treatment characteristics (e.g., instrumentation). Using these risk factors, numerous
models are being developed to predict the post-operative pain of root canal treatment
(Arias et al., 2013; Kayaoglu et al., 2016; Law et al., 2015). However, there are several
limitations to current research. The first is that the existing studies have not compared the
predictive ability of the predictors from across different domains of variables (e.g., clinical,
sociodemographic domains). Moreover, sociodemographic characteristics summarise a
combination of variables related to socio-economic position, cultural background, biology,
and the impact of racism on health. Using sociodemographic characteristics for prediction
in clinical settings may seem to push these variables from social paradigm to biological
and legitimise the notions of racial/sexual essentialism (Paulus and Kent, 2017). Another
limitation in much of the current literature revolves around the statistical modelling ap-
proach. Frequently, the study data used in models are clustered within dental practice
or clinician (Bouwmeester et al., 2012). For example, patients treated by one clinician
may have some similarities when compared to the patients treated by another clinician,
thus making the patients treated by a particular physician clustered (dependent). However,
the use of techniques that account for ‘clustering’ was limited in previous oral health
prediction modelling research (Moerbeek et al., 2003; Twisk, 2006).
In this study, we employed a multisite prospective cohort and applied multilevel
regression analysis for predicting the post-operative pain following root canal treatment.
We compared the predictive performance of models which incorporated different domains





We used a publicly available data collected by the National Dental Practice-Based
Research Network in the US. Ethics approval was not required by the University of
Adelaide for secondary analysis of the de-identified open-access data. The study population
consisted of 708 patients who received root canal treatment undertaken by 62 dental
practitioners across six states in the US. Patient eligibility criteria and details of data
collection can be found elsewhere (Law et al., 2014). We used records collected at four
time points: before the initiation of treatment (pre-operative), immediately after treatment
(intra-operative), one week after tooth obturation, and six months after the initiation of
treatment (post-operative).
7.2.2 Predictor variables
Available predictors include: (1) Sociodemographic characteristics of patients and
practitioners (e.g., sex, race, ethnicity); (2) Pain characteristics (e.g., pre- and intra-
operative measures of pain intensity); (3) Systemic medical characteristics of patients
(e.g., diabetes); and (4) Procedural characteristics (e.g., tooth anatomy, use of rubber dam).
We organized the available information into three sets of predictors. The first set was
a combined set, comprising both clinical and sociodemographic predictors (number of
predictors = 76), the second set was a clinical set, consisting of only the clinical factors
(number of predictors = 67, and the third set was a sociodemographic set, consisting of only
the social and demographic characteristics (number of predictors = 9) from the patients
and practitioners.
7.2.3 Outcome variables
There were two outcome variables used in this study. The first outcome was one-week
acute pain following root canal treatment, i.e. severe pain (a rating of 7 on a scale of 0-10)
occurring in or around the location of a tooth that received root canal treatment within the
past week (Walton and Fouad, 1992). The other outcome was six-month persistent pain
following root canal treatment, i.e., pain lasts for six months after the initiation of root
canal treatment (Von Korff et al., 1992). This outcome was defined by an answer of 1
day(s) for the question ‘How many days in the past month have you had pain in the area
that was treated with a root canal?’. In this study, pre- and intra-operative information
were used for predicting one-week outcome while the six-month outcome was predicted
by the information from pre-, intra- and one-week post-operative.
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7.2.4 Handling of missing data
When missingness is informative, use of indicators of missing combined with multiple
imputation can minimize bias compared with the complete case analysis (Choi et al., 2019;
Fletcher Mercaldo and Blume, 2020; Sperrin and Martin, 2020). In the missing indicator
method, we first created the dummy variable (0, 1) that indicated whether or not the value
of that variable was missing. Then we incorporated this method with multiple imputation
with chained equation, aiming to optimise prediction accuracy by making use of missing
pattern information (Sperrin and Martin, 2020). To account for variance due to imputation,
analysis was conducted using five imputed datasets. Using Rubin’s rules, the estimates of
prediction performance were combined over these five imputed datasets.
7.2.5 Model development
In this study, generalized linear multilevel regression analysis incorporated with
10-fold cross validation was used to develop prediction models. Our data have a two-level
hierarchical structure with 708 patients at level 1, nested within 62 dental practitioners
at level 2 (a schematic structure of our data can be found in Appendix E Supplement 1).
A flowchart of statistical analyses can be found in Appendix E Supplement 2. Briefly, a
two-level model was used. Level 1 was called fixed-effect level, and it took into account
the patient-based characteristics. Level 2 was the random-effect level, and it took into
account the practitioner-based characteristics. Xi j refers to the level 1 predictor of ith
patient of cluster j (e.g., patient’s age), β j is the effect size parameter, which differs for
each practitioner, εi j refers to the random error of prediction for the level 1 equation. So,
for the ith patient of cluster j, the level 1 model is written as Equation (7.1):
Yi j = α +β jXi j + εi j (7.1)
Wj refers to the level 2 predictor (e.g., practitioner’s sex), γ1 refers to the regression
slope parameter of the level 2 predictor, and u j is the error term from level 2, therefore
β j = γ0 + γ1Wj + u j (Equation 2). For each of the outcomes, we fit three multilevel
models. The first was the full model (Models 1 & 4, for one-week and six-month outcome,
respectively) which contained the combined set of predictors. The second models (Model
2 & 5) contained only clinical factors from patients and practitioners. The third models
(Model 3 & 6) included only sociodemographic characteristics.
Variable selection
We used the least absolute selection and shrinkage operator (LASSO) (Tibshirani, 1996)
for variable selection. The LASSO minimizes the squared error between the observed and
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predicted values, and additionally imposes a penalty if coefficients are not zero (Ahrens










Where Yi and Ŷi are the observed and predicted outcome value for the patient i, n is the
number of patients, β̂x are the corresponding coefficients for predictor X , m is the number
of predictors and λ is the shrinkage penalty parameter or tuning parameter. Given that
our data were clustered, we fit multilevel LASSO models (Equation 4) introduced by
(Schelldorfer et al., 2011). Besides the penalty function as described in Equation (7.2), the
multilevel LASSO uses additional terms to account for the variance components (consists
of between cluster variance and within cluster variance) that are parts of the multilevel











where V is the covariance matrix from the multilevel model, and β̂x represents the mixed
parameters of the level-1 and level-2 coefficients.
7.2.6 Models’ discrimination, calibration and goodness of fit
Models’ discrimination
We used two measures for models’ discrimination: the Area Under the Receiver Operating
Characteristic curve (AUROC) and the Area Under the Precision Recall Curve (AUPRC).
AUROC uses two aspects of information, sensitivity (true positives/true positives + false
negatives) and 1-specificity (true negatives/true negatives + false positives), from the
confusion matrix (A cross tabulation of the observed and predicted outcome for a given
threshold). AUROC is then defined as the average sensitivity, regarding all values of
the specificity as equally likely (Hand, 2009). However, when the outcome data are
imbalanced, estimate of AUROC is severely impacted by the true negatives. To overcome
this, alternative measures such as AUPRC have been proposed (Saito and Rehmsmeier,
2015). AUPRC also uses two aspects of information, sensitivity (referred to as recall)
and positive predicted values (referred to as precision, true positives/true positives + false
positives), from the confusion matrix. AUPRC is then defined as the average positive
predictive values, regarding all values of the sensitivity as equally likely. In our study, we
are building classifiers to detect pain following root canal treatment, therefore identifying
all ‘individuals with pain’ is more important than predicting the ‘non-pain cases’. Thus,
true negatives are less of a concern, hence AUPRC is a more meaningful measure.
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Model calibration
To measure models’ calibration, we created a confidence belt for the calibration curve
(Nattino et al., 2016). Compared to the standard calibration curve, the calibration belt
can spot the range and direction of deviation from the ideal calibration, and it provides
suggestions for revising the model.
Model goodness of fit
Models’ goodness of fit was evaluated by Pseudo-R2, Akaike information criterion (AIC)
and Bayesian information criterion (BIC) value. A higher Pseudo-R2, a lower BIC and/or
AIC value indicates a better fit.
7.2.7 Statical software
The programming language R Version 3.6.2 was used for data pre-processing and
analysis. Imputation was conducted using ‘MICE’ package. LASSO analysis was per-
formed with ‘glmmLasso’ package, the ‘lme4’ package was used to produce the models.
The ROC, PRC and calibration belts were plotted using ‘pROC’, ‘ROCR’ and ‘givitiR’
packages, respectively.
7.2.8 Data availability and study reporting
Data and data dictionary can be freely downloaded:
https://www.nationaldentalpbrn.org/study-results/. R codes used for the analysis
can be found in Appendix E Supplement 3. We reported our studying following the
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or
Diagnosis (TRIPOD) statement (Collins et al., 2015).
7.3 Results
7.3.1 Characteristics of the participants
Table 7.1 reported the pre-operative (baseline) characteristics for patients. In this data
set, 707 patients were included in our study who completed tooth obturation. Their mean
age was 47.8 years and 408 (57.7%) were females. Of the 707 participants, 411 (58.1%)
patients provided one-week follow-up data and 651 (92.1%) provided six-month follow-up
data. We only included participants whose outcome data were available. At one-week
post-treatment, 100 patients (24.3%) reported a score of 7 or higher for the worst pain
following the first week of root canal treatment. At six-month follow-up, persistent pain
presented in 70 patients (10.8%).
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Table 7.1: Characteristics of the patients and outcome distribution. Characteristics are displayed at
patient-, tooth- and practitioner-level.
Patient-related characteristics
Age in years
Mean (SD) 47.8 (13.0)


























Highest level of education
<High school 14 (2.0%)
High school 115 (16.3%)

























Alabama (AL) 98 (13.9%)
Florida (FL) 130 (18.4%)
Minnesota (MN) 377 (53.3%)
Saskatchewan (SK) 53 (7.5%)
Oregon (OR) 36 (5.1%)










One-week acute pain (sample size = 411)
Yes 100 (24.3%)
No 311 (75.7%)




7.3.2 Selected-in variables by LASSO
According to the LASSO regression, there were 7-16 non-zero coefficient predictors
entering the final models (Table 7.2). We found that most of the included clinical factors
are related to pre-operative pain, such as the initial pain quality (e.g., ‘pain getting worse
by stress’) and intra-operative pain experience (e.g., ‘how numb felt during treatment’).
Besides this, a large proportion (6 out of 9) of sociodemographic characteristics were
selected in, including the patient’s race, dental insurance status, income, practitioner’s sex
and ethnicity. For predicting six-month outcome, variables of pain experience at one-week
follow-up were also identified important by LASSO regression, such as ‘present pain rating
at one-week follow-up’.
Table 7.2: Models specification and performance comparison
Outcome Model Selected-in variables by LASSO[1] Performance (discrimi-















patient’s race, pain gets worse by
stress, present time pain rating, #
days pain kept from activities past
wk[6], pain interfere work past wk,
pain interfere social/fam act past wk,
bleeding in pulp chamber, not nego-
tiable canal, swelling, intensity of
pain during treatment, how numb
felt during treatment, nitrous oxide
AUROC[2] = 0.85 [0.81,
0.89]
AUPRC[3] = 0.72
AIC[4] = 442.92, BIC[5]
= 688.06
Pseudo-R2 (fixed ef-





N= 7 in total
Practitioner-related: state of practice
Patient-related: pain gets worse by
stress, present time pain rating, #
days pain kept from activities past
wk, pain interfere work past wk,
pain interfere social/fam act past wk,
bleeding in pulp chamber
AUROC = 0.82 [0.77,
0.87]
AUPRC = 0.66
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Selected-in variables by LASSO Performance (discrimi-







N= 9 in total
Practitioner-related: sex, ethnicity,
graduation year
Patient-related: sex, race, ethnic-
ity, income, education, dental insur-
ance/3rd party coverage
AUROC = 0.68 [0.62,
0.74]
AUPRC = 0.40

















year, state of practice
Patient-related: patients’ race,
income, patients’ expectation of the
treatment outcome, pain gets worse
by cold, present time pain rating,
days pain kept from activities
past wk, location of the greatest
probing depth, pain interfering
daily activities in the first wk after
treatment, pain rating at one-wk
follow up
AUROC = 0.85 [0.80,
0.89]
AUPRC = 0.48











Selected-in variables by LASSO Performance (discrimi-





N= 12 in total
Practitioner-related: practitioners’
graduation year, state of practice
Patient-related: patients’ expecta-
tion of the treatment outcome, pain
gets worse by cold, present time
pain rating, pain intensity past wk,
days pain kept from activities past
wk, location of the greatest probing
depth, pain interfering daily activi-
ties in the first wk after treatment,
pain interfere work in the first wk af-
ter treatment, pain rating at one-wk
follow up, intensity of worst pain in
the first wk after treatment
AUROC = 0.89 [0.85,
0.92]
AUPRC = 0.53











N= 9 in total
Practitioner-related: sex, ethnicity,
graduation year
Patient-related: sex, race, ethnic-
ity, income, education, dental insur-
ance/3rd party coverage
AUROC = 0.66 [0.59,
0.72]
AUPRC = 0.22






[1]LASSO: Least Absolute Shrinkage and Selection Operator. [2]AUROC: Area Under
Receiver Operating Characteristics curve. [3]AUPRC: Area Under the Precision-
Recall Curve. [4]AIC: Akaike information criterion. [5]BIC: Bayesian information
criterion. [6]wk: week. All generalized linear mixed models were built with R glmm()
function. Combined set contains sociodemographic characteristics + clinical factors.
Clinical set contains only clinical factors and sociodemographic set contains only
sociodemographic characteristics.
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7.3.3 Models specification and performance measures
Model performance measures are specified in Table 7.2, Figures 7.1 and 7.2, and Ap-
pendix E Supplement 4. In terms of discrimination, models yield a wide range of AUROC
from 0.66-0.89. Figure 7.1 presents a visual discriminative ability of all models used. We
found that models with sociodemographic set of predictors underperformed others, and
minor difference were found between the combined set and clinical set alone. For example,
for predicting one-week outcome, the AUROC for Model 1-combined, Model 2-clinical,
and Model 3-sociodemographic are 0.85 [95% CI 0.81, 0.89], 0.82 [0.77, 0.87] and 0.68
[0.62, 0.74], respectively. Similar pattern was found in six-month outcome prediction
(AUROC for Model 4-combined, Model 5-clinical and Model 6-sociodemographic are
0.85 [0.80, 0.89], 0.89 [0.85, 0.92] and 0.66 [0.59, 0.72], respectively). In terms of AUPRC,
the models with combined and clinical sets of predictors yielded similar AUPRC, while
the models with only sociodemographic characteristics showed the lowest classification
ability. As shown in Figure 7.1, the AUPRC for Model 1 to 6 are 0.72, 0.66, 0.40, 0.48,
0.53 and 0.22, respectively. Results of other measures such as Sensitivity, Specificity can
be found in Appendix E Supplement 4.
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Figure 7.1: Models’ area under the receiver operating characteristic curve (AUROC) and precision-
recall curve (AUPRC) for predicting one-week and six-month post-operative pain in patients
undergoing root canal treatment.
Curves in different colours represent models with different sets of predictors.
Blue: combined set, containing sociodemographic characteristics + clinical
factors. Red: clinical set, containing only clinical factors. Green: sociodemo-
graphic set, containing only sociodemographic characteristics. In ROC, the
grey diagonal line represents a random classifier with an AUROC of 0.5. In
PRC, the grey dashed line represents the baseline. Due to the different distribu-
tion of positives (‘1’) and negatives (‘0’) for the one-week (positives: negatives
= 76% : 24%) and six-month outcome (positives: negatives = 89% : 11%), the
random classifiers have AUPRC of 0.24 and 0.11, respectively. Therefore, all
of the developed models have better AUPRC than random classifiers.
In terms of models’ calibration, as shown in Figure 7.2, models built on combined set
and clinical set of predictors calibrated well, whereas models built on sociodemographic
characteristics did not calibrate, meaning the models may under/over-estimate the risk of
developing pain, and even give extreme (too close to 0 and 1) risk estimates.
156









Figure 7.2: Models’ calibration belts.
In terms of goodness of fit, there were three main findings. First, the Pseudo-R2 for
models including clinical set of predictors (Model 1, 2, 4 and 5) were 1.5 times higher
than the models with sociodemographic set of predictors (Model 3 and 6). Second, similar
proportions of the explained variance were observed among the models containing clinical
factors, suggesting that minor differences in the included clinical factors does not change
the models’ goodness of fit. The third finding was that, when models were developed with
the involvement of clinical factors, Pseudo-R2 for fixed effects were equal to the Pseudo-
R2 for total effects, suggesting that majority of the explained variance was from level 1
(patient-level) characteristics, rather than the level 2 (practitioner-level) characteristics.
This can be explained by the variance due to fixed and random effects in Appendix E
Supplement 5.
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Finally, for completeness of reporting following TRIPOD, the estimated regression
coefficients and odds ratios are reported in Appendix E Supplement 6. TRIPOD checklist
can be found in Appendix E Supplement 7.
7.4 Discussion
Our first major finding was that among all the available predictors, the intensity of pre-
operative pain and the experience of intra-operative pain were important to the subsequent
development of post-operative tooth pain regardless of the investigated time period. This
is consistent with the previous literature in predicting post-operative pain in other health
areas, such as breast surgery, limb amputation and thoracotomy (Kehlet et al., 2006). This
finding also supports the importance of clinical factors for healthcare risk assessment.
Our second finding was that majority (6 out of 9) of the sociodemographic char-
acteristics were identified important to predict the outcome. This leads to our further
considerations on how to deal with variables from different domains in clinical prediction:
when we mix the predictors across domains, we integrate modifiable clinical variables and
unmodifiable sociodemographic variables that we may not intervene on. For example, in
our data, the variable “patient’s race” was one of the most relevant predictors for post-
operative pain. However, it is known that race-based differences in health risk may be,
in part, due to unmeasured differences between black and white patients that are related
to the differential lived experiences of blacks versus whites in the US. Given the final
goal of risk prediction is to assist on making intervention (i.e., changing a risk factor to
a protective factor), it might make little sense to include these unmodifiable variables in
clinical prediction models.
Our third finding was that in the presence of clinical factors, the sociodemographic
characteristics contributed less to either improving the models’ predictive performance
or explaining the variance in the model. Though there is a lack of consensus in how to
deal with sociodemographic variables in clinical prediction (Paulus and Kent, 2017), we
argue that with the inclusion of sociodemographic characteristics (e.g., race/ethnicity),
clinical prediction can create algorithmic bias, that is enhancing the inequality of healthcare
attainment. Other research has argued that different races experience different levels of
pain tolerance (Edwards et al., 2001; Wandner et al., 2012). When a patient is more tolerant
to pain, he/she might be underscored and predicted as ‘low’ risk of developing pain, thus,
less medical care would be allocated to him/her. As a result, individuals predicted to be at
lower risk of pain because of their race/ethnicity may not be beneficiaries of enhanced pain
care. In contrast, when a racial group is less tolerant to pain, this population are more likely
to be predicted as ‘high’ risk and might be overtreated in order to prevent the development
of post-operative pain.
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Strengths
The first strength relates to the methodology used in this study: 1) We applied multilevel
LASSO regressions to identify the importance of clinical and sociodemographic predictors
in clinical prediction. 2) Use of multilevel regression models that take the hierarchies of
data structure into consideration might increase both the amount of predictive information
and models’ overall predictive ability (Gelman, 2006). 3) Use of AUPRC along with
AUROC to evaluate the models’ performance increases our confidence in the findings. We
here take six-month models as an example to interpret AUROC and AUPRC. As shown
in Table 7.2, the proportion of positive cases in six-month cohort is 24%, meaning the
baseline AUPRC for six-month models is 0.24, then achieving an AUPRC of 0.48 and 0.53
in Model 4 and 5 (higher than the baseline) is ‘good’ while an AUPRC of 0.22 in Model 6
(lower than the baseline) is ‘bad’. For this reason, our findings can be interpreted as: No
matter whether we look at all participants or we focus on the positive class only, the models
with clinical set of predictors perform similar to models with combined set of predictors
while models with sociodemographic set of predictors yield the lowest classification ability,
even worse than not using the model. Second, the presented models are intended to have
direct clinical relevance, as the predictor variables are easy to obtain from daily dental
practices, making the models easy to validate. The third strength is that we are trying
to develop models that rectify, rather than amplify sexist and racial discrimination by
leaving out sociodemographic factors and maintaining comparable predictive ability. This
attempt draws attention on the potential racial/sexual/ethnic bias in clinical prediction
when involving sociodemographic variables into model development, particularly in oral
health field. Hispanics living in the US represent an increasing diversity of national-origin
groups with a relative lack of detailed epidemiological data on the incidence and prevalence
of common and important diseases (Escarce et al., 2006). When ‘Hispanic’ identity was
missing, the imputation could be challenging as ‘Hispanic’ identity is multidimensional
and multifaceted and will align with multiracial identity (Parker et al., 2015). Therefore,
the results need to be interpreted cautiously.
Limitations and future research
First, our models were developed and internally validated based on a small cohort, these
models should be validated in other populations and tested in clinical settings before using
in clinical practice. Second, there are a variety of biases which we did touch upon in our
prediction, such as measurement error. We assumed there was no measurement error in
the data which might not be the case. Third, when the original data has a two(multi)-
level structure, the imputation model can be either hierarchical or non-hierarchical. The
ideal way for imputation is to account for variance from both level-1 and level-2 using
hierarchical imputation methods, such as the method described in the ‘miceadds’ package
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(Robitzsch et al., 2017). However, the hierarchical imputation was not conducted in this
study for two reasons: i) the practitioner-level variance contributes less to the total variance;
and ii) the ‘miceadds’ packages does not support for imputing nominal variables. Fourth,
in this study, the AUROC was used as the loss function to select best λ as in equation 7.2
and 7.3, however, since the data set has an imbalanced outcome distribution, the AUPRC
may be a better replacement to AUROC. However, creating a new statistical method that
incorporates AUPRC with LASSO extends beyond the study, therefore, further research is
needed to address these methodological issues. Finally, more discussion is needed among
a variety of stakeholders, in terms of developing a consensus about the best practice of
coping with sociodemographic characteristics in clinical prediction modelling research.
7.5 Conclusion
Multiple multilevel models were built to predict the one-week acute pain and six-month
persistent pain following root canal treatment. The severity and experience of pre-operative
and intra-operative pain were discovered important to the subsequent development of
post-operative pain. This provides information for managing pain expectations for both
the patients and practitioners performing root canal treatment. Our results indicate that
clinical factors play more important role in clinical prediction than sociodemographic
characteristics. Using clinical factors over sociodemographic characteristics may reduce
the sexual/racial biases when predicting risk.
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General discussion and conclusion
Preface
Previous chapters have discussed the usefulness, strengths, and limitations pertaining to
each individual study. This chapter brings together the evidence obtained throughout this
PhD project and provides an overall discussion and conclusion. Section 8.1 presents an
executive summary and key findings from this project. Drawing from these findings, further
considerations are presented in Section 8.2 regarding a number of issues in prediction
modelling research, including (factual) prediction v. counterfactual prediction (causal
inference), individual-level v. population-level risk prediction, and the challenges of
applying machine learning to oral health data. Sections 8.3 and 8.4 highlight the strengths
and limitations of the design and the conduct of this project. Section 8.5 outlines the
implications for future research and clinical practice. Finally, Section 8.6 provides an
overall summarising conclusion.
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8.1 Executive summary and key findings from the
project
In recent years, eminent journals such as Nature, The Lancet and The BMJ have published
a number of articles calling for global action to improve the quality and reproducibility of
research in science, including the health and medical sciences (Baker, 2016; Begley and
Ioannidis, 2015; Beran et al., 2019; Grol et al., 2002; McNutt, 2014; Munafò, 2019). In
the field of prediction modelling, poor study quality and a lack of study reproducibility
also constitute major concerns (Hayden et al., 2006, 2013; Moons et al., 2014). In this
context, I commenced my PhD and structured the thesis with two systematic reviews and
two empirical analyses, revolving around the research quality and reproducibility of oral
health prediction models. The four studies included in this thesis address various aspects
of the identification, quality assessment, development, internal validation and performance
evaluation of clinical prediction models in various areas of oral health.
• The first two studies (systematic reviews in Chapters 4 and 5) were conducted to
achieve two aims:
1) to identify the prediction models in the major fields of oral health;
2) to assess study quality in terms of addressing bias and reporting completeness.
From these two studies, it was found that, the major oral health outcomes predicted
were periodontal diseases, tooth loss, dental caries, and oral cancers. Our studies
have shown that the majority of the existing studies do not incorporate various
sources of potential bias, such as measurement error or the effective management
of missing data. Moreover, opaque reporting and lack of reproducibility were also
identified in the existing oral health prediction modelling studies. For example, it
was found that 70% of the studies did not report the models’ calibration and 47%
of the studies did not report the methods for handling missing data. These findings
provided motivations to conduct two further studies (Chapters 6 and 7) with the aim
of demonstrating adherence to the recent guidelines in prediction modelling studies.
• Following the recommendations offered by PROBAST, the study in Chapter 6
was conducted to predict a time-to-event outcome - the survival of patients with
oral and pharyngeal cancers. Using data from the SEER program, three tree-based
machine learning methods (survival tree, random survival forest and conditional
inference forest) and a traditional statistical model (Cox regression) were used to
predict the three-year and five-year disease-specific survival of patients with oral
cancers. Additionally, this study demonstrated how missing data can be handled
in both machine learning and the traditional statistical models, using methods such
as the substantive model compatible version of the fully conditional specification
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imputation approach. Finally, C-index and IBS (Integrated Brier Score) were used
to evaluate the models’ predictive performance.
From this study, we observed comparable predictive capabilities between Cox regres-
sion and the non-parametric tree-based machine learning algorithms. For example,
the C-index for a Cox model and a random survival forest in predicting three-year
survival were 0.82 and 0.84, respectively. A novel application of this study was the
development of an online calculator using ShinyApp software in R to initiate the
open estimation of the survival probability for up to five years for patients. This cal-
culator has clinical translational potential and may be useful in patient stratification
and treatment planning, perhaps initially in the research context.
• Chapter 6 provides a simplistic view of data by considering a pre-specified set of
predictors. However, in many real-world data settings, some data complexities need
to be addressed prior to modelling. These complexities include the nesting of infor-
mation and the selection of predictors. Chapter 7 demonstrates how to accommodate
these issues using an example of developing clinical prediction models for the pain
following root canal treatment. Data used in this study were from a multisite prospec-
tive patient cohort who underwent root canal treatment. This analysis comprises
76 predictors in the analysis, including the patients’ sociodemographic descriptors
(e.g., age, sex) and clinical symptoms (e.g., pre-treatment pain experience). The data
set was hierarchically structured, with 708 patients being nested within 62 dental
practitioners. Multiple imputation with missing indicator methods were applied to
handle missing data. To fit the hierarchical structure of the data, multilevel logistic
regression was used for model development. To reduce the number of predictors in
the final models, the LASSO regression was used. In addition, since the data had
an imbalanced outcome distribution (the negatives being more than the positives),
measures such as the AUPRC were implemented to evaluate how well the positives
are predicted by the models.
From this study, we found that the pre-treatment clinical factors were identified
as being important to the development of postoperative pain following root canal
treatment, and that demographic characteristics did not add much to the models’ pre-
dictive performance. Among all the developed multilevel logistic regression models,
the models with a clinical set of predictors yielded similar predictive performance to
models with the combined (clinical and sociodemographic) set of predictors, while
the models with sociodemographic predictors alone showed the weakest predictive
ability. For example, for the prediction of one-week postoperative pain, the AUROC
for models with clinical, sociodemographic, and combined set of predictors were
0.82, 0.68 and 0,84 respectively, and the AUPRC were 0.66, 0.40 and 0.72, respec-
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tively. AUROC and AUPRC convey different information and hence results from
both these analyses are presented.
• Additionally, the transparent reporting and reproducibility of the empirical studies
were achieved by following the TRIPOD checklist and sharing all the data and
codes used via GitHub repositories (Chapters 6 and 7).
8.2 Issues to consider for future prediction modelling
research
Though our findings show a promising future for the application of clinical prediction
models in oral health, multiple issues remain to be considered.
8.2.1 Prediction v. causation and intervention
Discriminating between prediction and causation
Prediction relies on the correlation between the predictors and outcomes, however, the
correlation between these two variables does not guarantee causation (Obermeyer and
Emanuel, 2016). It is therefore critical to understand the difference between causation
and correlation. In Chapter 2, the differences between explanatory models and prediction
models were discussed. Their use in two different types of research can be described as:
• Counterfactual prediction (causal inference) research requires causation between
the predictor(s) and the outcome(s), and relies on causal explanatory models. This
is useful if the effect of interventions is the focus of the investigation.
• Factual prediction requires correlation between the predictor(s) and the out-
come(s), and uses prediction models.
The nature of (factual) prediction is to link the predictors to the outcomes regardless
of the data generating (causal) mechanism that produces the outcome in the real world.
Therefore, (factual) prediction may contain both causal and non-causal factors that predict
the outcome. In doing so, the focus of (factual) prediction lies in the identification of the
data generating mechanism while using little or no knowledge of the conceptual model
underlying it. Counterfactual prediction relies on posing a pre-specified data generating
(causal) mechanism to predict the potential outcomes as if the world had been different to
that which has been observed (Dickerman and Hernán, 2020; Hernán et al., 2019).
This distinction between the two types of prediction is perhaps best explained by
using an example. To predict the five-year risk of tooth loss (due to periodontal disease),
counterfactual prediction is used to answer questions such as: ‘Given the baseline char-
acteristics of the patients, what would be the five-year risk of having tooth loss if all
individuals received periodontal therapy v. no individual received periodontal therapy?’ It
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is the ‘what if’ approach that drives the counterfactual prediction and it measures how the
prediction of a particular outcome changes when the value for one or more predictors is
changed (Hernán and Robins, 2016; Wachter et al., 2017). In contrast, if the question is not
a ‘what if’ question (e.g., ‘What is the five-year risk of tooth loss among the individuals
receiving the periodontal therapy?’), then a factual prediction is formulated.
The need for a shift from prediction to causation and intervention
While prediction allows for the estimation of the probability of an event, it cannot provide
specific guidance on which interventions are appropriate to reduce the patients’ risk. This
is because we are often unaware of what variable(s) affect/lead to the predicted outcome.
The nature of the research questions answered in this thesis is: ‘What is the risk of having
an adverse outcome for a patient at a specific time given the available data at that time?’
The subsequent logical step is to answer: ‘Does a certain risk factor cause the outcome?
Would the adverse outcome be changed if an intervention targeting the risk factor was
implemented?’ To answer such questions, there must be a shift away from prediction
modelling (factual prediction) towards causal inference (counterfactual prediction or the
potential outcomes approaches). This shift in focus may assist in understanding the
impacts of the prediction tools on clinical decision-making, as well as evaluate evaluating
the effectiveness of interventions in improving patients’ health outcomes. However, causal
estimation has its own limitations, the major being the unmeasured confounding.
8.2.2 Population-level risk is not individual-level risk
As discussed in Chapter 2, definitive statements such as: ‘My risk of having tooth
loss is 10% in the next 10 years’ are problematic. Such statements are limited to forms
similar to: ‘If we consider a sample of 100 people exactly like ‘myself’, on average, 10
of them are predicted to have tooth loss in 10 years.’ This is because if a factor, X , is
reported to increase the risk of developing a disease in a population, it does not mean that
an individual, personally, will have a higher probability of developing the disease from
exposure to factor X .
In 2003 the Human Genome Project was completed, following which an increasing
number of researchers argue that ‘individualised risk prediction’ may be a possibility
based on the information contained within -omics (Chen and Snyder, 2013). However,
in a similar fashion to the commonly used predictors in health research such as sociode-
mographic characteristics, environmental factors and lifestyles, -omics data are unable to
make predictions regarding an individual patient’s likelihood of developing a disease or
how a specific patient will respond to any given treatment. Because people may have either
a protective or predisposing genotype with respect to a disease, there remains a genetically
based risk difference to disease development between these two subgroups. Although it is
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possible to identify the individuals with a genotype predisposition to disease development
by mapping their entire genome, this information itself is not sufficient to identify specific
individuals who will develop the disease. Achieving risk prediction at the level of the
individual, therefore, remains challenging, even when in possession of -omics data. Addi-
tionally, -omics data are not routinely recorded in daily practice, meaning their inclusion
as predictive variables in routine risk modelling approaches becomes problematic.
8.2.3 Racial and gender-based bias due to risk prediction
As discussed in Chapter 7, there has been a growing concern that predictive algorithms
may reproduce racial and gender disparities via the data used to train them (Barocas and
Selbst, 2016; Chouldechova and Roth, 2018). The ‘high-impact’ journal Science has
called for specific attention regarding the racism in risk prediction tools (Benjamin, 2019).
Empirical examples also support these concerns. One typical example of racial bias due to
risk prediction can be found in the study by (Obermeyer and Emanuel, 2016). In that study,
in order to inform the allocation of medical resources, the authors developed models aimed
at predicting the health risk among millions of people. One of the predictors used was
‘health need’, represented by the ‘cost on health care’. However, there was a problem with
using ‘cost’ as a proxy of health need, because Black people tend to spend less on health
care due to their relatively ‘lower’ economic status. But in fact, Black people with the same
‘cost on health care’ as White people tend to be much sicker and need much more health
care. When the algorithm used ‘cost’ to predict the health risk, it falsely concluded that
Black people are much healthier than White people. As a result, health care providers tend
to allocate fewer resources to Black people, leading to inequality in health care provision.
In this example, bias was introduced because the same sick Black person may not
expend an equivalent sum of money on health care as a result of a lower income. To
overcome this bias, the findings from Chapter 7 (Publication 4) provide a potential solution.
This may be achieved by removing the use of sociodemographic characteristics in model
development when large clinical information is available.
8.2.4 Common challenges in applying machine learning for prediction analysis in
oral health
Recent advances in machine learning present an exciting opportunity to improve oral
health care, with potential applications ranging across different disciplines in oral health.
However, challenges remain in applying machine learning algorithms to the analysis of
oral health data.
Hierarchical structure of data in oral health research
Differing from other medical data, data in oral health are characterised by their multilevel
structure. For example, for the assessment of periodontal parameters such as pocket depth,
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data are evaluated at a contextual level more specific than the affected tooth. As shown in
Figure 8.1, at least four, hierarchical, levels of lesion site, affected tooth, individual, and
community characteristics (e.g., dental practitioner) must be accounted for. To handle such
Figure 8.1: Hierarchical structure of data in oral health research
type of data, multilevel models were first applied in 1991 for assessing the craniofacial
growth curves in orthodontics (Beek et al., 1991). Similarly, in Chapter 7, the data set used
has a two-level structure with patients being nested within the overarching practitioner
taxon. Therefore, a two-level logistic regression model was adopted. However, the use of
multilevel machine learning models is still limited in predictive oral health research. Further
developments in this field of research are crucial to enable the analysis of hierarchical oral
health data using machine learning.
Data with an imbalanced outcome distribution
As shown in Chapter 7, the distribution of the real-world oral health outcome data is
usually imbalanced (there exist both minority and majority categories for positive and
negative observations). Usually, the population at high risk of adverse outcomes tend to be
in the minority category. A recent study has found that when the outcome distribution is
imbalanced, misclassification of the binary outcome is more likely to occur in the minority
than in the majority category (Banerjee et al., 2018). Therefore, for this type of data,
evaluating the models’ ability to detect the minority class is more important than predicting
both minority and majority categories. To address this, in Chapter 7, the imbalance of the
outcome was accounted for by applying an appropriate performance measure - the AUPRC
(Saito and Rehmsmeier, 2015). Studies have also shown that the imbalance of outcome
distribution presents a barrier to the generalisability of results from a particular algorithm
and a particular population to other populations (Kim, 2007; Zhang et al., 2010). Therefore,
further investigation regarding machine learning is required to effectively analyse data
with imbalanced outcome distribution.
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Interpretability and transparency of machine learning models
In clinical settings, machine learning algorithms raise concerns due to a lack of
transparency (Rudin and Radin, 2019). More specifically, if the connection between the
model’s input (the predictors) and output (the predicted outcome) is not knowable (hidden
inside a ‘black box’), then the question ‘How can the models be trusted?’ naturally
follows (Baselli et al., 2020; Miller, 2019; Zihni et al., 2020). In statistical models (e.g.,
linear and logistic regression models), interpretation of the statistical functions and how
variables are interrelated to construct the final model are readily appreciated. However,
when questions such as ‘Is the model interpretable at every step, or with regards to its
sub-components?’ as asked, some machine learning models provide no answer because
they do not decompose the analytical process into steps that can be agreed upon (Ahmad
et al., 2018). Improving process interpretability, therefore, presents an important challenge
for machine learning models.
In summary, the application of machine learning in oral health research faces various
challenges. Some of them cannot be addressed solely through the evolution of algorithms,
and there is a need for effective interdisciplinary collaboration between experts in various
fields. In doing so, it is possible to ask important questions, concerning appropriate study
design, standardised data collection, and suitable data analysis approaches.
8.3 Strengths and contributions
The primary strength of this thesis is that to the best of the our knowledge, this is the first
PhD project that comprehensively assesses the quality of oral health prediction modelling
studies since the development of PROBAST and TRIPOD instruments. Following this,
Chapter 5 provides recommendations to address multiple sources of bias that might arise
during prediction modelling. More importantly, different techniques have been adopted
to demonstrate, in Chapters 6 and 7, how some of these biases can be incorporated into
prediction modelling.
The second strength of this thesis lies in the use of the selected data sets. There
are two major advantages for using the data sets from SEER and DPBRN: 1) The two
cohorts were recruited from large and diverse populations of dental practitioners and
patients. This allows for rapid accrual of participants. 2) Both cohorts represent multiple
geographic and ethnic context within the US. This allows for the potential generalisability
of the results to a broader target population of interest.
The third strength of this thesis relates to its strict adherence to the most contem-
porary methodological standards outlined by the PROBAST group for clinical prediction
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modelling, as well as the TRIPOD reporting guidelines. The methodology used in this
thesis reflects the efforts to account for missing data (see examples in Chapters 6 and 7),
unmeasured predictors (see an example in Chapter 6), and selection of predictors into the
final models (see an example in Chapter 7), in both the machine learning as well as the
statistical models.
The fourth strength of this thesis is that the discussion on the common issues of
prediction modelling and machine learning extends beyond the field of oral health research.
These considerations can be generalised to other disciplines in broader health and medical
science.
Finally, from a clinical dentistry and oral health perspective, the models devel-
oped in this thesis hold the potential to assist in real-life dental practice. For example,
an attempt has been made to translate the products of this research into clinical use by
developing an online calculator for informing estimates of the risk of death due to oral and
pharyngeal cancers.
8.4 Limitations
The limitations of the four studies conducted as parts of this project are discussed in each
individual chapter. The following three points briefly discuss the overall limitations of the
conduct of this PhD project.
• In the empirical analysis (Chapters 6 and 7), each prediction models was limited
to the specific population upon which it was developed or validated. As a result,
external validation utilising a different time, population, and setting may demonstrate
a decline in model performance. Further validation and possibly re-calibration to
other populations is important. It should also be assured that the prediction models
have appropriate influences on clinical decision-making, which usually requires
an impact analysis by means of randomised controlled trials. Neither of these
requirements has been fulfilled by this thesis and must be addressed in future studies.
• Some of the empirical analyses were limited by the pre-specified statistical packages
in R. For example, in Chapter 7, when the LASSO was conducted for variable
selection using the R package ‘glmmLASSO’, AUROC was adopted as a loss function.
Since the data set has an imbalanced outcome distribution, the AUPRC may be a
better replacement to AUROC. However, creating a new statistical method that
incorporates AUPRC with LASSO extends beyond the thesis, for this reason, we
limited our analysis to the available statistical software, and further research is
needed to address this methodological issue.
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• A further concern regarding the empirical prediction analysis is the quality of the
data (e.g., the existence of measurement errors). Some of the data used in this
thesis were collected using questionnaires; thus, the measurement of predictors may
vary between investigators and studies. However, this thesis did not incorporate
methods to address bias due to measurement error. Nevertheless, and as noted in the
individual chapters, the study findings should be interpreted with caution due to the
presence of measurement errors in self-reported and clinical record data sets.
• Measuring Hispanic identify has proved challenging for research, as the Hispanic
individuals living in the US are cultural- and ethnical-diverse populations. The
imputation of such a fuzzy concept can be spurious, this is in part because grouping
together diverse racial backgrounds and nationalities into a single group masks
the difference among them (Song, 2009). Therefore, we need more geographical,
historical, epidemiological, and socio-political understanding of this group before
aggregating them as Hispanic. Alternatively, using the family’s country of origin
(such as "Mexican", "Cuban", "Dominican") over pan-ethnic terms can be an option
to describe their identity (Taylor et al., 2012).
8.5 Implications and future directions
In the context of these study limitations, there remain a number of implications for future
research.
• At the time when we were conducting the systematic reviews, we only had access to
PRISMA 2009 guidelines. It is for this reason in this thesis we followed PRISMA
2009 guidelines. However, in March 2021, the PRISMA 2020 statement was
published (Page et al., 2021). For those who are conducting systematic reviews are
advised to follow the up-to-date guidelines for transparent and complete reporting,
thus facilitating evidence-based decision making.
• PROBAST could be updated to account for sources of bias such as measurement
error. Additionally, some of the PROBAST items should be considered and revised
where necessary. For example, PROBAST item 4.4 suggests that multiple imputa-
tion is the only valid method to handle missing data regardless of the nature and the
extent of the missing data. However, this may not always be the case. Recent evi-
dence in the published literature provides practical guidelines regarding the effective
management and reporting of missing data in observational studies (Harrell Jr, 2015;
Hughes et al., 2019; Lee et al., 2021).
• Future research can validate, update, and test the clinical impacts of the models
developed in this thesis. For example, based on the prognostic models of oral and
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pharyngeal cancers in Chapter 6, further research could be conducted to explore new
prognostic factors that may improve the accuracy of survival prediction. Moreover,
risk prediction strategies, in combination with medically relevant images (e.g.,
radiology images and histopathology slides) and ‘advanced’ learning algorithms
(e.g., deep learning), can also be explored to provide information on the diagnosis
and prognosis of oral diseases.
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8.6 Concluding remarks
The significance of this research project is twofold. First, this research develops and
presents prediction models that may be of clinical use for various oral conditions. Second,
this project represents an attempt to standardise the conduct of this type of study in oral
health research. The main conclusions from this thesis are:
• Various clinical prediction models were identified in the major fields of oral health,
and their quality was examined using the latest guidelines. This research has found
that ‘high’ quality prediction models remain scarce in oral health. Future prediction
modelling studies should follow the appropriate methodological standards, including:
i) pre-specification of predictors using clinical expertise and the best available
knowledge in the literature, ii) consideration of missing data management and
variable selection, iii) use of appropriate models to manage the data complexity
(e.g., competing risk and multilevel data structures), iv) consideration of the internal
validity and external validity of the developed models, and v) improvement in the
completeness of study reporting.
• Chapter 5 provides suggestions for incorporating multiple sources of bias in pre-
diction modelling. These suggestions were applied in Chapters 6 and 7 to develop
reliable prediction tools for the diagnosis and prognosis of oral conditions. These
tools hold the potential to benefit clinical practice. However, multi-centre studies are
required to further refine these models and to confirm their predictive performance
and reliability. For future prediction modelling research, it is important that data
analysts work towards minimising bias, regardless of the areas where the models are
employed.
• Machine learning algorithms provide alternatives to statistical models for oral health
prediction purposes and have been successfully applied through the empirical analy-
ses of Chapters 6 and 7. The use of machine learning may assist in the incorporation
of data complexities such as hierarchical data structures and the selection of predic-
tors from a large number of variables.
• Clinical prediction modelling research has the potential to benefit health care activi-
ties. However, studies should be conducted with cautions. For example, when using
clinical information data sets of great size and complexity (e.g., data derived from
electronic health records) for model development, consideration could be made to
avoid the inclusion of sociodemographic characteristics in modelling, aiming to ex-
clude unhelpful extraneous data, thereby reducing the risks of potential gender-based
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Chapter 4 Supplement 1. Search strategy 
 




(((("periodontitis/epidemiology"[mh:noexp] OR "periodontitis"[tiab] OR “chronic 
periodontitis/epidemiology”[mh:noexp] OR “gingivitis”[mh:noexp] OR “tooth loss”[mh:noexp] OR “tooth 
loss”[tiab] OR “tooth mobility”[mh:noexp] OR “tooth mobility” OR “clinical attachment loss”[tiab] OR “alveolar 
bone loss”[tiab] OR “probing depth”[tiab])) AND (“forecasting”[mh] OR forecast*[tiab] OR predict*[tiab] OR 
“incidence”[mh] OR “incidence”[tiab] OR “progression”[tiab] OR “disease progression/epidemiology”[mh] OR 
“risk assessment/epidemiology”[mh] OR “risk assessment”[tiab] OR “risk factors”[mh] OR “risk factors”[tiab])) 
AND (“Adult”[mh] OR adult*[tiab] OR “population”[mh] OR “population”[tiab] OR “Adolescent”[mh] OR 
“adolescent*”[tiab])) AND (“cohort studies”[mh] OR “cohort”[tiab] OR “longitudinal studies”[mh] OR 
“longitudinal”[tiab] OR “prospective studies”[mh] OR “prospective”[tiab] OR “follow-up studies”[mh] OR 
“follow up”[tiab] OR “retrospective studies”[mh] OR “retrospective”[tiab]) 
Embase #1 AND #2 AND #3 AND #4 
#1: periodontitis/de OR "chronic periodontitis"/de OR gingivitis/exp OR “tooth loss”:ti,ab OR “tooth 
mobility”:ti,ab 
#2: “prediction and forecasting”/de OR prediction/de OR ”predictive value”/de OR forecasting/de OR 
Incidence/de OR incidence:ti,ab OR progression:ti,ab OR “risk assessment”/de OR risk:ti,ab OR “risk factor”/de 
#3: Adult/de OR aged/exp OR adult*:ti,ab OR population/de OR “aged people”:ti,ab OR “aged person”:ti,ab OR 
elderly:ti,ab 
#4: “longitudinal study”/de OR longitudinal:ti,ab  OR “prospective study”/de OR prospective:ti,ab OR 






( DE periodontitis OR TI  periodontitis OR AB periodontitis OR DE gingivitis OR TI gingivitis OR AB gingivitis 
OR TI “tooth loss” OR AB “tooth loss” OR DE “tooth loss” OR DE “tooth mobility” OR TI “tooth mobility” OR 
AB “tooth mobility” ) AND ( DE forecasting OR TI forecast* OR AB forecast* OR TI predict* OR AB predict* 
OR DE “disease incidence” OR TI incidence OR AB incidence OR TI progression OR AB progression OR DE 
“disease progression” OR DE “risk assessment” OR TI risk OR AB risk OR DE “disease risk factors” ) AND 
( DE Adults OR TI adult* AB adult* OR TI population OR AB population ) AND ( DE “cohort analysis” OR TI 
cohort OR AB cohort OR DE “longitudinal method” OR TI  longitudinal OR AB longitudinal OR DE 
“prospective studies” OR TI prospective OR AB prospective OR DE “retrospective studies” OR TI retrospective 
OR AB retrospective OR "follow-up studies (Medicine)" ) 
Scopus ( ( TITLE-ABS-KEY ( periodontitis  OR  {chronic periodontitis}  OR  gingivitis  OR  {tooth loss}  OR  {tooth 
mobility} )  AND  TITLE-ABS-KEY ( predict*  OR  forecast*  OR  incidence  OR  progression  OR  {risk 
assessment}  OR  {risk factor} )  AND  TITLE-ABS-KEY ( {cohort study}  OR  {cohort 
studies}  OR  {longitudinal study}  OR  {longitudinal studies}  OR  {prospective study}  OR  {prospective 
studies}  OR  {retrospective study}  OR  {retrospective studies}  OR  {follow up}  OR  {follow-
up} ) ) )  AND  ( ( TITLE ( adult  OR  population )  OR  ABS ( adult  OR  population ) ) ) 
Web of 
Science 
TS= (periodontitis OR “chronic periodontitis” OR gingivitis OR “tooth loss” OR “tooth mobility”) AND TS= 
(Predict* OR forecast* OR Incidence OR progression OR “risk assessment” OR “risk factor”) AND TS= (Adult 
OR population) AND TS= (“cohort study” OR “cohort studies” OR “longitudinal study” OR “longitudinal 
studies” OR “prospective study” OR “prospective studies” OR “retrospective study” OR “retrospective studies” 
OR “follow up” OR “follow-up”) 
ProQuest all(periodontitis OR “chronic periodontitis” OR gingivitis OR “tooth loss” OR “tooth mobility”) AND 
all(Predict* OR forecast* OR Incidence OR progression OR “risk assessment” OR “risk factor”) AND all(Adult 
OR population) AND all(“cohort study” OR “cohort studies” OR “longitudinal study” OR “longitudinal studies” 
OR “prospective study” OR “prospective studies” OR “retrospective study” OR “retrospective studies” OR 
“follow up” OR “follow-up”) 
  
Chapter 4 Supplement 2. CHARMS checklist 
 
Source:  Moons KGM, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, et al. (2014) Critical Appraisal and Data Extraction for 
Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist. PLoS Med 11(10): e1001744. 
doi:10.1371/journal.pmed.1001744. assessment scale (Cohort study).
Domain Key items Reported 
on page # 
Source of data Source of data (e.g., cohort, case-control, randomized trial participants, or registry data)  
Participants Participant eligibility and recruitment method (e.g., consecutive participants, location, number of 
centers, setting, inclusion and exclusion criteria) 
 
Participant description  
Details of treatments received, if relevant  
Study dates  
Outcome(s) to be 
predicted 
Definition and method for measurement of outcome  
Was the same outcome definition (and method for measurement) used in all patients?  
Type of outcome (e.g., single or combined endpoints)  
Was the outcome assessed without knowledge of the candidate predictors (i.e., blinded)?  
Were candidate predictors part of the outcome (e.g., in panel or consensus diagnosis)?  
Time of outcome occurrence or summary of duration of follow-up  
Candidate 
predictors  
(or index tests) 
Number and type of predictors (e.g., demographics, patient history, physical examination, additional 
testing, disease  characteristics) 
 
Definition and method for measurement of candidate predictors  
Timing of predictor measurement (e.g., at patient presentation, at diagnosis, at treatment initiation)  
Were predictors assessed blinded for outcome, and for each other (if relevant)?  
Handling of predictors in the modelling (e.g., continuous, linear, non-linear transformations or 
categorised) 
 
Sample size Number of participants and number of outcomes/events  
Number of outcomes/events in relation to the number of candidate predictors (Events Per Variable)  
Missing data Number of participants with any missing value (include predictors and outcomes)   
Number of participants with missing data for each predictor  
Handling of missing data (e.g., complete-case analysis, imputation, or other methods)  
Model 
development  
Modelling method (e.g., logistic, survival, neural network, or machine learning techniques)   
Modelling assumptions satisfied  
Method for selection of predictors for inclusion in multivariable modelling (e.g., all candidate 
predictors, pre-selection based on unadjusted association with the outcome) 
 
Method for selection of predictors during multivariable modelling (e.g., full model approach, 
backward or forward selection) and criteria used (e.g., p-value, Akaike Information Criterion) 
 





Calibration (calibration plot, calibration slope, Hosmer-Lemeshow test) and Discrimination   
(C-statistic, D-statistic, log-rank) measures with confidence intervals 
 
Classification measures (e.g., sensitivity, specificity, predictive values, net reclassification 




Method used for testing model performance: development dataset only (random split of data, 
resampling methods e.g. bootstrap or cross-validation, none) or separate external validation (e.g. 
temporal, geographical, different setting, different investigators) 
 
In case of poor validation, whether model was adjusted or updated (e.g., intercept recalibrated, 
predictor effects adjusted, or new predictors added) 
 
Results Final and other  multivariable models (e.g., basic, extended, simplified) presented, including 
predictor weights or regression coefficients, intercept, baseline survival, model performance 
measures (with standard errors or confidence intervals) 
 
Any alternative presentation of the final prediction models, e.g., sum score, nomogram, score chart, 
predictions for specific risk subgroups with performance 
 





Interpretation of presented models (confirmatory, i.e., model useful for practice versus exploratory, 
i.e., more research needed) 
 
Comparison with other studies, discussion of generalizability, strengths and limitations.  




Items to be considered for potential bias 
Participant 
selection 
Low risk of bias if  
- selection bias was unlikely,  
- study avoided inappropriate inclusions or exclusions,  
- in- and exclusion criteria were adequately described   
- participants were enrolled at a similar presentation of their disease   
- differences were accounted for by including appropriate predictors in the analysis   
Moderate risk of bias sample if  
- not satisfying one of the above or 
- no adequate description of recruitment of study sample 
- no adequate description of the sample for key predictors 
High risk of bias if both items were not adequately described 
Predictor 
assessment  
Low risk of bias if   
- predictor definitions were the same for all participants, 
- predictor measurement was blinded to outcome data 
- all predictors were available at the time the model is intended to be used 
- predictors were measured with valid and reproducible methods such that misclassification was limited  
and if 
- predictors were assessed in a similar way for all study participants 
Moderate risk of bias sample if one of the criteria was not satisfied 
High risk of bias if predictor assessment was not adequately described 
Outcome 
assessment 
Low risk of bias if outcome was pre-specified, measured with sufficient validity and reproducibility, measured in a 
similar way for all study participants and if the outcome was assessed independent from assessment of predictors. 
Note: for easy to obtain predictors such as gender, it is not possible to assess outcome independent of predictor 
information 
Moderate risk of bias if method for xxx 
High risk of bias if method for assessment of outcome was not adequately described 
Attrition Low risk of bias if   
- there was no loss-to-follow-up     
- there were no important differences on key characteristics between included participants and those who were lost-
to-follow-up or missing 
Moderate risk of bias if  
- loss-to-follow-up was lower than 20% and there were no important differences on key characteristics between 
included participants and those who were lost-to-follow-up or missing 
OR: 
- loss-to-follow-up was higher than 20% but missing data and loss-to-follow-up were imputed adequately or there 
were no important differences on key characteristics between included participants and those who were lost-to-
follow-up or missing 
High risk of bias if 
- loss-to-follow-up was higher than 20% and/or 
- there were important differences on key characteristics between included participants and those who were lost-to-
follow-up or missing 












Low risk of bias if 
- relevant aspects of analysis were described allowing to judge the quality of the analysis to be adequate  
- # outcome events per candidate predictor reasonable 
- missing data handled appropriately or no differences   
- predictors included independent of p-value 
- overfitting and optimism accounted for 
- weights assigned according to regression coefficient 
- calibration and discrimination assessed 
- recalibrated or described that it was not needed 
Moderate risk of bias if: 
- relevant aspects of analysis were described allowing to judge the quality of the analysis to be adequate and part or 
none of the model evaluation items were reported 
High risk of bias if 
- not satisfying any of the aspects under low risk of bias 
Source: Smit HA, Pinart M, Antó JM, et al. Childhood asthma prediction models: a systematic review. Lancet Respir Med 
2015;3(12):973-84. doi: 10.1016/S2213-2600(15)00428-2.   
 
 
Chapter 4 Supplement 4. Newcastle- Ottawa quality assessment scale (Cohort study) 
 
Note: A study can be awarded a maximum of one star for each numbered item within the Selection and Outcome 
categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _______________ (describe) in the community  
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes  
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate specific                   
control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ % (select an                     
adequate %) follow up, or description provided of those lost)  
c) follow up rate < ____% (select an adequate %) and no description of those lost 




Chapter 4 Supplement 5. Full texts exclusion reasons 
 
Study Reasons 
Chen 2010 Older adults with physical disabilities, cognitive impairment or mental disorders included. 
Chen 2011  Introduced a multidimensional risk assessment tool for longitudinal tooth loss. 
Costa 2011 Aimed at the influence of compliance in the progression of periodontitis and tooth loss. 
Costa 2012 Validation study. Aimed at investigating the association of PRA model with the recurrence of 
periodontitis and tooth loss. 
Eichnolz 2008 Validation study. The PRA score at the start of SPT was significantly associated with tooth loss. 
Genco 1998 Aimed at the association between stress and periodontal diseases, and presenting models explaining the 
mechanisms. 
Gillbert 2007 Prevalence prediction. Aimed at the relationship between self-reported status and outcome. 
Gilthorpe 2001   Aimed at introducing multilevel model and providing a new analytical way to longitudinal periodontal 
research. 
Gilthorpe 2003  
 
Presented a comprehensive multilevel model that describes the underlying progression of periodontal 
disease. 
Gregg 2007  Use baseline self-reported information predict longitudinal prevalence. 
Guarnizao 2014 Cross-sectional study. 
Heaton 2017 Used self-reported information predict prevalence. 
Hyun 2014 Screening model. 
Jansson 2002 Aimed at evaluating the influence of potential risk predictors/risk factors on the longitudinal marginal 
bone loss and tooth loss. No prediction model mentioned. 
Jansson 2008 Validation study. Aimed at evaluating PRA in periodontitis patients during SPT. 
LaMonte 2014 Completion of self-reported periodontal disease does not align with either the baseline or the follow-up. 
Leininger 2010 Updating study. Modified PRA to PRAS, and investigated the association between baseline periodontal 
risk assessment diagram surface (PRAS) and the outcomes. 
Lindskog 2010 
(Inflammatory) 
The predictive value for using inflammatory test predict periodontitis. The association between 
inflammatory tests with periodontitis outcome and some risk factors. 
Martin 2010  Validation study. Baseline disease score and risk score were significantly associated with tooth loss. 
Martin 2009  Validation study. Baseline disease score and risk score were significantly associated with tooth loss. 
Matuliene 2010 Validation study. Association between PRA risk level and periodontitis recurrence. 
Mcleod 1998 Aimed at evaluating the predictability of given prognosis on tooth loss. Retrospectively test the 
predictability of treatment prognosis by tooth loss measurement. 
Mdala 2014 Targeting on site-level. Use clinical attachment loss or pocket depth classify the progression sites. 
Compare two models. 
Nieri 2002 Indicate the predictors on patients, tooth, and sites level, the association between predictors and outcomes. 
There were some formulas, but no model predictive performance. 




Page 2003 Development and Validation study. Proposed PRC. Aimed at the association between baseline score and 
outcome. 
Page 2007 Updated PRC score. Adding disease severity score. 
Peres 2012 Aimed at testing the accuracy of three partial protocols in estimating the prevalence of periodontal 
outcomes. 
Reddy 2000 Targeting on site level. Use baseline clinical measurement such as plaque, gingival inflammation, 
attachment loss, and probing depth predict the regression, measured by digital subtraction radiography. No 
clustering of risk factors. 
Renvert 2014 Cross-sectional study. Use patient-based data (smoking habit, bleeding on probing, plaque score, and 
pocket depth) predict alveolar bone loss. 
Stoykova 2014  The association between each variables and outcomes. 
Teles 2016  Does not construct a model to predict disease. Applied linear mixed models on longitudinal data. 
Targeting on site-level instead of patient level. Used sex, age, baseline CAL to classify progression sites. 
Teles 2017 Description of periodontitis progression pattern. 
Tu 2004 Aimed at the application of multilevel model in periodontal research. 























Take drugs resulting 
in soft tissue 
reactions due to heat 
disease, diabetes, 
ulcers and anxiety; 
Regularly use 
mouthwash or rinse; 
BANA of 3 or 4; Baseline P.g. + at 2+%; 




Age; Perceived lack 
self-care; Don’t see 
friends and relatives  














less than 12 teeth 
Leite 
2017 
Model 1 Family income at 
birth;  Sex;  Number 
of people living in 
the house;  
Smoking; Diastolic 
blood pressure  
 
Proportion of teeth with pocket, bleeding or 
calculus;  Number of anterior teeth lost; 
Number of remaining teeth; Number of 
DMFT;  
  
Model 2 Sex; Family income 
at birth;  
BMI 
 
Number of posterior teeth lost; Proportion 
of teeth with pocket, bleeding or calculus;  
Number of remaining teeth;  Number of 
DMFT 
Model 3 Sex; Education; 
Family income at 
birth;  
BMI Frequency of tooth 
brushing 
Number of posterior teeth lost;   Proportion 
of teeth with pocket, bleeding or calculus;  
Number of sound teeth;  Number of anterior 
teeth lost;  
Model 4 Sex; Family income 













Age;  Family 
history of chronic 
periodontitis, 
Smoking; Systemic 
disease* and related 
diagnoses; Result of 
skin provocation 













periodontal care;  
Bacterial plaque (oral hygiene);  
Endodontic pathology;  FI;  Angular bony 
destruction;  Radiographic marginal bone 
loss;   PPD;  BOP;  Marginal dental 
restorations;  Increased tooth mobility; 







Age Smoking; Bruxism Severe periodontitis; baseline number of 
teeth; type of tooth; FI;  PPD; bone loss; 








Age; Sex; Race; Smoking; Diabetes; 
 
University of North Carolina-Periodontal 
profile class (UNC-PPC): IAL, direct 
attachment level, interproximal PPD, direct 
PPD, interproximal gingival recession, 
direct GR, BOP, GI, PI, decayed coronal 
surface, filled coronal surface, decayed root 
surface, filled root surface, 
presence/absence of full prosthetic crowns. 
 
 
* including diabetes, immunopathies and hematologic disorders, hereditary disorders relevant to formation and maintenance of 
connective tissue and bone, granulomatous disease, osteoporosis, renal disorders, inflammatory vascular disease, Sjo¨gren 
syndrome, and rheumatism.  
 
 











Beck 1994 L L L H M 
Leite 2017 M L L H M 
Lindskog 2010 L L L H M 
Martinez-Canut 
2018 
M L L M M 
Morelli 2018 L L L H M 
CHARMS checklist Criteria are listed in the appendix. CHARMS=Checklist for Critical Appraisal and Data Extraction for 
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not present at 
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-  Poor 
Leite 2017 
       
 - Good 
Lindskog 
2010 
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Chapter 4 Supplement 9. TRIPOD checklist for 5 selected studies 
 
Section/Topic  Page (in selected journals) 
  Beck 1994 Leight 2017 Lindskog 2010 Martinez-
Canut 2018 
Morelli 2018 
Title and abstract       
Title 1 468 731 584 46 148 
Abstract 2 468 731 584 46 148 
Introduction        
Background and objectives 3a 471 NP NP 47 NP 
 3b 471 732 585 47 149 
Methods       
Source of data 4a 472 732-733 585 47 149 
 4b 472 733 585 NP 149 
Participants 5a 472 733 585 47 149 
 5b NP NP 585 NP NP 
 5c n/a n/a n/a 47 n/a 
Outcome 6a 474 733, S. Table 2 586-587 50 150 
 6b NP NP NP NP NP 
Predictors 7a 473 S. table 1 586 47-48 150 
 7b NP NP NP NP NP 
Sample size  8 472 733 585 47 149 
Missing data 9 472 NP 587 NP NP 
Statistical analysis methods 10a 473-474 733 n/a NP NP 
 10b 475,477 733 n/a 48 NP 
 10c n/a n/a 585 n/a n/a 
 10d 474 736 587 48,50 150 
 10e n/a n/a NP n/a n/a 
Risk groups 11 473 NP NP NP NP 
Development vs. validation 12 n/a n/a NP 50 n/a 
Results       
Participants 13a 472 737 NP 47 NP 
 13b 474 734-735,737 587 NP 150 
 13c n/a n/a NP NP 153 
Model development 14a 474 NP n/a 48 NP 
 14b NP S. Table 5-11 589,591 49 151 
Model specification 15a NP 739 n/a 48 151 
 
 
 15b 476-477 737,739 n/a 48 151-152 
Model performance 16 476-477 738 587-590 50 152-153 
Model updating 17 n/a n/a NP n/a n/a 
Discussion       
Limitations 18 478 741 NP 52-53 155 
Interpretations 19a n/a n/a 591 NP n/a 
 19b 478 742 593 53 155 
Implications 20 NP 741 592 53-54 NP 
Other information       
Supplementary information 21 n/a 733-740 n/a 55 156 
Funding 22 478 742 592 54 155 




Chapter 4 Supplement 10. Criteria for TRIPOD checklist (Checklist of Items to Include When Reporting a Study 
Developing or Validating a Multivariable Prediction Model for Diagnosis or Prognosis) 
Section/Topic Item Development 
or Validation? 
Checklist Item 
Title and abstract    
Title 1 D;V Identify the study as developing and/or validating a multivariable prediction model, the target 
population, and the outcome to be predicted. 
Abstract 2 D;V Provide a summary of objectives, study design, setting, participants, sample size, predictors, 
outcome, statistical analysis, results, and conclusions. 
Introduction     
Background and 
objectives 
3a D;V Explain the medical context (including whether diagnostic or prognostic) and rationale for 
developing or validating the multivariable prediction model, including references to existing 
models. 
 3b D;V Specify the objectives, including whether the study describes the development or validation of the 
model, or both. 
Methods    
Source of data 4a D;V Describe the study design or source of data (e.g., randomized trial, cohort, or registry data), 
separately for the development and validation datasets, if applicable. 
 4b D;V Specify the key study dates, including start of accrual; end of accrual; and, if applicable, end of 
follow-up. 
Participants 5a D;V Specify key elements of the study setting (e.g., primary care, secondary care, general population) 
including number and location of centres. 
 5b D;V Describe eligibility criteria for participants. 
 5c D;V Give details of treatments received, if relevant. 
Outcome 6a D;V Clearly define the outcome that is predicted by the prediction model, including how and when 
assessed. 
 6b D;V Report any actions to blind assessment of the outcome to be predicted. 
Predictors 7a D;V Clearly define all predictors used in developing the multivariable prediction model, including how 
and when they were measured. 
 7b D;V Report any actions to blind assessment of predictors for the outcome and other predictors. 
Sample size  8 D;V Explain how the study size was arrived at. 
Missing data 9 D;V Describe how missing data were handled (e.g., complete-case analysis, single imputation, multiple 
imputation) with details of any imputation method. 
Statistical analysis 
methods 
10a D Describe how predictors were handled in the analyses. 
 10b D Specify type of model, all model-building procedures (including any predictor selection), and 
method for internal validation. 
 10c V For validation, describe how the predictions were calculated. 
 10d D;V Specify all measures used to assess model performance and, if relevant, to compare multiple 
models. 
 10e V Describe any model updating (e.g., recalibration) arising from the validation, if done. 
Risk groups 11 D;V Provide details on how risk groups were created, if done. 
Development vs. 
validation 
12 V For validation, identify any differences from the development data in setting, eligibility criteria, 
outcome, and predictors. 
Results    
Participants 13a D;V Describe the flow of participants through the study, including the number of participants with and 





Source: Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent Reporting of a multivariable prediction model for 
Individual Prognosis Or Diagnosis TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55-63. 
 13b D;V Describe the characteristics of the participants (basic demographics, clinical features, available 
predictors), including the number of participants with missing data for predictors and outcome. 
 13c V For validation, show a comparison with the development data of the distribution of important 
variables (demographics, predictors, and outcome). 
Model development 14a D Specify the number of participants and outcome events in each analysis. 
 14b D If done, report the unadjusted association between each candidate predictor and outcome. 
Model specification 15a D Present the full prediction model to allow predictions for individuals (i.e., all regression 
coefficients, and model intercept or baseline survival at a given time point). 
 15b D Explain how to use the prediction model. 
Model performance 16 D;V Report performance measures (with CIs) for the prediction model. 
Model updating 17 V If done, report the results from any model updating (i.e., model specification, model performance). 
Discussion    
Limitations 18 D;V Discuss any limitations of the study (such as nonrepresentative sample, few events per predictor, 
missing data). 
Interpretations 19a V For validation, discuss the results with reference to performance in the development data, and any 
other validation data. 
 19b D;V Give an overall interpretation of the results, considering objectives, limitations, results from similar 
studies, and other relevant evidence. 
Implications 20 D;V Discuss the potential clinical use of the model and implications for future research. 
Other information    
Supplementary 
information 
21 D;V Provide information about the availability of supplementary resources, such as study protocol, Web 
calculator, and datasets. 



















Incites journal citation report, Browse by category, Journals by rank, Choose ‘DENTISTRY, ORAL SURGERY 
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International 
journal of oral 
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Oral oncology 



















International Journal of 
Epidemiology 
Journal of Clinical 
Epidemiology 
Epidemiology 
European Journal of 
Epidemiology 
American Journal of 
Epidemiology 
Clinical epidemiology 
Annals of epidemiology 
Cancer epidemiology, 





Statistical methods in 
medical research 
Statistics in medicine 
The International Journal 
of Biostatistics 
 
Note: In three databases mentioned in Appendix table 1, biostatistics was not independent from general statistics field, thus we 




Chapter 5 Supplement 3. Search strategy 
 
 








("International journal of epidemiology"[Journal] OR "European journal of epidemiology"[Journal] OR 
"American journal of epidemiology"[Journal] OR "Epidemiology"[Journal] OR "Journal of clinical 
epidemiology"[Journal] OR "Clinical epidemiology"[Journal] OR "Annals of epidemiology"[Journal] OR 
"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer 
Research, cosponsored by the American Society of Preventive Oncology"[Journal] OR "International journal of 
oral science"[Journal] OR "Journal of public health dentistry"[Journal] OR "European journal of oral 
sciences"[Journal] OR "Community dentistry and oral epidemiology"[Journal] OR "clinical oral 
investigations"[Journal] OR "Journal of endodontics"[Journal] OR "Clinical oral implants research"[Journal] OR 
"Journal of prosthodontic research"[Journal] OR "Journal of dentistry"[Journal] OR "Journal of clinical 
periodontology"[Journal] OR "Journal of periodontology"[Journal] OR "Journal of dental research"[Journal] OR 
"Oral oncology"[Journal] OR "Caries research"[Journal]) AND (“forecasting”[mh] OR forecast*[tiab] OR 
predict*[tiab] OR diagnos*[tiab] OR prognos*[tiab]) AND ("2016/01/01"[Date - Publication] : 








("Biometrical journal. Biometrische Zeitschrift"[Journal] OR "Biostatistics (Oxford, England)"[Journal] OR 
"Biometrics"[Journal] OR "Biometrika"[Journal] OR "Statistics in medicine"[Journal] OR "Statistical methods in 
medical research"[Journal] OR "The international journal of biostatistics"[Journal]) AND (count[all] OR 
dental[tiab] OR dentist*[tiab] OR dentistry[mh] OR oral[All] OR mouth[All] OR tooth[All] OR teeth[All]) AND 
(“forecasting”[mh] OR forecast*[tiab] OR predict*[tiab] OR diagnos*[tiab] OR prognos*[tiab]) AND 
("2016/01/01"[Date - Publication] : "2018/12/31"[Date - Publication]) 
 
Note: search strategy for this systematic review consists of #1 and #2. In order to search prediction models in statistical journals, 




Chapter 5 Supplement 4. Answers for each signalling question in PROBAST for 34 studies 
 
 










Chapter 5 Supplement 5. Reasons for being answered “N/PN (No/Probably No)” for signalling question in PROBAST for 
34 studies 
 







Chapter 5 Supplement 6. Criteria for TRIPOD checklist (Checklist of Items to Include When Reporting a Study 
Developing or Validating a Multivariable Prediction Model for Diagnosis or Prognosis) 
Section/Topic Item Development or 
Validation? 
Checklist Item 
Title and abstract    
Title 1 D;V Identify the study as developing and/or validating a multivariable prediction model, the target 
population, and the outcome to be predicted. 
Abstract 2 D;V Provide a summary of objectives, study design, setting, participants, sample size, predictors, 
outcome, statistical analysis, results, and conclusions. 
Introduction     
Background and 
objectives 
3a D;V Explain the medical context (including whether diagnostic or prognostic) and rationale for 
developing or validating the multivariable prediction model, including references to existing 
models. 
 3b D;V Specify the objectives, including whether the study describes the development or validation of the 
model, or both. 
Methods    
Source of data 4a D;V Describe the study design or source of data (e.g., randomized trial, cohort, or registry data), 
separately for the development and validation datasets, if applicable. 
 4b D;V Specify the key study dates, including start of accrual; end of accrual; and, if applicable, end of 
follow-up. 
Participants 5a D;V Specify key elements of the study setting (e.g., primary care, secondary care, general population) 
including number and location of centres. 
 5b D;V Describe eligibility criteria for participants. 
 5c D;V Give details of treatments received, if relevant. 
Outcome 6a D;V Clearly define the outcome that is predicted by the prediction model, including how and when 
assessed. 
 6b D;V Report any actions to blind assessment of the outcome to be predicted. 
Predictors 7a D;V Clearly define all predictors used in developing the multivariable prediction model, including how 
and when they were measured. 
 7b D;V Report any actions to blind assessment of predictors for the outcome and other predictors. 
Sample size  8 D;V Explain how the study size was arrived at. 
Missing data 9 D;V Describe how missing data were handled (e.g., complete-case analysis, single imputation, multiple 
imputation) with details of any imputation method. 
Statistical analysis 
methods 
10a D Describe how predictors were handled in the analyses. 
 10b D Specify type of model, all model-building procedures (including any predictor selection), and 
method for internal validation. 
 10c V For validation, describe how the predictions were calculated. 
 10d D;V Specify all measures used to assess model performance and, if relevant, to compare multiple 
models. 
 10e V Describe any model updating (e.g., recalibration) arising from the validation, if done. 
Risk groups 11 D;V Provide details on how risk groups were created, if done. 
Development vs. 
validation 
12 V For validation, identify any differences from the development data in setting, eligibility criteria, 
outcome, and predictors. 
Results    
Participants 13a D;V Describe the flow of participants through the study, including the number of participants with and 





Source: Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent Reporting of a multivariable prediction model for 
Individual Prognosis Or Diagnosis TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55-63. 
 
 13b D;V Describe the characteristics of the participants (basic demographics, clinical features, available 
predictors), including the number of participants with missing data for predictors and outcome.  
 13c V For validation, show a comparison with the development data of the distribution of important 
variables (demographics, predictors, and outcome). 
Model development 14a D Specify the number of participants and outcome events in each analysis. 
 14b D If done, report the unadjusted association between each candidate predictor and outcome. 
Model specification 15a D Present the full prediction model to allow predictions for individuals (i.e., all regression 
coefficients, and model intercept or baseline survival at a given time point). 
 15b D Explain how to use the prediction model. 
Model performance 16 D;V Report performance measures (with CIs) for the prediction model. 
Model updating 17 V If done, report the results from any model updating (i.e., model specification, model performance). 
Discussion    
Limitations 18 D;V Discuss any limitations of the study (such as nonrepresentative sample, few events per predictor, 
missing data). 
Interpretations 19a V For validation, discuss the results with reference to performance in the development data, and any 
other validation data. 
 19b D;V Give an overall interpretation of the results, considering objectives, limitations, results from similar 
studies, and other relevant evidence. 
Implications 20 D;V Discuss the potential clinical use of the model and implications for future research. 
Other information    
Supplementary 
information 
21 D;V Provide information about the availability of supplementary resources, such as study protocol, Web 
calculator, and datasets. 
Funding 22 D;V Give the source of funding and the role of the funders for the present study. 
 
 
Chapter 5 Supplement 7. Signalling questions for PROBAST 
 
1. Participants  2. Predictors  3. Outcome  4. Analysis 
Signalling questions    
1.1. Were appropriate data 
sources used, e.g., cohort, RCT, 
or nested case–control study 
data? 
2.1. Were predictors defined and 
assessed in a similar way for all 
participants? 
3.1. Was the outcome 
determined appropriately? 
4.1. Were there a reasonable 
number of participants with the 
outcome? 
1.2. Were all inclusions and 
exclusions of participants 
appropriate? 
2.2. Were predictor assessments 
made without knowledge of 
outcome data? 
3.2. Was a prespecified or 
standard outcome definition 
used? 
4.2. Were continuous and 
categorical predictors handled 
appropriately? 
 2.3. Are all predictors available 
at the time the model is intended 
to be used? 
3.3. Were predictors excluded 
from the outcome definition? 
4.3. Were all enrolled 
participants included in the 
analysis? 
  3.4. Was the outcome defined 
and determined in a similar way 
for all participants? 
4.4. Were participants with 
missing data handled 
appropriately? 
  3.5. Was the outcome 
determined without knowledge 
of predictor information? 
4.5. Was selection of predictors 
based on univariable analysis 
avoided?† 
  3.6. Was the time interval 
between predictor assessment 
and outcome determination 
appropriate? 
4.6. Were complexities in the 
data (e.g., censoring, competing 
risks, sampling of control 
participants) accounted for 
appropriately? 
   4.7. Were relevant model 
performance measures evaluated 
appropriately? 
   4.8. Were model overfitting, 
underfitting, and optimism in 
model performance accounted 
for?† 
   4.9. Do predictors and their 
assigned weights in the final 
model correspond to the results 
from the reported multivariable 
analysis?† 
 
PROBAST = Prediction model Risk Of Bias ASsessment Tool.  † Development studies only.  
Source: Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS et al. (2019). PROBAST: A Tool to Assess the Risk of Bias 




Chapter 5 Supplement 8: Guidance notes for rating risk of bias using PROBAST 
 
https://www.probast.org/translations/  
Source: 1) Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS et al. (2019). PROBAST: A Tool to Assess Risk of Bias 
and Applicability of Prediction Model Studies: Explanation and Elaboration. Ann Intern Med 170(1):W1-W33.   
2) Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS et al. (2019). PROBAST: A Tool to Assess the Risk of Bias and 









Teles et al, 2016  No multivariate model was constructed. Applied linear mixed models on longitudinal data. 
Targeting on site-level instead of patient level. Used sex, age, baseline CAL to classify 
progression sites. 
Wostmann et al, 2017 Created an assessment tool (chewing efficiency test) for dental treatment needs, targeting on 
non-dental staff. 
Nasrin et al, 2017 Proposed a new staging system and then applied to an existing dataset. 
Silveira et al, 2016 No model established, aimed to identify the association between risk factors and dental 
outcomes. 
Jäger  et al,  2016  Outcome was demanding of dentists and dental device. 
Abreu-Placeres et al,  2018  Outcome was caries management for dentists. 
Baelum et al, 2016 Different classification tool were compared in terms of if the same predictors were identified 
when different outcomes were used. Models were built based on different definition of outcome 
measurements. 
Castilho et al, 2016  Models were on tooth level. Model were built to detecting occlusal caries on permanent molars. 
Joda et al, 2017  Validate a diagnostic tool to classify fixed implant restorations by assigning 44 dentists 
applying the tool on 10 cases, and then compare the consistency.  
Håkansson et al, 2017  Not distinguish head and neck cancer from oral cavity and pharyngeal cancer (OCPC). 
Ashizawa et a,l 2017  Not distinguish head and neck cancer from OCPC. 
Rasmussen et al, 2017  Not distinguish head and neck cancer from OCPC. 
Ou et al, 2017  Not distinguish head and neck carcinoma from OCPC. 
Morelli et al, 2017 Generated a new classification and definition of periodontal disease. 
Chatzopoulos et al, 
2018 
Validated the predictive value of ‘predictors’, no multivariate model was constructed. 
Fischer et al, 2018 Validated a clinical tool to differentiate between thin, moderate, and thick gingival biotypes. 
 
 
Chapter 5 Supplement 10. Study characteristics description 
 
Study Characteristics 
Most studies were conducted in high-income countries (n=27), were patient oriented (n=26) concerned diagnosis of 
oral conditions (n=24) and used administrative data sources (n=28). Ten studies focused on prognosis, including 
progression (n=2), survival (n=7) and treatment outcome (n=1). Data were from cross-sectional studies (n=12), 
retrospective cohorts (n=10), prospective cohorts (n=10), case-control (n=1) and RCT (n=1).  
 
Oral health outcomes 
The most investigated outcomes were periodontal disease (n=9 plus 5 for tooth loss) and oral cancer (n=9). Other 
outcomes included implantitis (n=3), dental caries (n=3), dental pain (n=2), mucositis (n=1), periapical cyst (n=1), 
and oromandibular dystonia (n=1). 
 
Predictors Used 
Final prediction models included between 3 and 23 predictors. As shown in Appendix 11, popular predictors for 
periodontal outcomes were smoking (n=13), age (n=11), sex (n=11), general health conditions (n=9), and 
socioeconomic indicators (n=7). Regarding oral cancer survival models, popular prognostic factors included age 
(n=12), sex (n=7), T (tumor size) (n=7) and N (nodule involvement) category (n=9). In addition, studies included 
biomarkers such as metabolites (n=2), DNA (n=5), and other protein molecules (n=3) as predictors of oral cancer. 
 
Model Derivation 
Among the 24 model development studies, logistic regression (n=13), Cox proportional hazards regression (n=4), 
least absolute shrinkage and selection operator (LASSO) regression (n=1), decision tree (n=4), neural network 
(n=2), support vector machine (n=2), recursive partitioning analysis (n=1) were adopted.  
 
Model Presentation 
Complete regression formula, including regression coefficients and intercepts were presented in 29 models (out of 
the 58 models identified corresponding to 51%). Another 18 models (31%) were presented as web-based calculator 
or mobile application (n=4), questionnaires (n=6), scoring system or chart (n=3), nomogram (n=4) or cariogram 
(n=1). Machine learning algorithms were presented in 9 models (16%), including decision tree structure (n=5), 





Chapter 5 Supplement 11. Variables included in periodontal- and oral cancer-related prediction models 
 
 
 Study  
(Author 
/Year) 

















Periodontal disease Age, sex, four questionnaire items 
Eke 2016 Periodontal disease Age, sex, race, smoking, poverty 
Lee 2018 Periodontal disease 
Age(3), sex(3), smoking(3), residence area(3), education(3), stress(3), alcohol(3), 
hyperlipidaemia(3) 
Leite 2017 Periodontal disease 
Sex (4), family income at birth (4), education, number of people living in the house, smoking, BMI 
(2), diastolic blood pressure (2), frequency of tooth brushing, proportion of teeth with pocket (3), 
bleeding or calculus (4);  number of teeth lost (4); number of DMFT (2) 
Carra 2018 Periodontal disease 12 questionnaire items 
Heaton 
2017 




8  metabolites (Ornithine, 5-Oxoproline, Valine, Proline, Spermidine, Hydrocinnamate, Histidine, 
Cadaverine) 




Tooth loss  
Age(2), smoking(2), bruxism(2), severe periodontitis(2); number of teeth loss(2); type of tooth(2); 




Tooth loss  
Age, smoking, bruxism, severe periodontitis; number of teeth loss; type of tooth; furcation 
involvement; PPD; bone loss; mobility; crown-to-root ratio 
Meisel 2018 Tooth loss ǂ 
Age, sex, education, financial condition, smoking, antidiabetic drug, mobile dentures, number of 
dental visits, oral health rating 
Morelli 
2018 
Tooth loss and 
periodontitis 
progression   
Age, sex, race, smoking, diabetes, University of North Carolina-Periodontal profile class (UNC-
PPC): IAL, direct attachment level, interproximal PPD, direct PPD, interproximal gingival 
recession, direct GR, BOP, GI, PI, decayed coronal surface, filled coronal surface, decayed root 
surface, filled root surface, presence/absence of full prosthetic crowns. 
Schwendick
e 2018 
Tooth loss ǂ 
Age, sex, smoking (3), systemic diseases (2), financial condition, PPD (3), bone loss (5), FI (2), 
calculus (2), crown-root ratio (2), mobility (2), aesthetic zone involvement, adherent to recall 
interval, root-canal filling 
Gul 2016 Treatment of 
periodontal disease 










OC survival ( among 
HPV-positive TSCC 
and BOTSCC patients) 
Þ 
Age, diagnosis, sex, T category and N category, M category, overall stage, CD8+ TILs, HPV16 E2 
and E5 mRNA expression, treatment 
Bobdey 
2018 
OC survival (among 
surgically treated T4 
buccal mucosa cancer 
patients) õ 
Sex, invasion, lymph node involvement, bone infilteration 
OuYang 
2017 
OC survival (among 
NPC) Þ 
Age (2), sex (2), BMI, T category (2), N category (2), EBV DNA (2), CRP (2), LDH (2), Hb 
Prince 2016 OC survival õ Age (5), sex(3), race(4), comorbidity(3), tumour site(4),  T category (2), N category (3), M 
category, invasion, Grade (2), smoking, histology, prior tumour, ECS  
 
 
Note: CPI: Community periodontal index; PPD: Probing pocket depth; OC: oral cancer; Þ: Progression-free survival, õ: Overall survival; NPC: 
Nasopharyngeal carcinoma; HPV: Human papilloma virus; EVB: Epstein-Barr virus; ǂ: Original articles reported outcome as tooth loss, 
however, the authors assumed tooth loss due to periodontal disease, as the predictors are periodontal-related, and papers are published on 
periodontal journals. 
  
Zhang 2017 OC survival Þ Age, P53, CA9, degree of dysplasia 
Xu 2017 OC survival (among 
NPC) Þ õ 
Age (2), histology (2), T category (2), N category (2), EBV DNA(2), neutrophil-lymphocyte ratio  
Peng 2018 OC survival (among 
NPC) Þ 
Nodal category, overall stage,  EVB DNA 
Rao 2016 Oral cancer  Smoking, chewing tobacco, quid with tobacco, quid without tobacco, alcohol consumption, family 




Recurrence of laryngeal 
glottic cancer 
Age, lymph node involvement, alcohol consumption, overall stage 
Orlandi 
2018 
Mucositis (among NPC) Oral cavity EUD, Combined parotid glands EUD, BMI 
 
 
Chapter 5 Supplement 12. Threats to reproducible science 
 
Appendix Figure 1. Threats to reproducible science. Threats to reproducible science. An idealized version of the 
hypothetico-deductive model of the scientific method is shown. Various potential threats to this model exist (indicated in red), 
including lack of replication, hypothesizing after the results are known (HARKing), poor study design, low statistical power, 
analytical flexibility, P-hacking, publication bias and lack of data sharing. Together these will serve to undermine the 
robustness of published research, and may also impact on the ability of science to self-correct. 
Source: Munafò MR, Nosek BA, Bishop DVM, Button KS, Chambers CD, Percie du Sert N, Simonsohn U, Wagenmakers E-J, 
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Chapter 6 Supplement 1. Demographic characteristics of patients with oral and pharyngeal cancers in SEER cohorts (for 
imputed data) 
 
 3-year cohort  5-year cohort  
 Imputed data  
(n=21,154) 
Imputed data  
(n=21,000) 
Death status   
Alive 13494 (63.8%) 12347 (58.8%) 
Dead 7660 (36.2%) 8653 (41.2%) 
Survival months   
Mean (SD) 65.9 (44.8) 66.0 (44.9) 
Median [min, max] 76.0 [2.00, 143] 77.0 [2.00, 143] 
Age(years)   
Mean (SD) 59.1 (12.3) 59.1 (12.3) 
Median [min, max] 58.0 [18.0, 105] 58.0 [18.0, 105] 
Sex   
Female 5451 (25.8%) 5398 (25.7%) 
Male 15703 (74.2%) 15602 (74.3%) 
Race   
American Indian/Alaska native 112 (0.5%) 110 (0.5%) 
Asian or Pacific Islander 1349 (6.4%) 1335 (6.4%) 
Black 2057 (9.7%) 2044 (9.7%) 
White 17636 (83.4%) 17511 (83.4%) 
Marital status   
Divorced 2746 (13.0%) 2701 (12.9%) 
Married (including common law) 12188 (57.6%) 12108 (57.7%) 
Separated 254 (1.2%) 254 (1.2%) 
Single (never married) 4160 (19.7%) 4123 (19.6%) 
Widowed 1806 (8.5%) 1814 (8.6%) 
 
  
Chapter 6 Supplement 2. Tumour-related characteristics of patients with oral and pharyngeal cancers in SEER cohorts 
(for imputed data) 
 
 3-year cohort  5-year cohort  
 Imputed data  
(n=21,154) 
Imputed data  
(n=21,000) 
Differentiation grade   
Well differentiated; grade I 2911 (13.8%) 2890 (13.8%) 
Moderately differentiated; grade II 9801 (46.3%) 9768 (46.5%) 
Poorly differentiated; grade III 7893 (37.3%) 7805 (37.2%) 
Undifferentiated; anaplastic; grade IV 549 (2.6%) 537 (2.6%) 
T category   
T1 5425 (25.6%) 5389 (25.7%) 
T2 5544 (26.2%) 5500 (26.2%) 
T3 2209 (10.4%) 2202 (10.5%) 
T4 3659 (17.3%) 3637 (17.3%) 
Tx 4317 (20.4%) 4272 (20.3%) 
N category   
N0 7652 (36.2%) 7583 (36.1%) 
N1 4285 (20.3%) 4255 (20.3%) 
N2 7227 (34.2%) 7191 (34.2%) 
N3 836 (4.0%) 831 (4.0%) 
Nx 1154 (5.5%) 1140 (5.4%) 
M category   
M0 19075 (90.2%) 18944 (90.2%) 
M1 809 (3.8%) 806 (3.8%) 
Mx 1270 (6.0%) 1250 (6.0%) 
Stage   
I 3489 (16.5%) 3436 (16.4%) 
Ii 2405 (11.4%) 2337 (11.1%) 
Iii 3708 (17.5%) 3689 (17.6%) 
Iv 11552 (54.6%) 11538 (54.9%) 
Lymph nodes removed   
None 13160 (62.2%) 13063 (62.2%) 
Yes 7994 (37.8%) 7937 (37.8%) 
Tumour size   
0~1cm 2746 (13.0%) 2684 (12.8%) 
1~2cm 4857 (23.0%) 4878 (23.2%) 
2~3cm 5433 (25.7%) 5405 (25.7%) 
3~4cm 3704 (17.5%) 3680 (17.5%) 
4~5cm 2455 (11.6%) 2410 (11.5%) 
5~6cm 1009 (4.8%) 1019 (4.9%) 
6~7cm 463 (2.2%) 461 (2.2%) 
7~8cm 241 (1.1%) 217 (1.0%) 
8~9cm 100 (0.5%) 99 (0.5%) 
9~10cm 69 (0.3%) 71 (0.3%) 
>10cm 77 (0.4%) 76 (0.4%) 
Surgical therapy   
Surgery not performed 10488 (49.6%) 10421 (49.6%) 
Surgery performed 10666 (50.4%) 10579 (50.4%) 
Tumour sites (icd code)   
Lip (C00) 1240 (5.9%) 1227 (5.8%) 
Base of tongue (C01) 3989 (18.9%) 3968 (18.9%) 
Other parts of tongue (C02) 3500 (16.5%) 3468 (16.5%) 
Gum (C03) 612 (2.9%) 609 (2.9%) 
Floor of mouth (C04) 1118 (5.3%) 1108 (5.3%) 
Palate(C05) 607 (2.9%) 601 (2.9%) 
Other oral cavity(C06) 1040 (4.9%) 1029 (4.9%) 
Parotid gland (C07) 414 (2.0%) 411 (2.0%) 
Other salivary glands (C08) 72 (0.3%) 70 (0.3%) 
Tonsil (C09) 4921 (23.3%) 4885 (23.3%) 
Oropharynx (C10) 801 (3.8%) 800 (3.8%) 
Nasopharynx (C11) 1187 (5.6%) 1176 (5.6%) 
Pyriform sinus (C12) 754 (3.6%) 752 (3.6%) 
Hypopharynx (C13) 616 (2.9%) 614 (2.9%) 
Others (C14) 283 (1.3%) 282 (1.3%) 
Chapter 6 Supplement 3. Hazard ratios of each predictors returned by Cox regression 
 
                                               exp(coef) exp(-coef) lower .95 upper .95 
Age                                            1.0319     0.9691    1.0287    1.0351 
SexMale                                      1.0209     0.9795    0.9430    1.1052 
RaceAsian or Pacific Islander                   0.6215     1.6091    0.4064    0.9503 
RaceBlack                                        0.8914     1.1219    0.5905    1.3455 
RaceWhite                                        0.6653     1.5030    0.4443    0.9962 
Marital_sMarried (including common law)         0.7011     1.4263    0.6370    0.7717 
Marital_sSeparated                               0.9629     1.0386    0.7255    1.2779 
Marital_sSingle (never married)                 1.1360     0.8803    1.0198    1.2655 
Marital_sWidowed                                 1.0733     0.9317    0.9409    1.2243 
GradePoorly differentiated; Grade III           0.9313     1.0738    0.8663    1.0010 
GradeUndifferentiated; anaplastic; Grade IV     0.9324     1.0725    0.7261    1.1972 
GradeWell differentiated; Grade I               0.8087     1.2365    0.7221    0.9057 
T_nT2                                            1.1621     0.8605    0.9507    1.4205 
T_nT3                                            1.3497     0.7409    1.0879    1.6746 
T_nT4                                            1.8214     0.5490    1.4871    2.2310 
T_nTX                                            1.5970     0.6262    0.9733    2.6206 
N_nN1                                            1.4340     0.6973    1.2673    1.6227 
N_nN2                                            1.4997     0.6668    1.3168    1.7079 
N_nN3                                            1.8992     0.5265    1.5593    2.3131 
N_nNX                                            1.6248     0.6155    1.0521    2.5093 
M_nM1                                            2.5649     0.3899    2.2253    2.9565 
M_nMX                                            1.6576     0.6033    1.2633    2.1748 
StageII                                           1.3670     0.7315    1.1251    1.6610 
StageIII                                          1.2592     0.7941    1.0296    1.5400 
StageIV                                          1.3917     0.7186    1.1263    1.7195 
LN_rYes                                          0.8905     1.1229    0.8145    0.9737 
TS_n0~1cm                                        0.3714     2.6924    0.2213    0.6235 
TS_n1~2cm                                        0.5840     1.7124    0.3568    0.9559 
TS_n2~3cm                                        0.5996     1.6679    0.3726    0.9649 
TS_n3~4cm                                        0.7123     1.4039    0.4431    1.1451 
TS_n4~5cm                                        0.8386     1.1924    0.5234    1.3437 
TS_n5~6cm                                        0.8903     1.1232    0.5523    1.4352 
TS_n6~7cm                                        0.9833     1.0170    0.6011    1.6086 
TS_n7~8cm                                        1.2497     0.8002    0.7483    2.0870 
TS_n8~9cm                                        1.2781     0.7824    0.7298    2.2384 
TS_n9~10cm                                       0.8710     1.1481    0.4684    1.6198 
SurgerySurgery performed                        0.6187     1.6163    0.5611    0.6822 
ICD_nBase of tounge (C01)                       1.1606     0.8616    0.8537    1.5778 
ICD_nOther parts of tounge (C02)                2.9980     0.3336    2.2311    4.0285 
ICD_nGum (C03)                                   2.2024     0.4541    1.5841    3.0620 
ICD_nFloor of mouth (C04)                       3.1474     0.3177    2.3132    4.2824 
ICD_nPalate(C05)                                 2.1562     0.4638    1.5388    3.0214 
ICD_nOther oral cavity(C06)                     2.9675     0.3370    2.1729    4.0526 
ICD_nParotid gland (C07)                        1.8092     0.5527    1.2708    2.5757 
ICD_nOther salivary glands (C08)                3.1383     0.3186    1.8906    5.2093 
ICD_nTonsil (C09)                                0.8786     1.1381    0.6471    1.1931 
ICD_nOropharynx (C10)                           1.6830     0.5942    1.2041    2.3525 
ICD_nNasopharynx (C11)                          1.3728     0.7284    0.9671    1.9488 
ICD_nPyriform sinus (C12)                       2.0788     0.4810    1.5005    2.8799 
ICD_nHypopharynx (C13)                          2.2264     0.4492    1.5960    3.1057 
 
Note: Results are from the complete-case analysis of training datasets (80% of the original data) of 3-year cohort. 
  
Chapter 6 Supplement 4. C-indexes for models predicting the 3- and 5-year disease-specific survival of OPCs in the model 




Three-year survival cohort 
 Development dataset (80%) 
(Median (IQR)) 
Testing dataset (20%) 
(Median (IQR)) 
Data set with complete cases (N=11,888)   
Cox 0.768 (0.767, 0.770) 0.764 (0.758, 0.768) 
Survival tree 0.702 (0.701, 0.703) 0.703 (0.693, 0.705) 
Random forest for survival 0.834 (0.834, 0.838) 0.766 (0.760, 0.773) 
Conditional inference forest 0.833 (0.827, 0.856) 0.759 (0.755, 0.763) 
Data set with imputation (N=21,154) 
Cox 0.768 (0.768, 0.769) 0.768 (0.766, 0.768) 
Survival tree 0.696 (0.688, 0.706) 0.688 (0.684, 0.700) 
Random forest for survival 0.831 (0.791, 0.837) 0.775 (0.771, 0.776) 
Conditional inference forest 0.850 (0.838, 0.873) 0.768 (0.767, 0.770) 
 Development dataset (70%) 
(Median (IQR)) 
Testing dataset (30%) 
(Median (IQR)) 
Data set with complete cases (N=11,888)   
Cox 0.769 (0.767, 0.770) 0.763 (0.760, 0.767) 
Survival tree 0.702 (0.699, 0.705) 0.699 (0.693, 0.705) 
Random forest for survival 0.841 (0.833, 0.841) 0.769 (0.764, 0.774) 
Conditional inference forest 0.848 (0.828, 0.852) 0.775 (0.771, 0.777) 
Data set with imputation (N=21,154) 
Cox 0.770 (0.769, 0.772) 0.764 (0.760, 0.765) 
Survival tree 0.697 (0.690, 0.707) 0.696 (0.688, 0.701) 
Random forest for survival 0.840 (0.831, 0.845) 0.776 (0.775, 0.777) 
Conditional inference forest 0.843 (0.835, 0.846) 0.767 (0.765, 0.767) 
 Development dataset (50%) 
(Median (IQR)) 
Testing dataset (50%) 
(Median (IQR)) 
Data set with complete cases (N=11,888)   
Cox 0.771 (0.767, 0.772) 0.764 (0.763, 0.767) 
Survival tree 0.703 (0.698, 0.707) 0.696 (0.692, 0.700) 
Random forest for survival 0.839 (0.828, 0.843) 0.768 (0.766, 0.769) 
Conditional inference forest 0.840 (0.839, 0.842) 0.758 (0.754, 0.760) 
Data set with imputation (N=21,154) 
Cox 0.771 (0.769, 0.772) 0.764 (0.763, 0.765) 
Survival tree 0.698 (0.691, 0.705) 0.694 (0.686, 0.698) 
Random forest for survival 0.836 (0.835, 0.842) 0.775 (0.774, 0.775) 
Conditional inference forest 0.852 (0.850, 0.856) 0.771 (0.771, 0.772) 
 Development dataset (30%) 
(Median (IQR)) 
Testing dataset (70%) 
(Median (IQR)) 
Data set with complete cases (N=11,888)   
Cox 0.771 (0.766, 0.774) 0.762 (0.760, 0.764) 
Survival tree 0.698 (0.697, 0.710) 0.695 (0.688, 0.699) 
Random forest for survival 0.842 (0.836, 0.845) 0.757 (0.762, 0.766) 
Conditional inference forest 0.853 (0.851, 0.854) 0.752 (0.750, 0.756) 
Data set with imputation (N=21,154) 
Cox 0.772 (0.770, 0.773) 0.765 (0.764, 0.766) 
Survival tree 0.703 (0.693, 0.708) 0.689 (0.685, 0.698) 
Random forest for survival 0.839 (0.830, 0.847) 0.770 (0.770, 0.772) 




Five-year survival cohort 
 Development dataset (80%) 
(Median (IQR)) 
Testing dataset (20%) 
(Median (IQR)) 
Data set with complete cases (N=11,807)   
Cox 0.762 (0.761, 0.763) 0.756 (0.761, 0.764) 
Survival tree 0.694 (0.692, 0.698) 0.688 (0.680, 0.696) 
Random forest for survival 0.826 (0.826, 0.833) 0.762 (0.761, 0.764) 
Conditional inference forest 0.850 (0.837, 0.856) 0.752 (0.751, 0.764) 
Data set with imputation (N=21,000) 
Cox 0.764 (0.761, 0.764) 0.762 (0.762, 0.767) 
Survival tree 0.692 (0.690, 0.695) 0.689 (0.683, 0.695) 
Random forest for survival 0.829 (0.828, 0.830) 0.773 (0.769, 0.776) 
Conditional inference forest 0.849 (0.843, 0.854) 0.767 (0.766, 0.767) 
Modelling approaches Development dataset (70%) 
(Median (IQR)) 
Testing dataset (30%) 
(Median (IQR)) 
Data set with complete cases (N=11,807)   
Cox 0.762 (0.761, 0.763) 0.758 (0.756, 0.761) 
Survival tree 0.693 (0.692, 0.698) 0.688 (0.685, 0.694) 
Random forest for survival 0.828 (0.827, 0.832) 0.760 (0.757, 0.763) 
Conditional inference forest 0.843 (0.837, 0.845) 0.760 (0.759, 0.762) 
Data set with imputation (N=21,000) 
Cox 0.764 (0.761, 0.764) 0.762 (0.762, 0.767) 
Survival tree 0.692 (0.690, 0.696) 0.685 (0.690, 0.695) 
Random forest for survival 0.828 (0.819, 0.836) 0.772 (0.771, 0.773) 
Conditional inference forest 0.850 (0.842, 0.856) 0.769 (0.766, 0.769) 
 Development dataset (50%) 
(Median (IQR)) 
Testing dataset (50%) 
(Median (IQR)) 
Data set with complete cases (N=11,807)   
Cox 0.763 (0.761, 0.765) 0.758 (0.756, 0.760) 
Survival tree 0.696 (0.691, 0.701) 0.690 (0.684, 0.695) 
Random forest for survival 0.825 (0.817, 0.826) 0.761 (0.759, 0.764) 
Conditional inference forest 0.829 (0.821, 0.835) 0.759 (0.754, 0.761) 
Data set with imputation (N=21,000) 
Cox 0.764 (0.761, 0.764) 0.762 (0.761, 0.764) 
Survival tree 0.694 (0.689, 0.700) 0.689 (0.684, 0.696) 
Random forest for survival 0.824 (0.820, 0.829) 0.766 (0.766, 0.767) 
Conditional inference forest 0.830 (0.830, 0.832) 0.764 (0.761, 0.765) 
 Development dataset (30%) 
(Median (IQR)) 
Testing dataset (70%) 
(Median (IQR)) 
Data set with complete cases (N=11,807)   
Cox 0.764 (0.761, 0.768) 0.756 (0.754, 0.758) 
Survival tree 0.696 (0.690, 0.704) 0.684 (0.681, 0.692) 
Random forest for survival 0.830 (0.812, 0.835) 0.755 (0.754, 0.759) 
Conditional inference forest 0.854 (0.842, 0.859) 0.756 (0.751, 0.758) 
Data set with imputation (N=21,154) 
Cox 0.762 (0.762, 0.763) 0.762 (0.761, 0.762) 
Survival tree 0.693 (0.690, 0.702) 0.688 (0.683, 0.692) 
Random forest for survival 0.832 (0.826, 0.838) 0.764 (0.764, 0.766) 
Conditional inference forest 0.850 (0.842, 0.856) 0.765 (0.759, 0.769) 
Chapter 6 Supplement 5. Overtime C-index for predicting 3- and 5-year disease-specific survival of oral and pharyngeal 
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Chapter 6 Supplement 6. The prediction error curves for various models in predicting disease-specific survival of oral and 
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Chapter 6 Supplement 7. Calibration plots for predicting 3- and 5-year disease-specific survival of oral and pharyngeal 
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Chapter 6 Supplement 8. Time-dependent receiver operator curves for predicting 1- to 5-year disease-specific survival of 
oral and pharyngeal cancers with Cox models 
 
Description of the methods for plotting the time-dependent ROC 
The time-dependent receiver operator curves (ROC) are extensions of the standard ROC curves (developed for binary data) and 
are developed for situations where the event status (e.g. death) occurs at various time point during the study period, and it is 
suitable to time-to-event analysis. The time-dependent ROC can be constructed based on the cumulative sensitivity (SeC) and 
dynamic specificity (SpD), which have been well defined in the literature*:  
Let Ti denote the predicted time of event onset and 𝜂𝑖    is the predicted ‘risk’ (represented by hazard ratios of predictor values at 
baseline) for individual i, (i = 1, …, n). At each observed time point t, each individual is classified as a case or control (e.g. has 
event/no event at that time point in between time periods Ti  = 0 and t). A case is defined as any individual experiencing the event 
between baseline t = 0 and time t and a control as an individual remaining event-free at time t. The cases and controls change over 
time and each individual may play the role of control at the earlier time (when the event time is greater than the target time, 
i.e. Ti  > t) but then contributes as a case for later times (when the event time is less than or equal to the target time, i.e. Ti  ≤ t). For 
an observed threshold c, the cumulative sensitivity of our model is defined as the probability that the individual has an predicted 
‘risk’ greater than c among the individuals who experienced the event before time t, and the dynamic specificity is the probability 
that an individual has a predictor value less than or equal to c among those event-free individuals beyond time t. Thus:  
𝑆𝑒𝐶(𝑐, 𝑡) = 𝑃(𝜂𝑖 > 𝑐|𝑇𝑖 ≤ 𝑡) 
𝑆𝑝𝐷(𝑐, 𝑡) = 𝑃 (𝜂𝑖 ≤ 𝑐|𝑇𝑖 ≥ 𝑡) 
𝐴𝑈𝐶𝐶,𝐷  (𝑡) = 𝑃(𝜂𝑖 > 𝜂𝑗|𝑇𝑖 ≤ 𝑡, 𝑇𝑗 > 𝑡), 𝑖 ≠ 𝑗 
Results 
Once the time-dependent setting is applied, the death status is observed and predicted at each time point which yields different 
values of sensitivity and specificity throughout the investigated time period. So that we could choose to plot the time-dependent 
ROC curves at a specific time of interest. For example, the following plots give the cumulative prediction performance at 12, 24, 
36, 48 and 60 months.  
 
Source: Kamarudin, Adina Najwa, Trevor Cox, and Ruwanthi Kolamunnage-Dona. Time-dependent ROC curve analysis in 
medical research: current methods and applications. BMC medical research methodology 17.1 (2017): 53. 
 
  









Here's an example call to the sensitivity analysis (R Code): 
obsSensSCC(cox1, which=1, g0=c(0.1,0.5,2), p0=seq(0,1,0.2), p1=seq(0,1,0.2), logHaz=F) 
where: 
• obsSensSCC = a sensitivity analysis for three variables: outcome Y is a survival outcome, exposure X is a categorical 
variable such as sex, and latent variables U are categorical variables) 
• model = the Cox regression model 
• which = the parameter in the regression model that specifies the predictor, e.g. 2 refers to the second predictor, which 
was sex-male in our analysis 
• g0 = strength of the relationship between U and the outcome (specified here as a hazard ratio); also called gamma 
• p0 = prevalence of U in unexposed group (or when exposure = 0) 
• p1 = prevalence of U in the exposed group (or when exposure = 1) 
• logHaz = whether log of the hazard or the hazard ratio should be returned 
 
In the sensitivity analysis, a range of g is chosen to include the unadjusted 𝜷 before adjusting for unmeasured predictors. Together 
with a range of p, 𝜷 is then estimated for different values of g and p. For example, a range of g of 0.1 to 2 was chosen as the 
hypothetical effect of unmeasured predictors that could explain away the 𝜷 or reduce it to a specific level.  If the confidence 
intervals of the adjusted 𝜷 do not include 1, this suggests a direct beneficial relationship between survival outcome and predictors. 
On the other hand, if the confidence interval included 1, then the unmeasured predictor could explain the relationship between 




Let’s look at two examples:  
The following table presents the impact of unmeasured predictor on the hazard ratios of the association between two predictors 
and 3-year survival outcome.  For the predictor ‘whether the surgery was performed or not’, we found that the range of 𝜷 did not 
include 1 across all scenarios, which means the added unmeasured predictor did not impact on the effect of ‘Surgery’ on the 
outcome. However, for the predictor ‘T category, T3’, when larger proportion of T3 patients have the unmeasured predictor than 
the non-T3 patients (e.g. this meets the chemotherapy scenario), the effect might be changed only when the unmeasured predictors 
has effect 2-fold larger than the existing predictor ‘T category, T3’. 
               
 
* g(Gamma) refers to the effect estimate of the association between predictors and an unmeasured covariate; p refers to the 
correlation between survival outcome and unmeasured covariate. Effect estimates not including 1 represent conditions where 
survival outcome is associated with the presence of predictors, whereas those including 1 represent conditions where survival 
outcome is not associated with predictors. 
Chapter 6 Supplement 11. Pruning parameters for survival tree and random forests for survival 
 
  
Model Pruning Parameters  
Survival tree (‘minsplit’, lower=1,upper=20), corresponds to the minimum number of observations that must exist 
in a node in order for a split to be attempted. 
(‘maxdepth’,lower=1,upper=30), corresponds to the maximum depth of a tree. Depth is the length of 
the longest path from a Root node to a Leaf node. 
Random forests for 
survival 
(‘ntree', lower=1000, upper=2000), corresponds to the total number of trees in the forest. 
('mtry',lower = 1,upper = 12), corresponds to the number of variables tested in any split. 
('nsplit',lower = 0, upper=20), corresponds to the size of random split points for 
each ‘mtry’ candidate. 
('splitrule',values = 'logrank', special.vals = list('logrank','logrankscore','random')), corresponds to the 
split rule and formula.  
('nodedepth',lower = …, upper =…), corresponds to the length of the longest path from a root to a 
leaf of any tree in the forest. The default behaviour is that this parameter is ignored. 
('nodesize',lower =…, upper=…), corresponds to the minimum number of unique cases (data points) 




(‘ntree', lower=1000, upper=2000), corresponds to the total number of trees in the forest. 
('mtry',lower = 1,upper = 12), corresponds to the number of variables tested in any split. 
('minsplit',lower = 0, upper=20), corresponds to the minimum size of random split points for 
each ‘mtry’ candidate. 
(‘teststat’, values= ‘quad’, special.vals = list(‘quad', ‘max')), corresponds to a character specifying the 
type of the test statistic to be applied. 
(‘mincriterion’), corresponds to the depth of the trees. Usually unstopped and unpruned trees are used 
in random forests. To grow large trees, set it to a small value. The default behaviour is that this 
parameter is ignored. 
 
Chapter 6 Supplement 12. The step-by-step practical procedure of developing a ST, RF and CF algorithm 
 
The development of a ST algorithm can be summarized as follows: 
1 Start function F build survival tree 
2  Create an initial survival tree with root node t0 
3  Create an empty stack S of open nodes  
4  while S is not empty do  
5  t = t0 + t1,  
  if stopping criterion is met for t end  
else Find the split on F that maximizes the survival difference between children nodes 
6   Partition data in to two child nodes of t 
7  end 
8  end 
9 End 
For the tree growing and pruning purposes, one needs a splitting statistic (log-rank) that handles the dependence of failure times 
and a measure (C-index) to evaluate the performance of the tree. 
 
The development of a RF algorithm can be summarized as follows: 
1 Start 
2 Select the number of trees to build, ntree  
3  for i = 1 to ntree do  
4  Generate a B bootstrap sample (usually two thirds) of the original data, one third is left as out-of-bag 
(OOB) data  
5   Train a tree model on this sample  
6   for each split do  
7    Randomly select k (< K) of the original predictors  
8  Select the best predictor among the k predictors  
for each splitting point of the best k do  
Compare the survival curves of the two groups using one splitting rule r among 
a) log-rank splitting rule, b) log-rank score splitting rule, or c) random log-rank 
splitting rule. 
Select the best splitting rule and partition the data 
    end for determining splitting rule  
9   end for determining one split in one tree 
10  Use tree stopping criteria to determine when a tree is complete. 
11  Using OOB data, the prediction ability is calculated and represented by C-index. The cumulative hazard 
function (CHF) is also calculated for each tree. 
12  end for one tree 
13 The individual C-index are then averaged to obtain the ensemble C-index. The individual CHFs are then averaged to 
obtain the ensemble CHF. 
14 End 
 
The development of a conditional inference tree can be summarized as follows: 
1: For case weights w, test the global null hypothesis of independence between any of the p covariates and the response 
variable. Stop if this hypothesis cannot be rejected otherwise the the jth covariate X with strongest associate to the outcome. 
2. Select a set A ∈ X in order to split X into two disjoint sets. The weights wL and wR determine the two subgroups with wL,i 
= wiI (Xj,i ∈ A) and wR,I = wiI (Xj,i ≠ A) for all i=1,2,…n. 
3. Recursively repeat steps 1 and 2 with modeified case weights wL and wR, respectively. 
 
Source:  
1. Ishwaran H, Kogalur UB, Blackstone EH, and Lauer MS. Random survival forests. Ann. Appl. Statist., 2:841–860, 2008. 
2. Kuhn, M. and Johnson, K., Applied predictive modeling (Vol. 26). New York: Springer. 2013. 
3. Torsten Hothorn, Kurt Hornik & Achim Zeileis. Unbiased Recursive Partitioning: A Conditional Inference 
Framework, Journal of Computational and Graphical Statistics, 15:3, 651-674, 2006. 
 
Chapter 6 Supplement 13. Type of regression methods used to impute each variable when using Multiple Imputation of 
Covariates by Substantive Model (smcfcs) package 
  
Variables Methods 
Race, Marital status, Lymph node removal, 
Surgery, tumour site 
‘mlogit’ multinomial logistic regression for unordered 
categorical variables 
Grade, TNM category, Stage, Tumour size ‘podds’ proportional odds regression for ordered 
categorical variables 
Age, Sex, Survival time, Death status ‘’, fully observed, does not need to be imputed 
Chapter 6 Supplement 14. TRIPOD checklist for study reporting 
 
TRIPOD: Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis. 
 
Section/Topic Item Development 
or Validation? 
Checklist Item Page 
Title and abstract     
Title 1 D;V Identify the study as developing and/or validating a multivariable prediction model, the 
target population, and the outcome to be predicted. 
1 
Abstract 2 D;V Provide a summary of objectives, study design, setting, participants, sample size, predictors, 
outcome, statistical analysis, results, and conclusions. 
1 
Introduction      
Background and 
objectives 
3a D;V Explain the medical context (including whether diagnostic or prognostic) and rationale for 
developing or validating the multivariable prediction model, including references to existing 
models. 
1-2 
 3b D;V Specify the objectives, including whether the study describes the development or validation 
of the model, or both. 
1-2 
Methods     
Source of data 4a D;V Describe the study design or source of data (e.g., randomized trial, cohort, or registry data), 
separately for the development and validation datasets, if applicable. 
10 
 4b D;V Specify the key study dates, including start of accrual; end of accrual; and, if applicable, end 
of follow-up. 
10 
Participants 5a D;V Specify key elements of the study setting (e.g., primary care, secondary care, general 
population) including number and location of centres. 
10 
 5b D;V Describe eligibility criteria for participants. 10-11 
 5c D;V Give details of treatments received, if relevant. NA 
Outcome 6a D;V Clearly define the outcome that is predicted by the prediction model, including how and 
when assessed. 
11 
 6b D;V Report any actions to blind assessment of the outcome to be predicted. NA 
Predictors 7a D;V Clearly define all predictors used in developing the multivariable prediction model, 
including how and when they were measured. 
11 
 7b D;V Report any actions to blind assessment of predictors for the outcome and other predictors. NA 
Sample size  8 D;V Explain how the study size was arrived at. NA 
Missing data 9 D;V Describe how missing data were handled (e.g., complete-case analysis, single imputation, 




10a D Describe how predictors were handled in the analyses. 11 
 10b D Specify type of model, all model-building procedures (including any predictor selection), 
and method for internal validation. 
11-12 
 10c V For validation, describe how the predictions were calculated. NA 
 10d D;V Specify all measures used to assess model performance and, if relevant, to compare multiple 
models. 
13 
 10e V Describe any model updating (e.g., recalibration) arising from the validation, if done. NA 
Risk groups 11 D;V Provide details on how risk groups were created, if done. NA 
Development vs. 
validation 
12 V For validation, identify any differences from the development data in setting, eligibility 
criteria, outcome, and predictors. 
NA 
Results     
Participants 13a D;V Describe the flow of participants through the study, including the number of participants 
with and without the outcome and, if applicable, a summary of the follow-up time. A 
diagram may be helpful. 
2-3 
 13b D;V Describe the characteristics of the participants (basic demographics, clinical features, 
available predictors), including the number of participants with missing data for predictors 
and outcome. 
3-5 
 13c V For validation, show a comparison with the development data of the distribution of important 




14a D Specify the number of participants and outcome events in each analysis. 3-4, Table 1 
 14b D If done, report the unadjusted association between each candidate predictor and outcome. NA 
Model 
specification 
15a D Present the full prediction model to allow predictions for individuals (i.e., all regression 
coefficients, and model intercept or baseline survival at a given time point). 
Table S3 
 15b D Explain how to use the prediction model. 8 
Model 
performance 
16 D;V Report performance measures (with CIs) for the prediction model. 6-8 
Model updating 17 V If done, report the results from any model updating (i.e., model specification, model 
performance). 
NA 
Discussion     
Limitations 18 D;V Discuss any limitations of the study (such as nonrepresentative sample, few events per 
predictor, missing data). 
9 
Interpretations 19a V For validation, discuss the results with reference to performance in the development data, 
and any other validation data. 
NA 
 19b D;V Give an overall interpretation of the results, considering objectives, limitations, results from 
similar studies, and other relevant evidence. 
10 
Implications 20 D;V Discuss the potential clinical use of the model and implications for future research.  8, 10 
Other 
information 
    
Supplementary 
information 
21 D;V Provide information about the availability of supplementary resources, such as study 
protocol, Web calculator, and datasets. 
14 
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Here we use an example of one-week pain prediction: 
https://github.com/dumizai/Predicting_pain_following_RCT  
 
Chapter 7 Supplement 4. Models’ performance 
 
Measure Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
H 0.43 0.38 0.15 0.41 0.49 0.12 
Gini 0.70 0.64 0.36 0.69 0.78 0.32 
AUC 0.85 0.82 0.68 0.85 0.89 0.66 
AUCH 0.86 0.83 0.70 0.86 0.90 0.68 
KS 0.54 0.51 0.31 0.54 0.64 0.24 
MER 0.15 0.17 0.24 0.09 0.09 0.10 
MWL 0.17 0.18 0.25 0.09 0.07 0.15 
Spec.Sens95 0.46 0.33 0.11 0.45 0.57 0.14 
Sens.Spec95 0.50 0.42 0.10 0.43 0.51 0.10 
ER 0.16 0.17 0.24 0.10 0.10 0.11 
Sens 0.48 0.45 0.03 0.21 0.23 0 
Spec 0.96 0.95 0.99 0.99 0.98 1 
Precision 0.8 0.74 0.5 0.65 0.64 NA 
Recall 0.48 0.45 0.03 0.21 0.23 0 
TPR 0.48 0.45 0.03 0.21 0.23 0 
FPR 0.04 0.05 0.01 0.01 0.02 0 
F 0.60 0.56 0.06 0.32 0.34 NA 
Youden 0.44 0.40 0.02 0.20 0.21 0 
TP 48 45 3 15 16 0 
FP 12 16 3 8 9 0 
TN 299 295 308 573 572 581 
FN 52 55 97 55 54 70 
Model 1 & 4: combined set of predictors; Model 2 & 5: clinical set of predictors; Model 3 & 6: 
sociodemographic set of predictors. H: the H-measure. Gini: the Gini coefficient. AUC: the Area Under the 
ROC Curve. AUCH: the Area Under the convex Hull of the ROC Curve . KS: the Kolmogorov-Smirnoff 
statistic. MER: the Minimum Error Rate. MWL: the Minimum cost-Weighted Error Rate. Spec.Sens95: 
Specificity when Sensitivity is held fixed at 95%. Spec.Sens95: Sensitivity when Specificity is held fixed at 
95%. TPR: Ture Positive Rate. FPR: False Positive Rate. 
 
  
Chapter 7 Supplement 5. Models’ variance and R2 
 
Model 1 with 
combined set of 
variables 
 Variance-fixed Variance-random 
  63.39535 0.3290074 
 𝑅2 -total  𝑅2- fixed 𝑅2- random 
 0.95 0.95  
 
Model 2 with only 
clinical variables 
 Variance-fixed Variance-random 
  20.77257 0.139763 
 𝑅2-total  𝑅2- fixed 𝑅2- random 
 0.86 0.86  
 
Model 3 with only 
social variables 
 Variance-fixed Variance-random 
  0.2676462 0.3572107 
 𝑅2-total  𝑅2- fixed 𝑅2- random 
 0.16 0.07  
 
Model 4 with 
combined set of 
variables 
 Variance-fixed Variance-random 
  14.46139 N/A 
 𝑅2-total  𝑅2- fixed 𝑅2- random 
 0.81 0.81  
 
Model 5 with 
clinical variables 
 Variance-fixed Variance-random 
  30.97322 0. 0812948 
 𝑅2-total  𝑅2- fixed 𝑅2- random 
 0.90 0.90  
 
Model 6 with only 
social variables 
 Variance-fixed Variance-random 
  0.2055059 0.04684805 
 𝑅2-total  𝑅2- fixed 𝑅2- random 
 0.07 0.06  
 
  
Chapter 7 Supplement 6. Models specification 
 
NOTE: Data dictionary is available at:  
https://github.com/dumizai/Predicting_pain_following_RCT 
 




                              Est.       S.E.   z val.      p 
---------------------- -------- ---------- -------- ---------------------------- 
(Intercept)                  -0.58       1.45    -0.40   0.69 
Q04P0STRES1                 1.94       0.58     3.36   0.00 
Q04P0NWPAIN1            -1.76       0.72    -2.44   0.01 
Q04P0NWPAIN2              -1.16       0.63    -1.84   0.07 
Q04P0NWPAIN3               -0.49       0.54    -0.91   0.36 
Q04P0NWPAIN4                0.49       0.50     0.97   0.33 
Q04P0NWPAIN5                1.58       0.69     2.30   0.02 
Q04P0NWPAIN6                0.01       0.60     0.01   0.99 
Q04P0NWPAIN7               -0.49       0.72    -0.68   0.49 
Q04P0NWPAIN8                1.15       0.78     1.48   0.14 
Q04P0NWPAIN9                0.49       0.87     0.57   0.57 
Q04P0NWPAIN10               1.45       1.17     1.24   0.21 
Q04P0NOACDAY1              -0.36       0.69    -0.52   0.60 
Q04P0NOACDAY2               1.87       0.74     2.53   0.01 
Q04P0NOACDAY3              -0.91       0.97    -0.94   0.35 
Q04P0NOACDAY4              -0.79       1.31    -0.60   0.55 
Q04P0NOACDAY5               0.54       1.14     0.47   0.64 
Q04P0EDU2                  -0.37       1.17    -0.32   0.75 
Q04P0EDU3                  -0.46       1.15    -0.40   0.69 
Q04P0EDU4                   0.13       1.14     0.12   0.91 
Q04P0EDU5                  -0.64       1.17    -0.55   0.58 
Q04P0NOREC1                 0.12       0.69     0.18   0.86 
Q04P0NOREC2                -1.51       1.01    -1.49   0.14 
Q04P0NOREC3                -0.17       0.82    -0.20   0.84 
Q04P0NOREC4                 1.43       1.45     0.99   0.32 
Q04P0NOREC5                 1.81       1.10     1.64   0.10 
Q04P0NOREC6                -0.39       1.28    -0.31   0.76 
Q04P0NOREC7                -1.12       1.48    -0.76   0.45 
Q04P0NOREC8                 1.18       1.68     0.70   0.48 
Q04P0NOREC9                19.84    6647.94     0.00   1.00 
Q04P0NOWRK1                -0.65       0.68    -0.95   0.34 
Q04P0NOWRK2                 0.54       0.83     0.65   0.51 
Q04P0NOWRK3                 0.50       0.87     0.57   0.57 
Q04P0NOWRK4                -1.75       1.50    -1.17   0.24 
Q04P0NOWRK5                -1.68       1.27    -1.33   0.18 
Q04P0NOWRK6                 0.48       1.32     0.37   0.71 
Q04P0NOWRK7                 0.61       1.40     0.44   0.66 
Q04P0NOWRK8                -1.04       1.90    -0.54   0.59 
Q04P0NOWRK9               -55.72   11369.08    -0.00   1.00 
Q_09P1PAIN1                 0.24       0.39     0.62   0.54 
Q_09P1PAIN2                 0.66       0.60     1.10   0.27 
Q_09P1PAIN3                -0.11       0.76    -0.15   0.88 
Q_09P1PAIN4                 1.60       1.17     1.37   0.17 
Q_09P1PAIN5                 0.69       0.78     0.88   0.38 
Q_09P1PAIN6                -0.53       0.96    -0.55   0.58 
Q04P0RACEv2Black            0.11       0.90     0.12   0.90 
Q04P0RACEv2Asian           -0.05       1.45    -0.03   0.97 
Q04P0RACEv2Other           21.48    7888.22     0.00   1.00 
STATEFL                     0.19       0.59     0.32   0.75 
STATEMN                    -0.18       0.50    -0.36   0.72 
STATENA                    -0.71       0.88    -0.80   0.42 
STATEOR                     0.94       0.77     1.22   0.22 
STATEWI                     1.54       1.00     1.54   0.12 
Q_07D1SWELL1               -1.70       0.81    -2.10   0.04 
Q_07D1BLEED1                1.14       0.52     2.19   0.03 
PMNO1                       -1.10       0.77    -1.43   0.15 
Q_09P1NUMB2                -1.26       0.69    -1.82   0.07 





      Group           Parameter    Std. Dev.  
----------------- ------------- ------------------------------------ 
 data_1wk.PRACID     (Intercept)     0.18     
   DDShispanic       (Intercept)     0.55     





      Group          # groups   ICC   
----------------- ---------- ------------------------------- 
 data_1wk.PRACID       57       0.01  
   DDShispanic          2        0.08  
    DDSgender           2        0.00  
------------------------------------------------------------ 
 




                         Est.      S.E.   z val.      p 
------------------- -------- --------- -------- -------------------- 
(Intercept)             -2.77      0.60    -4.65   0.00 
Q04P0STRES1             1.52      0.51     3.00   0.00 
Q04P0NWPAIN1           -1.68      0.70    -2.40   0.02 
Q04P0NWPAIN2           -0.97      0.58    -1.67   0.10 
Q04P0NWPAIN3           -0.32      0.52    -0.62   0.53 
Q04P0NWPAIN4            0.45      0.46     0.98   0.33 
Q04P0NWPAIN5            1.43      0.61     2.33   0.02 
Q04P0NWPAIN6            0.21      0.56     0.38   0.70 
Q04P0NWPAIN7           -0.65      0.69    -0.95   0.34 
Q04P0NWPAIN8            1.40      0.74     1.91   0.06 
Q04P0NWPAIN9            0.45      0.81     0.55   0.58 
Q04P0NWPAIN10           1.27      1.09     1.17   0.24 
Q04P0NOACDAY1          -0.13      0.65    -0.20   0.84 
Q04P0NOACDAY2           1.58      0.62     2.56   0.01 
Q04P0NOACDAY3          -1.08      0.89    -1.22   0.22 
Q04P0NOACDAY4           0.04      1.07     0.03   0.97 
Q04P0NOACDAY5           0.57      1.05     0.54   0.59 
Q04P0NOREC1             0.29      0.67     0.43   0.66 
Q04P0NOREC2            -1.66      0.97    -1.71   0.09 
Q04P0NOREC3            -0.09      0.79    -0.12   0.91 
Q04P0NOREC4             1.39      1.38     1.00   0.32 
Q04P0NOREC5             1.85      1.03     1.80   0.07 
Q04P0NOREC6            -0.03      1.18    -0.02   0.98 
Q04P0NOREC7            -0.26      1.37    -0.19   0.85 
Q04P0NOREC8             0.39      1.40     0.28   0.78 
Q04P0NOREC9            17.91   3997.95     0.00   1.00 
Q04P0NOWRK1            -0.57      0.65    -0.88   0.38 
Q04P0NOWRK2             0.59      0.77     0.76   0.44 
Q04P0NOWRK3             0.44      0.81     0.55   0.58 
Q04P0NOWRK4            -1.68      1.40    -1.20   0.23 
Q04P0NOWRK5            -1.59      1.18    -1.35   0.18 
Q04P0NOWRK6             0.29      1.15     0.25   0.80 
Q04P0NOWRK7             0.65      1.28     0.51   0.61 
Q04P0NOWRK8             0.15      1.52     0.10   0.92 
Q04P0NOWRK9           -36.26   6486.32    -0.01   1.00 
Q_07D1BLEED1            1.14      0.48     2.36   0.02 
STATEFL                 0.46      0.56     0.82   0.41 
STATEMN                 0.27      0.46     0.58   0.56 
STATENA                -0.11      0.86    -0.13   0.90 
STATEOR                 1.22      0.72     1.69   0.09 





      Group          Parameter    Std. Dev.  
----------------- ------------- ------------------------- 





      Group         # groups   ICC   
----------------- ---------- -------------------- 
 data_1wk.PRACID      57      0.04  
------------------------------------------------- 
 
Model3: One-week pain prediction, sociodemographic set 
FIXED EFFECTS: 
---------------------------------------------------------- 
                                 Est.   S.E.   z val.      p 
--------------------------- ------- ------ -------- ------ 
(Intercept)                    -0.78   1.43    -0.54   0.59 
Q04P0GENDERFemale         -0.06   0.26    -0.24   0.81 
Q04P0HISPNon-hispanic       -0.57   0.68    -0.85   0.40 
Q04P0DENINS1                   0.22   0.34     0.63   0.53 
Q04P0INCOME2                   0.74   0.87     0.85   0.39 
Q04P0INCOME3                   0.64   0.83     0.77   0.44 
Q04P0INCOME4                   0.96   0.80     1.20   0.23 
Q04P0EDU2                      -0.46   0.84    -0.54   0.59 
Q04P0EDU3                      -0.79   0.83    -0.95   0.34 
Q04P0EDU4                      -0.16   0.82    -0.20   0.84 
Q04P0EDU5                      -0.66   0.87    -0.76   0.45 
Q04P0RACEv2Black               0.06   0.56     0.11   0.91 
Q04P0RACEv2Asian               1.02   0.98     1.05   0.30 
Q04P0RACEv2Other               2.56   1.18     2.16   0.03 
DecGrad3                       -0.63   0.32    -1.97   0.05 
DecGrad4                       -0.42   0.45    -0.94   0.35 





    Group       Parameter    Std. Dev.  
------------- ------------- ----------- 
 DDShispanic   (Intercept)     0.41     





    Group      # groups   ICC   
------------- ---------- -------------------- 
 DDShispanic      2       0.05  
  DDSgender       2       0.05  
--------------------------------------------- 
 




                               Est.      S.E.   z val.      p 
------------------------ -------- --------- -------- -------------------- 
(Intercept)                   -5.28    1.14    -4.63   0.00 
Q04P0OUTC2                    1.08      0.32     3.36   0.00 
Q04P0OUTC3                    0.19      0.76     0.25   0.80 
Q04P0TEMP1                    0.79      0.33     2.35   0.02 
Q04P0NWPAIN1                  1.37      0.50     2.76   0.01 
Q04P0NWPAIN2                 -0.34      0.64    -0.53   0.60 
Q04P0NWPAIN3                 -0.43      0.66    -0.65   0.52 
Q04P0NWPAIN4                 -0.14      0.73    -0.19   0.85 
Q04P0NWPAIN5                 -0.75      0.72    -1.04   0.30 
Q04P0NWPAIN6                  0.03      0.66     0.04   0.97 
Q04P0NWPAIN7                 -1.50      0.96    -1.56   0.12 
Q04P0NWPAIN8                 -0.29      0.88    -0.33   0.74 
Q04P0NWPAIN9                  0.54      0.89     0.61   0.54 
Q04P0NWPAIN10                 0.46      0.55     0.83   0.41 
Q04P0NOACDAY1               -0.62      0.76    -0.83   0.41 
Q04P0NOACDAY2               1.66      0.53     3.12   0.00 
Q04P0NOACDAY3               -0.78      0.91    -0.85   0.39 
Q04P0NOACDAY4               -0.48      1.21    -0.40   0.69 
Q04P0NOACDAY5               -0.04      1.00    -0.04   0.97 
Q04P0INCOME2                  1.05      0.87     1.21   0.23 
Q04P0INCOME3                  0.17      0.85     0.20   0.84 
Q04P0INCOME4                 -0.27      0.81    -0.34   0.73 
Q05D0DEEPLOCdistal         -0.09      0.42    -0.21   0.84 
Q05D0DEEPLOCmesial        0.63      0.39     1.60   0.11 
STATEFL                       0.38      0.74     0.51   0.61 
STATEMN                      0.77      0.64     1.21   0.23 
STATENA                       1.73      0.75     2.30   0.02 
STATEOR                       1.20      0.81     1.49   0.14 
STATEWI                      -0.26      1.46    -0.18   0.86 
Q04P0RACEv22                  0.10      0.86     0.11   0.91 
Q04P0RACEv24                 -1.10      1.24    -0.89   0.37 
Q04P0RACEv26                  1.49      0.76     1.96   0.05 
Q11_P1NWPAIN1                 0.49      0.55     0.89   0.37 
Q11_P1NWPAIN2                 0.93      0.64     1.45   0.15 
Q11_P1NWPAIN3                 1.77      0.63     2.79   0.01 
Q11_P1NWPAIN4                 0.53      1.00     0.53   0.59 
Q11_P1NWPAIN5                 3.73      0.75     4.95   0.00 
Q11_P1NWPAIN6               -17.01   4272.31    -0.00   1.00 
Q11_P1NWPAIN7               -0.94      0.86    -1.09   0.28 
Q11_P1NWPAIN8                -0.88      0.79    -1.12   0.26 
Q11_P1NODAC1                  1.38      0.49     2.79   0.01 
Q11_P1NODAC2                -16.45   2638.92    -0.01   1.00 
Q11_P1NODAC3                  1.32      0.69     1.93   0.05 
Q11_P1NODAC4                  1.81      1.00     1.82   0.07 
Q11_P1NODAC5                  1.06      0.96     1.11   0.27 
Q11_P1NODAC6                 -0.25      1.24    -0.20   0.84 





       Group            Parameter    Std. Dev.  
------------------- ------------- ------------------------- 
 data_6m_00.PRACID    (Intercept)     0.13     





       Group          # groups   ICC   
------------------- ---------- -------------------- 
 data_6m_00.PRACID       59      0.00  
      DecGrad             4       0.00  
--------------------------------------------------- 
 




                               Est.      S.E.   z val.      p 
------------------------ -------- --------- -------- ------ 
(Intercept)                   -6.68      1.17    -5.73   0.00 
Q04P0OUTC2                    0.95      0.35     2.70   0.01 
Q04P0OUTC3                    0.18      0.87     0.21   0.84 
Q04P0TEMP1                    0.75      0.37     2.05   0.04 
Q04P0NWPAIN1                  1.27      0.54     2.35   0.02 
Q04P0NWPAIN2                 -0.73      0.70    -1.03   0.30 
Q04P0NWPAIN3                 -1.14      0.75    -1.54   0.12 
Q04P0NWPAIN4                 -0.39      0.84    -0.46   0.65 
Q04P0NWPAIN5                 -1.10      0.80    -1.38   0.17 
Q04P0NWPAIN6                 -0.30      0.72    -0.41   0.68 
Q04P0NWPAIN7                 -2.31      1.14    -2.02   0.04 
Q04P0NWPAIN8                 -1.05      0.98    -1.07   0.28 
Q04P0NWPAIN9                  0.29      0.96     0.31   0.76 
Q04P0NWPAIN10                 0.76      0.62     1.22   0.22 
Q04P0WSTPAIN1                 0.18      1.03     0.17   0.87 
Q04P0WSTPAIN10               0.15      0.79     0.19   0.85 
Q04P0WSTPAIN2                 1.20      0.85     1.41   0.16 
Q04P0WSTPAIN3                 0.83      0.94     0.88   0.38 
Q04P0WSTPAIN4                 1.58      1.00     1.57   0.12 
Q04P0WSTPAIN5                 0.89      0.92     0.96   0.33 
Q04P0WSTPAIN6                 0.68      0.87     0.78   0.44 
Q04P0WSTPAIN7                 0.50      0.79     0.63   0.53 
Q04P0WSTPAIN8                 1.04      0.78     1.33   0.18 
Q04P0WSTPAIN9                 1.82      0.80     2.28   0.02 
Q04P0NOACDAY1               -0.35      0.74    -0.47   0.64 
Q04P0NOACDAY2               1.60      0.63     2.52   0.01 
Q04P0NOACDAY3               -0.65      0.91    -0.71   0.48 
Q04P0NOACDAY4               0.02      1.54     0.01   0.99 
Q04P0NOACDAY5                0.67      1.08     0.62   0.54 
Q05D0DEEPLOCdistal          -0.36      0.46    -0.80   0.43 
Q05D0DEEPLOCmesial         0.46      0.43     1.07   0.28 
STATEFL                       0.44      0.83     0.53   0.60 
STATEMN                       0.76      0.74     1.03   0.30 
STATENA                       2.11      0.84     2.50   0.01 
STATEOR                       1.15      0.89     1.30   0.19 
STATEWI                      -1.92      1.84    -1.05   0.29 
Q11_P1NWPAIN1                -0.25      0.67    -0.37   0.71 
Q11_P1NWPAIN2                 1.10      0.71     1.54   0.12 
Q11_P1NWPAIN3                 1.75      0.76     2.31   0.02 
Q11_P1NWPAIN4                 1.30      1.09     1.19   0.23 
Q11_P1NWPAIN5                 3.62      0.91     4.00   0.00 
Q11_P1NWPAIN6               -20.64   9012.90    -0.00   1.00 
Q11_P1NWPAIN7                1.17      1.09     1.07   0.28 
Q11_P1NWPAIN8                1.16      1.07     1.08   0.28 
Q11_P1WSTPAIN1              1.71      0.86     1.98   0.05 
Q11_P1WSTPAIN10            0.23      1.22     0.19   0.85 
Q11_P1WSTPAIN2               1.25      0.89     1.40   0.16 
Q11_P1WSTPAIN3               0.42      0.89     0.47   0.64 
Q11_P1WSTPAIN4               0.15      0.91     0.16   0.87 
Q11_P1WSTPAIN5               1.85      0.83     2.22   0.03 
Q11_P1WSTPAIN6               2.19      0.99     2.20   0.03 
Q11_P1WSTPAIN7               2.42      0.86     2.80   0.01 
Q11_P1WSTPAIN8               1.51      1.01     1.49   0.14 
Q11_P1WSTPAIN9              -0.27      1.06    -0.25   0.80  
Q11_P1NODAC1                 1.05      0.63     1.66   0.10 
Q11_P1NODAC2               -20.34   9425.71    -0.00   1.00 
Q11_P1NODAC3                 0.71      0.97     0.73   0.47 
Q11_P1NODAC4                 1.57      1.34     1.17   0.24 
Q11_P1NODAC5                 0.27      1.43     0.19   0.85 
Q11_P1NODAC6                -2.24      1.55    -1.45   0.15 
Q11_P1NODAC7                 3.89      1.11     3.51   0.00 
Q11_P1NOWRK1                 0.44      0.70     0.63   0.53 
Q11_P1NOWRK2                 0.72      1.12     0.64   0.52 
Q11_P1NOWRK3                 0.45      0.87     0.52   0.60 
Q11_P1NOWRK4               -17.57   4297.49    -0.00   1.00 
Q11_P1NOWRK5                 0.88      1.04     0.85   0.40 
Q11_P1NOWRK6                -1.04      2.16    -0.48   0.63 




       Group            Parameter    Std. Dev.  
------------------- ------------- ------------------------- 
 data_6m_00.PRACID    (Intercept)     0.29     




       Group          # groups   ICC   
------------------- ---------- -------------------- 
 data_6m_00.PRACID       59      0.02  
      DecGrad             4       0.00  
--------------------------------------------------- 
 




Est.      S.E.    z val.      p 
------------------ ------- ------ -------- -------------------- 
(Intercept)            -3.44   1.37    -2.52   0.01 
Q04P0GENDER2           0.24   0.28     0.87   0.39 
Q04P0HISP2             0.23   0.61     0.38   0.70 
Q04P0DENINS1           0.20   0.35     0.56   0.58 
Q04P0INCOME2           0.63   0.71     0.89   0.37 
Q04P0INCOME3          -0.13   0.71    -0.18   0.86 
Q04P0INCOME4          -0.28   0.68    -0.41   0.68 
Q04P0EDU2              0.83   1.10     0.75   0.45 
Q04P0EDU3               0.65   1.09     0.60   0.55 
Q04P0EDU4               1.14   1.08     1.05   0.29 
Q04P0EDU5               0.83   1.13     0.74   0.46 
Q04P0RACEv22         -0.64   0.76    -0.84   0.40 
Q04P0RACEv24          -0.63   1.08    -0.58   0.56 





    Group       Parameter    Std. Dev.  
------------- ------------- ------------------------- 
   DecGrad      (Intercept)     0.22     
 DDShispanic   (Intercept)     0.00     





    Group       # groups   ICC   
------------- ---------- -------------------- 
   DecGrad         4       0.01  
 DDShispanic       2       0.00  
  DDSgender        2       0.00  
--------------------------------------------- 
  
Chapter 7 Supplement 7. TRIPOD checklist for study reporting  
 
Section/Topic Item Development or 
Validation? 
Checklist Item Page 
Title and abstract     
Title 1 D;V Identify the study as developing and/or validating a multivariable prediction model, the target 
population, and the outcome to be predicted. 
1 
Abstract 2 D;V Provide a summary of objectives, study design, setting, participants, sample size, predictors, 
outcome, statistical analysis, results, and conclusions. 
1 
Introduction      
Background and 
objectives 
3a D;V Explain the medical context (including whether diagnostic or prognostic) and rationale for 
developing or validating the multivariable prediction model, including references to existing 
models. 
1-2 
 3b D;V Specify the objectives, including whether the study describes the development or validation of the 
model, or both. 
1-2 
Methods     
Source of data 4a D;V Describe the study design or source of data (e.g., randomized trial, cohort, or registry data), 
separately for the development and validation datasets, if applicable. 
9 
 4b D;V Specify the key study dates, including start of accrual; end of accrual; and, if applicable, end of 
follow-up. 
9 
Participants 5a D;V Specify key elements of the study setting (e.g., primary care, secondary care, general population) 
including number and location of centres. 
9 
 5b D;V Describe eligibility criteria for participants. 9-10 
 5c D;V Give details of treatments received, if relevant. NA 
Outcome 6a D;V Clearly define the outcome that is predicted by the prediction model, including how and when 
assessed. 
10 
 6b D;V Report any actions to blind assessment of the outcome to be predicted. NA 
Predictors 7a D;V Clearly define all predictors used in developing the multivariable prediction model, including how 
and when they were measured. 
10 
 7b D;V Report any actions to blind assessment of predictors for the outcome and other predictors. NA 
Sample size  8 D;V Explain how the study size was arrived at. NA 
Missing data 9 D;V Describe how missing data were handled (e.g., complete-case analysis, single imputation, multiple 




10a D Describe how predictors were handled in the analyses. 10 
 10b D Specify type of model, all model-building procedures (including any predictor selection), and 
method for internal validation. 
10-11 
 10c V For validation, describe how the predictions were calculated. NA 
 10d D;V Specify all measures used to assess model performance and, if relevant, to compare multiple 
models. 
11-12 
 10e V Describe any model updating (e.g., recalibration) arising from the validation, if done. NA 
Risk groups 11 D;V Provide details on how risk groups were created, if done. NA 
Development vs. 
validation 
12 V For validation, identify any differences from the development data in setting, eligibility criteria, 
outcome, and predictors. 
NA 
Results     
Participants 13a D;V Describe the flow of participants through the study, including the number of participants with and 
without the outcome and, if applicable, a summary of the follow-up time. A diagram may be 
helpful. 
2-3 
 13b D;V Describe the characteristics of the participants (basic demographics, clinical features, available 
predictors), including the number of participants with missing data for predictors and outcome. 
3-5 
 13c V For validation, show a comparison with the development data of the distribution of important 
variables (demographics, predictors, and outcome). 
NA 
Model development 14a D Specify the number of participants and outcome events in each analysis.  
 14b D If done, report the unadjusted association between each candidate predictor and outcome. NA 
Model specification 15a D Present the full prediction model to allow predictions for individuals (i.e., all regression 
coefficients, and model intercept or baseline survival at a given time point). 
 
 15b D Explain how to use the prediction model. 7-8 
Model performance 16 D;V Report performance measures (with CIs) for the prediction model. 6-7 
Model updating 17 V If done, report the results from any model updating (i.e., model specification, model performance). NA 
Discussion     
Limitations 18 D;V Discuss any limitations of the study (such as nonrepresentative sample, few events per predictor, 
missing data). 
9 
Interpretations 19a V For validation, discuss the results with reference to performance in the development data, and any 
other validation data. 
NA 
 19b D;V Give an overall interpretation of the results, considering objectives, limitations, results from similar 
studies, and other relevant evidence. 
 
Implications 20 D;V Discuss the potential clinical use of the model and implications for future research. 13-14 
Other information     
Supplementary 
information 
21 D;V Provide information about the availability of supplementary resources, such as study protocol, Web 
calculator, and datasets. 
12 
Funding 22 D;V Give the source of funding and the role of the funders for the present study. 12 
TRIPOD: Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis. 
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